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Bacterial infections are a serious problem for patients with burns and other wounds. 
Such burn wound infection accounts for the pathogenic bacteria by colonising onto 
burned areas. Therefore, the need for detection and inhibition of such bacterial 
colonisation requires a methodology for sensing/killing pathogenic bacteria.    
This research project aims to design a ‗smart‘ wound dressing system which can respond 
to the microbiological environment of the wound via a simple colour change and will 
release antimicrobials only when required. Two strains of pathogenic bacteria 
Staphylococcus aureus (MSSA 476) and Pseudomonas aeruginosa (PAO1) were used in 
the study. The non-pathogenic bacterium E.coli (DH5α) was used as a control organism 
as it does not secrete virulence factors and therefore does not lyse membranes of vesicles. 
The key contributions of this thesis are outlined below.   
Firstly, an initial responsive nanocapsule system was studied. The fundamental work 
with giant unilamellar vesicles proved such a responsive system can provide 
antimicrobial properties when antimicrobial agents were encapsulated within the 
vesicles.  
Secondly, partially polymerised vesicles—polydiacetylene/phospholipid vesicles were 
then developed to improve vesicle stability. The vesicle system was optimised by 
varying molar concentration of diacetylene monomers (TCDA) in order to obtain 
relatively stable vesicles as well as sensitivity to the toxins secreted by the pathogenic 
strains. Measurements proved that the polydiacetylene/phospholipid vesicles can 
respond to pathogenic bacteria when fluorescent dye/antimcirobials were encapsulated 
in the vesicles.  
Finally, a simple prototype dressing was constructed. Plasma polymerised maleic 
anhydride (pp-MA) deposited onto non-woven polypropylene was shown to be a good 
method to stabilise vesicles via covalent bonding. Vesicle adhered to pp-MA non-woven 
polypropylene showed the ability to inhibit/kill the pathogenic strains, quantified by the 
Japanese Industry Standard assay and also gave a fluorimetric colour response in the 
presence of pathogenic bacteria when a fluorescent dye is encapsulated within vesicles. 
Other simple prototypes were also attempted by using hydrogels (gelatine and collagen) 





                     ―I am digging my way to something, 
                         To something better‖ 
- James Hetfield - 
 
Studying abroad for PhD degree is certainly never easy at the beginning and especially 
in a country with different culture and language. Now, looking back from the end of this 
journey, I am surprised to find that what I have gained is not just professional knowledge 
but also a wonderful adventure in my life. By this time, I would like to acknowledge the 
contributions of the following groups and individuals to the development of this thesis.  
 
First of all, I would like to give my sincere thanks to my supervisor Dr. Toby Jenkins for 
his kind guidance over the course of my research. Especially, he directed me to a wide 
range of new avenues such as plasma and answered all of my questions as well as asked 
me questions that helped me to narrow my research. Without him, I will not make such 
good progress so fast.  
 
Secondly, I am indebted to many people for their contributions into my current project 
work. I am thankful to Dr. Xavier Muñoz-Berbel and Dr. Geraldine Mulley for their kind 
guidance about microbiology. Although they have left our group, without them, I will 
not make such good progress so fast. I also would like to thank my colleagues in 
Jenkins‘ group: Dr. Neil Poulter, Dr. June June D. Mercer-Chalmers, Dr. Thet Naing Tun, 
Andrew Loftus, Charlotte James, Maisem Laabei, David Jamieson, Sung-ha Hong, 
Jessica Bean, Serena Marshall, and all the other members of EMBEK project.  
Thirdly, I would like to thank all of my dear friends for their help and support, who 
constitute my memorable experience in UK.  
 




Last, but most importantly, I would like to give my deepest thanks to my parents, 
Lizhong Zhou, Xinlian Xia and Xiaojun Wen, it was their boundless love and supports 
































Table of Contents 
 
Abstract ............................................................................................................................ iii 
Acknowledgements ........................................................................................................... iv 
Table of Contents .............................................................................................................. vi 
List of figures ................................................................................................................... xii 
List of tables .................................................................................................................... xvi 
Acronyms and Abbreviations ......................................................................................... xvii 
List of Symbols ............................................................................................................... xxi 
 
Chapter 1   Introduction .................................................................................................. 1 
1.1  Burn Wound Infection ........................................................................................ 1 
1.1.1  Burn Injuries of Paediatrics ..................................................................... 1 
1.1.2  Classification of Burn Wound Infection .................................................. 2 
1.1.3  Clinical Management of Burn Wound Infection ...................................... 3 
1.2  Bacteria .............................................................................................................. 5 
1.2.1  Classification of Bacteria ......................................................................... 6 
1.2.2  Bacterial Cell Wall Structure ................................................................... 7 
1.2.3  Pathogenic Bacteria ................................................................................. 8 
1.2.4  Pathogenic Toxins .................................................................................... 9 
1.2.4.1  Endotoxins ................................................................................... 10 
1.2.4.2  Exotoxins ..................................................................................... 11 
1.2.4.3  Pore Forming Toxins (PFTs) ........................................................ 12 
1.2.4.4  Exoenzymes ................................................................................. 13 
1.2.4.5  Superantigens ............................................................................... 13 
1.2.5  Mode of Action of Bacterial Toxins ....................................................... 14 
1.2.5.1  Transmembrane Pore Formation .................................................. 14 
1.2.5.2  Lipid Damaging ........................................................................... 16 
1.2.5.3  Inhibition of Protein Synthesis..................................................... 18 
1.2.5.4  Activation of Secondary Messenger Pathways ............................ 19 
1.2.5.5  Inhibition of the Release of Neurotransmitters ............................ 20 
1.2.6  Biofilms.................................................................................................. 20 
1.2.6.1  Biofilm Formation ....................................................................... 20 
1.2.6.2  Antimicrobial Resistance of Biofilms .......................................... 22 
1.2.6.3  Biofilm Related Infectious Diseases ............................................ 23 
1.3  Pathogenesis of Burn Wound Infection ........................................................... 23 
1.4  Antimicrobial Agents Used for the Treatment of Burn Wound Infection ........ 26 
1.4.1  Introduction to Antimirobials ................................................................. 26 
1.4.2  Topical Antimicrobial Agents ................................................................ 27 
1.4.2.1  Silver Products ............................................................................. 27 
1.4.2.2  Mafenide Acetate ......................................................................... 28 
1.4.2.3  Nitrofurazone ............................................................................... 29 
1.4.2.4  Povidone-Iodine ........................................................................... 29 
vii 
 
1.4.2.5  Gentamicin Sulfate....................................................................... 29 
1.4.2.6  Silver Nitrate Solution (0.5%) ..................................................... 30 
1.4.2.7  Chlorhexidine ............................................................................... 31 
1.5  Biomembranes ................................................................................................. 31 
1.5 .1  Basics of Lipid and Cell Membrane Structures .................................... 31 
1.5.1.1  Glycerophospholipids .................................................................. 32 
1.5.1.2  Membrane Fluidity....................................................................... 34 
1.5.1.3  Cholesterol ................................................................................... 35 
1.5.2  Description of the Background for Lipid Vesicles ................................. 35 
1.5.3  Introduction to Polydiacetylene Vesicles ............................................... 37 
1.5.3.1  Polydiacetylene Vesicles .............................................................. 37 
1.5.3.2  Mixed Lipid/PDA Liposomes ...................................................... 39 
1.6  Application of Liposomes --- As Drug Carriers .............................................. 40 
1.6.1  Lipid Vesicles/Liposomes ...................................................................... 40 
1.6.2   Polydiacetylene Vesicles as Drug Carriers .......................................... 41 
1.7  Problem Statement & Aims ............................................................................. 42 
1.8  References ........................................................................................................ 45 
Chapter 2  Instrumentation and Theory ......................................................................... 59 
2.1  Fundamentals of Plasma Polymerisation and Surface Modification ............... 59 
2.1.1  Main Sources of Gas Discharge Plasmas ............................................... 59 
2.1.2  The Plasma Polymerisation Mechanism ................................................ 60 
2.1.3  Plasma Reactor....................................................................................... 63 
2.2  Fluorescence .................................................................................................... 64 
2.2.1  Principles of Fluorescence ..................................................................... 64 
2.2.2  Fluorescence Quenching ........................................................................ 68 
2.3  Instrumentation for Characterisation and Visualisation of Vesicles ................ 69 
2.3.1  Fourier-transform Infra-red Spectroscopy ............................................. 69 
2.3.2  Fluorescent tagging ................................................................................ 70 
2.3.2.1  Fluorescence Spectroscopy .......................................................... 70 
2.3.2.2  Fluorescence Microscopy ............................................................ 71 
2.3.3  Scanning Electron Microscopy (SEM) .................................................. 72 
2.3.4  UV-Vis Spectroscopy ............................................................................. 74 
2.4  Microbiology.................................................................................................... 74 
2.4.1  Bacteria Used in the Work ..................................................................... 75 
2.4.1.1  Pseudomonas aeruginosa ............................................................ 75 
2.4.1.2  Staphylococcus aureus ................................................................. 77 
2.4.1.3  Escherichia coli ........................................................................... 78 
2.4.2  Methodology of Detection for Bacteria ................................................. 79 
2.4.2.1  Basics of Bacterial Growth .......................................................... 79 
2.4.2.2  Colony Counting .......................................................................... 81 
2.4.2.3  Solution Turbidity ........................................................................ 82 
2.4.2.4  Optical Density-CFU Relationship of Bacteria ........................... 83 
2.4.3  Sterilisation ............................................................................................ 83 
2.4.4  Antimicrobial Evaluation Assays ........................................................... 84 
viii 
 
2.4.4.1  Solution Assays ............................................................................ 84 
2.4.4.2  Surface Assays ---JIS ................................................................... 84 
2.4.4.3  Minimum Inhibitory Concentration Assays ................................. 85 
2.5  Estimation of Minimum Encapsulation Volume .............................................. 85 
2.5.1  Structure and Organisation of Lipid Bilayer .......................................... 85 
2.5.2  GUVs ..................................................................................................... 87 
2.5.3  Polydiacetylene Vesicles ........................................................................ 88 
2.6  References: ....................................................................................................... 90 
Chapter 3   Experimental Methods ............................................................................... 95 
3.1  Material Science............................................................................................... 95 
3.1.1  Synthesis and Purification of Giant Unilamellar Vesicles ..................... 95 
3.1.1.1  Formation of GUVs ..................................................................... 95 
3.1.1.2  Purification of Giant Unilamellar Vesicles (GUVs) .................... 97 
3.1.2  Synthesis and Purification of Polydiacetylene/Phospholipid Vesicles .. 98 
3.1.2.1  Preparation of Stock Lipid Solution (SLS) .................................. 98 
3.1.2.2  Compositions of Phospholipid/PDA Vesicles .............................. 99 
3.1.2.3  Synthesis of Polydiacetylene/Phospholipid vesicles ................... 99 
3.1.2.4  Polymerisation ........................................................................... 101 
3.1.2.5  Purification of Phospholipid/PDA Vesicles ............................... 103 
3.2  Physical Science............................................................................................. 103 
3.2.1  Characterisation of Chromatic Property for Phospholipid/TCDA vesicles
.......................................................................................................................... 103 
3.2.2  Colorimetric Detection of Bacteria-Vesicle Interactions ..................... 104 
3.2.3  Carboxyfluorescein Fluorescence – Concentration Analysis .............. 104 
3.2.4  Carboxyfluorescein Photobleach Analysis .......................................... 105 
3.2.5 Stability Study of Phospholipid/PDA Vesicles–Dehydration & 
Rehydration Assay ........................................................................................... 105 
3.2.6  Sensitivity Study of Phospholipid/PDA Vesicles to Lytic Agents ....... 106 
3.2.7  Plasma Polymerisation ......................................................................... 107 
3.3  Microbiological Assays .................................................................................. 107 
3.3.1  Bacterial Culture .................................................................................. 108 
3.3.2  MIC Assays .......................................................................................... 108 
3.3.3  Antimicrobial Analysis ........................................................................ 109 
3.3.3.1  Colony Counting ........................................................................ 109 
3.3.3.2  Solution Turbidity Assay ........................................................... 110 
3.3.3.3  JIS Assays –Antimicrobial Test on Modified Surface ............... 110 
3.3.4  Fluorescence Response Assay ---Pathogenicity Assay in Suspension . 111 
3.4  Attachment of Vesicles to Treated Fabrics ..................................................... 111 
3.4.1  Pulse Plasma Polymerisation ............................................................... 112 
3.4.1.1  Pathogenicity Assay on pp-MA Treated Fabrics ........................ 112 
3.4.2  Surface Photografting of Poly (acrylic acid) on Non-woven 
Polypropylene .................................................................................................. 112 
3.4.2.1 Pathogenicity Assay on UV-Induced PAA Grafed Non-woven 
Polypropylene ........................................................................................... 113 
ix 
 
3.4.3  Gelatine ................................................................................................ 113 
3.4.4  Collagen Grafted pp-MA Non-woven Polypropylene ......................... 114 
3.4.4.1  Pathogenicity Assay on Collagen Grafted pp-MA Non-woven 
Polypropylene ........................................................................................... 114 
3.5  Visualisation of Vesicles ................................................................................ 115 
3.5.1  Visualisation of GUVs with bacteria by Using Fluorescent Microscopy
.......................................................................................................................... 115 
3.5.2  Visualisation of Phospholipid/PDA Vesicles on pp-MA Treated Fabrics 
by Scanning Electron Microscopy ................................................................... 115 
3.6  References: ..................................................................................................... 115 
Chapter 4  Giant Unilamellar Vesicles as Response System for Killing/Inhibiting 
Growth of Pathogenic Bacteria ...................................................................................... 116 
4.1  Formation and Purification of GUVs ............................................................. 117 
4.1.1  Materials .............................................................................................. 117 
4.1.1.1  DMPC ........................................................................................ 117 
4.1.1.2  DMPE ........................................................................................ 118 
4.1.1.3  Cholesterol ................................................................................. 118 
4.1.1.4  Temperature Effect on Lipid Membranes .................................. 119 
4.1.2  Mechanism of GUVs Formation .......................................................... 121 
4.1.3  Purification of GUVs ........................................................................... 122 
4.2  Surface Design – Pulsed Plasma Deposited Maleic Anhydride Thin Films as 
Supports for Vesicles ............................................................................................... 125 
4.2.1  Chemical Structural Characterisation for Plasma Polymerised Maleic 
Anhydride ........................................................................................................ 126 
4.2.2  Chemical Characterisation for Vesicles Attachment to pp-MA 
Non-woven Polypropylene .............................................................................. 127 
4.3  Antimicrobial Activity Measurement of GUVs ............................................. 128 
4.3.1  Antimicrobials Studied in this Work for killing Bacteria .................... 128 
4.3.1.1  Sodium Azide ............................................................................. 128 
4.3.1.2  Gentamicin Sulfate..................................................................... 129 
4.3.2  Pathogens Studied in This Work .......................................................... 129 
4.3.2.1  In-Vitro Haemolysis Test ............................................................ 129 
4.3.3  Determination of Bacterial Susceptibility ............................................ 130 
4.3.3.1  Minimum Inhibitory Concentration (MIC 50) ............................ 130 
4.3.3.2  Minimum Encapsulation Concentration .................................... 133 
4.3.4  Solution Assay ..................................................................................... 134 
4.3.4.1  Time Resolved Bacterial Killing by Sodium Azide Vesicles ..... 134 
4.3.4.2  Time Resolved Bacterial Killing by Gentamicin Sulfate Vesicles
................................................................................................................... 136 
4.3.5  Fabric Assay Japanse Industry Standard (JIS) ..................................... 138 
4.4  Visualisation of Vesicle Lysis by Bacteria under Fluorescence Microscopy . 140 
4.5  Conclusion ..................................................................................................... 142 
4.6  References ...................................................................................................... 145 
Chapter 5  Study of Partially Polymerised Polydiacetylene/Phospholipid Vesicles Based 
x 
 
Upon Construction of a Fluorescence Sensing System ................................................. 146 
5.1  Formation and Purification of TCDA/phospholipid Vesicles ........................ 147 
5.1.1  Materials .............................................................................................. 147 
5.1.1.1  TCDA ......................................................................................... 147 
5.1.1.2  Structure and Phase Separation .................................................. 148 
5.1.1.3  Temperature Effect of TCDA on Mixed Vesicle System ........... 149 
5.1.2  Vesicle Formation and Polymerisability .............................................. 150 
5.1.3  Purification of Phospholipid/TCDA Vesicles ...................................... 151 
5.2  Study of Colorimetric Property of Polydiacetylene/Phospholipid Vesicles ... 151 
5.2.1  UV-Vis Spectra of Vesicles Depending upon the Molar Ratios of 
Lipid-PDA........................................................................................................ 151 
5.2.2  Thermochromic Property of Phospholipid/PDA Vesicles .................... 153 
5.2.3  Colorimetric Detection of Bacteria-Vesicle Interactions ..................... 155 
5.3  Fluorescence Sensing System ........................................................................ 156 
5.3.1  Preparatory Work ................................................................................. 157 
5.3.2  Carboxyfluorescein Fluorescence – Concentration Analysis .............. 158 
5.3.3  Calculation of Fluorescence Release from Vesicles After Total Lysis . 159 
5.3.4 Carboxyfluorescein Fluorescence – Photobleach Analysis by UV 
Irradiation ......................................................................................................... 159 
5.4  Study of Vesicle Stability and Sensitivity ...................................................... 160 
5.4.1 Alpha-Haemolysin (α-HL) and Phospholipase A2 (PLA 2 ) .................... 160 
5.4.2  Stability Study ...................................................................................... 160 
5.4.3  Sensitivity Study .................................................................................. 162 
5.4.4  Summary .............................................................................................. 163 
5.5  Pathogenicity Assay in Suspension ................................................................ 164 
5.6  Conclusion ..................................................................................................... 166 
5.7  References: ..................................................................................................... 168 
Chapter 6   Construction of a Prototype for Stabilising Vesicles and Assisting Wound 
Healing ........................................................................................................................... 170 
6.1  Construction of Wound Dressing ................................................................... 170 
6.2  Pulsed Plasma Deposited Maleic Anhydride Thin Films as Supports for 
Vesicles ................................................................................................................... 172 
6.2.1  FT-IR for Surface Characterisation ...................................................... 172 
6.2.2  SEM for Analysis of Vesicle Modified Surface ................................... 173 
6.2.3  Attachment of Vesicles to Fabric and Stability /Response Testing ...... 175 
6.3  Graft Polymerisation of Poly(acrylic acid) onto Non-woven Polypropylene 178 
6.4  A Simple Prototype Construction .................................................................. 183 
6.4.1  Gelatine as Supports for Stabilising Vesicles ....................................... 183 
6.4.2  Plasma Polymerised Maleic Anhydride Deposited onto Non-woven 
Polypropylene and Following Subsequent Grafting of Collagen onto Polymer 
Films ................................................................................................................ 185 
6.4.2.1 Stability Study of Collagen Grafted pp-MA Non-woven 
Polypropylene ........................................................................................... 185 
6.4.2.2  Pathogenicity Assay on Collagen Grafted pp-MA Non-woven 
xi 
 
Polypropylene ........................................................................................... 188 
6.5  Conclusion ..................................................................................................... 189 
6.6  References ...................................................................................................... 191 
Chapter 7  Development of Antimicrobial Property for Phospholipid/PDA Vesicles . 192 
7.1  Silver Nitrate .................................................................................................. 192 
7.1.1  Determination of Bacterial Susceptibility (MIC50) .............................. 193 
7.1.2  Minimum Encapsulation Concentration .............................................. 195 
7.1.3  Antimicrobial Activity of Vesicles Containing AgNO3 in Suspension 196 
7.1.4  Antimicrobial Activity on Vesicle Modified Fabrics ---JIS ................. 199 
7.2  Gentamicin Sulfate......................................................................................... 201 
7.2.1  Determination of Bacterial Susceptibility (MIC50) .............................. 202 
7.2.2  Minimum Encapsulation Concentration .............................................. 202 
7.2.3  Antimicrobial Activity of Vesicles Containing Gentamicin Sulphate in 
Suspension ....................................................................................................... 202 
7.2.4  Antimicrobial Activity on Vesicle Modified Fabrics ---JIS ................. 205 
7.3  Chlorhexidine ................................................................................................. 207 
7.3.1  Determination of Bacterial Susceptibility (MIC50) .............................. 207 
7.3.2  Minimum Encapsulation Concentration .............................................. 210 
7.3.3 Antimicrobial Activity of Vesicles Containing Chlorhexidine in 
Suspension ....................................................................................................... 210 
7.4  Conclusion ..................................................................................................... 212 
Chapter 8    Conclusions ............................................................................................ 215 
8.1  Summary of Results ....................................................................................... 215 
8.2  Future Research Areas ................................................................................... 219 
8.2.1  Stability ................................................................................................ 219 
8.2.2  Encapsulating Agents ........................................................................... 220 
8.2.3  Bacteria Related to Wound Infection ................................................... 221 
8.2.4  Prototype Construction ........................................................................ 222 
8.3  References ...................................................................................................... 224 
Appendix A  Detailed Operations of Plasma Reactor .................................................. 225 












                          
xii 
 
List of Figures 
 
Figure 1.1: A paediatric patient with partial thickness scald injury was cured by 
Biobrane. ...................................................................................................... 4 
Figure 1.2: Construction of the cell walls of Gram-negative and Gram-positive bacterial 
cell walls. ..................................................................................................... 8 
Figure 1.3: Schematic of array of membrane bound bacterial cell and secretion of 
proteins/toxins that pathogenic bacteria can deploy against healthy tissue.
.................................................................................................................... 10 
Figure 1.4: Ribbon diagram of the α-haemolysin of S. aureus. ...................................... 16 
Figure 1.5: Cleavage sites of different phospholipases (shown with red dashed line) ... 18 
Figure 1.6: Stages of biofilm formation with corresponding photomicrographs. ........... 21 
Figure 1.7: Basic construction of a typical eukaryotic cell membrane. .......................... 32 
Figure 1.8: Lipid bilayer containing hydrophilic head and hydrophobic tail. ................ 34 
Figure 1.9: Structure of liquid-crystal phase of lipid bilayer .......................................... 35 
Figure 1.10: Basic structure of lipid vesicles with hydrophilic head and hydrophobic tail.
.................................................................................................................... 36 
Figure 1.11: Schematic of polydiacetylene vesicle formation. ....................................... 38 
Figure 1.12: Diacetylene structures ................................................................................ 39 
Figure 1.13: Structure of mixed lipid/PDA vesicle. ........................................................ 40 
Figure1.14: Schematic of responsive antimicrobial system showing an immobilised 
vesicle with encapsulated antimicrobial/fluorescent dyes. ........................ 44 
Figure 2.1: Overall plasma polymerisation mechanism showing a bi-cyclic step-growth.
.................................................................................................................... 62 
Figure 2.2: Home-made plasma reactor .......................................................................... 62 
Figure 2.3: Diagram of a plasma reactor. ........................................................................ 63 
Figure 2.4: Excitation and relaxation of molecules due to absorption and emission of 
light. ........................................................................................................... 65 
Figure 2.5: Spectra of Stokes‘ shift. ................................................................................ 66 
Figure 2.6: FLUOstar Omega microplate reader ............................................................ 71 
Figure 2.7: Schematic of fluorescence microscope ....................................................... 72 
Figure 2.8: Schematic diagram of a SEM; ...................................................................... 73 
Figure 2.9: P. aeruginosa colonies on an agar plate and its micrograph in SEM. .......... 76 
Figure 2.10: Micrograph of S.aureus in SEM and wound infection caused by MRSA.. 78 
Figure 2.11: False colour SEM (× 22,000) of hemorrhagic E. coli O256:H7  .............. 79 
Figure 2.12: Foure stages of bacterial growth. ............................................................... 81 
Figure 2.13: S.aureus (MSSA 476) colonies on an agar plate grown from individual 
cells ............................................................................................................ 82 
Figure 2.14: UV-vis measurement to determine the optical density of bacterial culture 82 
Figure 2.15: Optical density of S. aureus (MSSA 476) against the number of CFU mL 
-1
.................................................................................................................... 83 
Figure 2.16: A typical lipid bilayer with several chemical regions. ............................... 86 
Figure 2.17: Simplified vesicles with estimation of inner and outer diameter. .............. 87 
xiii 
 
Figure 3.1: Details of polymerisation of polydiacetylene/phospholipid vesicle induced 
by UV irradiation and experimental setup in the A.T.A.Jenkins group. .. 102 
Figure 3.2: Representation of the positions that vesicles were placed .......................... 114 
Figure 4.1: Chemical structure of DMPC. .................................................................... 117 
Figure 4.2: Chemical structure of DMPE. .................................................................... 118 
Figure 4.3：Chemical structure of cholesterol and interaction of cholesterol and lipid 
bilayers. .................................................................................................... 119 
Figure 4.4: Diagram of the suggested mechanism of GUVs formation. ...................... 122 
Figure 4.5: Typical traces of NAP-10 column used on 5(6)-carboxyfluorescein 
containing vesicles. .................................................................................. 123 
Figure 4.6: Fluorescence intensity change of eluent using NAP-25 column. ............... 124 
Figure 4.7: Visual images of eluate from NAP-25 column. ......................................... 124 
Figure 4.8: Chain growth of a polymer growth during the pulsed off period of PPP ... 125 
Figure 4.9: Schematic diagram & simplified reaction showing GUVs attached to pp-MA 
treated non-woven polypropylene via amide bond. ................................. 126 
Figure 4.10: FT-IR spectra of pulsed plasma-polymerised maleic anhydride. ............. 127 
Figure 4.11: FTIR data for vesicles attachment onto treated non-woven polypropylene.
.................................................................................................................. 128 
Figure 4.12: Blood agar plate showing the lysis of haemoglobin around colonies of 
typical pathogenic bacteria ...................................................................... 130 
Figure 4.13: MIC50 of sodium azide and gentamicin sulfate against the three strains of 
bacteria. .................................................................................................... 132 
Figure 4.14: Reduction in the number of viable bacteria (CFU mL
-1
) following exposure 
to vesicles containing sodium azide in aqueous suspension, over a 4 h 
period. ...................................................................................................... 135 
Figure 4.15: Time-course of viable number of pathogenic and non-pathogenic bacteria 
with GUVs containing gentamicin sulfate. .............................................. 137 
Figure 4.16: JIS results of lipid vesicles (containing sodium azide) against three strains 
of bacteria................................................................................................. 140 
Figure 4.17: Fluorescence imaging of surface attached vesicles exposed to the three 
strains of bacteria. .................................................................................... 142 
Figure 5.1: Chemical structure and polymerisation of 10, 12 - tricosadiynoic acid. .... 148 
Figure 5.2: Organisation of phospholipid/TCDA vesicles and their colorimetric sensing.
.................................................................................................................. 149 
Figure 5.3: SEM image of phoshpolipid/TCDA vesicles composed of 10 mol% TCDA, 
20 mol% cholesterol, 2 mol% DMPE and 68 mol% DMPC. .................. 150 
Figure 5.4: Colorimetric properties of phospholipid/TCDA vesicles after UV irradiation.
.................................................................................................................. 152 
Figure 5.5: The transition of backbone structures of polydiacetylene from planar to 
nonplanar.................................................................................................. 153 
Figure 5.6: Graph of colorimetric response (CR) calculated from the visible absorption 
spectra of DMPC/DMPE/ 40 mol % TCDA and 
DMPC/DMPE/Cholesterol/40 mol % TCDA as a function of the solution 
temperature. ............................................................................................. 155 
xiv 
 
Figure 5.7: UV-Vis absorption spectra showing colour transitions of vesicles 
(DMPC/DMPE/Cholesterol/ 40 mol % TCDA) induced by three strains of 
bacteria. .................................................................................................... 156 
Figure 5.8:  Chemical structure of 5(6)-carboxyfluorescein and images of the system in 
its pre-lysis (on left of frame) and post lysis (on right of frame) forms by 
Triton. ....................................................................................................... 157 
Figure 5.9: Graph showing self-quenching behaviour depending upon varying 
concentrations. ......................................................................................... 158 
Figure 5.10: Graph showing study of vesicle stability ................................................. 161 
Figure 5.11: Graphs of vesicle sensitivity to lytic agents. ............................................ 163 
Figure 5.12: Time course of the kinetics of the interaction of bacteria with 
phospholipid/TCDA vesicles. .................................................................. 165 
Figure 5.13: Similar graphs showing fluorescence release from vesicles (30 mol % 
TCDA/lipid vesicles) as bacteria grow in different media. ..................... 166 
Figure 6.1: Schematic representation of the hydrogel-vesicle modified fabric-hydrogel 
construction. ............................................................................................. 171 
Figure 6.2: FT-IR data showing vesicles attachment onto treated non-woven 
polypropylene. ......................................................................................... 173 
Figure 6.3: SEM images, recorded with JEM-6480LV scanning electron microscope 174 
Figure 6.4: SEM images of vesicles on non-woven polypropylene deposited with 
plasma polymerised maleic anhydride, recorded with JEM-6480LV 
scanning electron microscope. ................................................................. 175 
Figure 6.5: Polypropylene modified with vesicles containing initially self-quenched 
carboxyfluorescein (left-hand swatch) and switching on of fluorescence of 
dye following either vesicle destruction following part drying or direct 
lysis by Triton, as a function of mol % TCDA ........................................ 176 
Figure 6.6: Fluorescent images of vesicles in 96-well plate. ........................................ 177 
Figure 6.7: A crude ‗proof of principle‘ prototype: response of modified fabric 
following overnight growth of bacteria on polypropylene fabric with 30 
mol% TCDA vesicles. .............................................................................. 178 
Figure 6.8: Schematic representation of UV-induced graft polymerisation of poly 
(acrylic acid) on non-woven polypropylene. ........................................... 180 
Figure 6.9: Images of photo-grafting polymerisation of PAA on non-woven 
polypropylene in the central area with a diameter of 1 cm and fluorescence 
response induced by toxins secreted by pathogenic bacteria (PAO1 and 
MSSA 476) after 4h and overnight. ......................................................... 182 
Figure 6.10: Schematic of simple prototype in single vial of 96-well plate, 
phospholipid/PDA vesicles (30 mol% TCDA) containing self-quenched 
carboxyfluorescein sandwiched between two hydrolysed gelatine sheets.
.................................................................................................................. 184 
Figure 6.11: Graph showing stability test of phospholipids/PDA vesicles (30 mol% 
TCDA) in gelatine sheets for 25 days and significant fluorescence increase 
after lysis by Triton. ................................................................................. 185 
Figure 6.12: Schematic diagram of prototype construction: pp-MA modified non-woven 
xv 
 
polypropylene was dip coated in collagen solution, with vesicles 
containing self-quenched carboxyfluorescein following attached onto 
collagen grafted pp-MA surface............................................................... 186 
Figure 6.13: Graph showing stability test of phospholipids/PDA vesicles (30 mol% 
TCDA) sandwiched in collagen grafted pp-MA non-woven polypropylene 
for 25 days and significant fluorescence increase after lysis by Triton. .. 187 
Figure 6.14: Graph showing stability test of phospholipids/PDA vesicles sandwiched in 
collagen grafted pp-MA non-woven polypropylene at 37 
o
C and 
fluorescence increase after lysis by Triton. .............................................. 188 
Figure 6.15: Simple prototype dressings: fluorescence response of modified fabric 
following overnight growth of bacteria on polypropylene fabric with 30 
mol % TCDA vesicles. ............................................................................. 189 
Figure 7.1: MIC50 of silver nitrate to the three strains of bacteria. The shapes of 
bacterial optical density-antimicrobials graphs give a clue that at which 
concentration of bacteria starts to respond to AgNO3 and at which 
concentration of bacteria would be completely inhibited by the 
antimicrobial. Error bars represent standard deviations based on three 
measurements of each sample. ................................................................. 194 
Figure 7.2:  Time course of viable numbers of pathogenic and non-pathogenic bacteria 
incubated with phospholipid/PDA vesicles containing AgNO3. .............. 198 
Figure 7.3: JIS result of TCDA vesicle (containing AgNO3) bound to pp-MA nonwoven 
polypropylene against three strains of bacteria. ....................................... 201 
Figure 7.4:  Time course of viable numbers of pathogenic and non-pathogenic bacteria 
incubated with phospholipid/PDA vesicles containing gentamicin sulphate.
.................................................................................................................. 205 
Figure 7.5: MIC results of TCDA vesicle (containing gentamicin sulphate) bound to 
pp-MA nonwoven polypropylene against three strains of bacteria. ........ 206 
Figure 7.6: MIC50 of chlorhexidine versus the three strains of bacteria. Error bars 
represent standard deviations based on three measurements of each 
experiment................................................................................................ 209 
Figure 7.7: Overnight growth of pathogenic and non-pathogenic bacteria incubated with 
phospholipid/PDA vesicles containing chlorhexidine. ............................ 211 
Figure 8.1: Bilayer arrangements before/after UV irradiation in phospholipid/TCDA 
vesicles. .................................................................................................... 220 











List of Tables 
 
Table 1.1: Lists of microorganisms responsible for causing burn wound infection 
a
 ..... 24 
Table 1.2: Classes of antimicrobials and their mechanisms of action to the host 
137
 ...... 26 
Table 3.1: Encapsulated agents used in this work and the concentration prepared in 
different buffer systems ............................................................................... 96 
Table 3.2: Eluent buffer systems for different encapsulating compounds ...................... 97 
Table 3.3: Description of two types of columns used in the purification of vesicles 
including the parameters for sample and eluent volumes ............................ 98 
Table 3.4: Vesicle stock solutions ................................................................................... 99 
Table 3.5: Constituents of 20,30,40,50,60 mol % TCDA vesicles .................................. 99 
Table 3.6: Compositions of aqueous bulk solution for encapsulation, solvent is distilled 
water ............................................................................................................. 99 
Table 3.7: Composition of aqueous bulk solution system for 5(6)-carboxyfluorescein 
(50mM) in 50mL........................................................................................ 100 
Table 3.8: Eluent buffer (pH 7.4) for 50mM 5(6)-carboxyfluorescein (50 mL) ........... 103 
Table 3.9: HEPES buffer system for 95mM carboxyfluorescein .................................. 104 
Table 3.10: List of lytic agents for their ability to lyse vesicle membrane and hence 
release the contents .................................................................................... 106 
Table 4.1: Phase transition temperature with different tail length and number of double 
bonds
2
. ........................................................................................................ 120 
Table 4.2: Range finding test of NaN3 against three strains of bacteria (where ‗+‘ is 
positive growth and ‗-‘ indicates no growth.) ............................................ 131 
Table 4.3: Range finding test of gentamicin sulphate against three strains of bacteria 
(where ‗+‘ is positive growth and ‗-‘ indicates no growth) ........................ 131 
Table 4.4: MICs determined for sodium azide and gentamicin sulfate versus three 
strains of bacteria ....................................................................................... 133 
Table 5.1: Fluorescence intensity of three difference concentrations of 
5(6)-carboxyfluorescein before and after irradiation; hard UV was used to 
irradiate for 5 minutes. ............................................................................... 160 
Table 7.1: Range finding test of AgNO3 against three strains of bacteria (where ‗+‘ is 
positive growth and ‗-‘ indicated no growth) ............................................. 193 
Table 7.2: Summary of MIC50 of AgNO3 versus three bacterial strains ....................... 194 
Table 7.3: Summary of MIC50 of gentamicin sulphate versus three bacterial strains ... 202 
Table 7.4: Range finding results for chlorhexidine agains three strains of bacteria (where 
‗+‘ is positive growth and ‗-‘ indicated no growth) ................................... 208 














































Cholesterol binding toxins 
C. perfringens enterotoxins 
Clostridium perfringens 
Cytotoxic necrotizing factors 
Cyclic adenosine monophosphate 
Central nervous system (CNS) 
Continuous wave 










Escherichia coli DH5α 
Elongation factor-2 
Pseudomonas exotoxin A 
Endoplasmic reticulum 








































Fourier-transform infra-red spectroscopy 
Guanine nucleotide-binding proteins 








Large unilamellar vesicles 
Lysogeny broth 
Methicillin resistant Staphylococcus aureus 
Major histocompatibility molecules 
Multilamellar vesicles 
Multi-drug resistant organisms 
Nicotinamide adenine dinucleotide 
Optical density 
Pseudomonas aeruginosa 
Pseudomonas aeruginosa PAO1 
Pore forming toxins 
Phospholipases 
α-Pore forming toxins 
β-Pore forming toxins 

















































Pulse plasma polymerisation  
Poly acrylic acid 
Phosphorescence 
Phosphate saline buffer 
Quaternary ammonium cations (QCAs) 
Receptor-mediated endocytosis 












Small unilamellar vesicles 
Scanning electron microscopy 
Stock lipid solution 
Triplet state 
Lowest triplet state 
Tris(hydroxymethyl)aminomethane 
Toxic shock syndrome 
Toxic shock syndrome exotoxin-1 
Tryptic soya broth 
Ribonucleic acid 
Transfer ribonucleic acid 
10, 12- tricosadiynoic acid 




















































































































molar absorptivity or extinction coefficient 
fluorescence intensity of unquenched fluorophore  
fluorescence intensity of quenched fluorophore  
intensity of incident light 
transmitted intensity 
rate constant  
rate of fluorescence 
rate of quenching 
rate of energy transfer 
rate of intersystem crossing 
rate of internal conversion 
Stern-Volmer quenching constant 
bimolecular quenching constant 
association constant for the fluorophore-quencher 
complex 
length of light path through the sample 
start pressure 
final pressure 
value of control sample 
value of the vesicle solution after colour change 









































































Chapter 1   Introduction 
 
Burns are one of the most common and devastating forms of trauma. Patients with 
thermal injury require immediate care to minimise morbidity and mortality. Once burn 
injury occurs, bacteria rapidly colonise open skin wounds. Specialized antimicrobials 
and wound dressings are needed for the treatment of burn wounds. The work described 
in this thesis aims to create an advanced wound dressing technology which can detect 
and respond to the presence of pathogenic bacteria and release antimicrobials only when 
required. Such a responsive system is based on the use of phospholipid and partially 
polymerised vesicles which provide the cell membrane mimic. This introductory chapter 
covers the background and literature review of related knowledge and, further, addresses 
the open research challenges that have constituted the key motivations for the present 
Ph.D. work.  
 
1.1  Burn Wound Infection  
1.1.1  Burn Injuries of Paediatrics  
Burns have been recognised as the most painful and devastating injuries. Burn injuries 
range from the most severe requiring high levels of intensive care and multiple surgeries, 
to the most trivial, for which self-treatment may be sufficient. Almost all of us will 
experience a burn injury in our lifetime.  
 
Children under age 4 are at particular risk of infection, with an injury death rate more 
than two times that of children aged 5 to 14.
1-2
 This is because children, especially those 
who aged 4 and under, may not perceive danger, have less control of their environment, 
may lack the ability to escape a life-threatening burn situation and may not be able to 
tolerate the physical stress of a burn injury. One of the most severe infections after burn 
injury in children with a high mortality is Toxic Shock Syndrome (TSS).
3
 TSS is caused 
by exotoxins commonly produced by Staphylococcus aureus. The exotoxin responsible 
for causing TSS is TSS toxin-1 (TSST-1). Children of age less than 4 normally have low 
2 
 
levels of anti-TSST-1 antibodies, which will render them more susceptible to bacterial 
infection. Therefore, children of this age range are more susceptible to a scald injury.
3
 
1.1.2  Classification of Burn Wound Infection 
The majority of burn injuries only affect the epidermis such as sun burn. However, burns 
can be much more serious and can result in death. Burn wound infections were 
previously classified by changes in the burn wound and eschar appearance, time of 
occurrence, and associated mortality into distinct conditions, including impetigo, 
cellulitis, and invasive infection.
4
 The old classification system has now been replaced 




A first-degree burn is considered a superficial wound which does not blister and only 
affects the outer surface of the skin (epidermis). To manage a first-degree burn or even a 
minor second-degree burn, the wound is kept moist to reduce topical discomfort and 
pruritus.  
 
Second-degree burns are partial-thickness burns which can be characterised as 
superficial or deep. The epidermis is the primarily involved element in superficial 
partial-thickness burns. Normally, blisters form and the overlying skin sloughs. Healing 
usually occurs in about 14 days. In comparison, a deep partial-thickness burn may have 
a dark red or white base, because the wound injures the dermis and associated nerve 
structures. The healing time will take longer than 14 days. Surgery may be required to 
secondarily treat hypertrophic scarring and late sequelae.  
 
Burns which result in total destruction of both layers of the skin are termed third-degree 
burns or full-thickness burns. Because the skin and the surrounding tissues are destroyed, 
the healing process is slower than in more superficial burn injuries. Third degree burns 
which cover smaller areas are treated in a similar way as partial thickness burns with 






1.1.3  Clinical Management of Burn Wound Infection 
Restoration of a wound after injury is a natural phenomenon, and the resulting wound is 
the source of complication, and the patient remains at risk unless it is healed. Clinical 
management aims to close a burn wound infected by pathogens as soon as possible and 
minimise the chance of complication once burn wound infection occurs. Bacteria are 
able to infect and colonise open layers of dermis and proliferate with the loss of  skin 
barrier. Toxic factors will then be secreted by pathogenic bacteria which cause tissue 
damage and deeper penetration of the tissue once bacteria have colonised on the wound. 
In addition, bacterial attachment and colonisation are able to form complex communities 
(biofilms) with altered phenotypes resulting in increased resistance to antimicrobial 
agents and the host‘s immune systems. This tissue damage will prevent the wound from 
healing properly and even cause other complications such as toxic shock syndrome (TSS) 
which would give rise to the biggest challenge to wound-care product researchers. Also 
there are many factors which affect wound healing, such as infections, quality of healing, 
speed of healing, fluid loss and other complications. All of these detailed above would 




Clinical management for burn wound infection is dependent on the degree of infection. 
Established treatment for deep partial and full thickness burns involves early excision of 
necrotized tissue, skin grafting and dressing. This closes the wound immediately and 
prevents bacterial inoculation and bacteria which are present in the wound area before 
grafting may form biofilms and prevent the graft adhering. Antimicrobial dressings are 
also necessary in the treatment of full thickness and deep partial thickness injuries to 





 have been widely used in the treatment of superficial and partial burn 
injury. Currently, various biological, biosynthetic and synthetic wound dressings are 
used in burn care. Selection and use of these products depends on the condition of the 
wound bed, the inherent properties of the dressing and the goals of therapy.
8
 Various 
considerations should be taken into account 
9
 when selecting an ideal wound dressing, 
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for example, protecting the wound from physical damage and micro-organisms, being 
comfortable, compliant and durable, non-toxic, non-adherent, and non-irritant, allowing 
gaseous exchange and high humidity at the wound, being compatible with topical 
therapeutic agents, being able to allow maximum activity for the wound to heal without 
retarding or inhibiting any stage of the process. 
 
Biological dressings are designed to promote epitheliation and have improved healing in 
partial thickness scalds in children which result in the shorter lengths of stay and a 
reduced need for skin grafting.
3
 Biobrane is currently most commonly used for the 
treatment of superficial burn injuries. Biobrane consists of a silicone layer and nylon 
fabric which has collagen bonded to it. Collagen, which is a naturally occurring protein 
in anmimals and is a main component in connective tissues, is often used in food and 
medical applications such as burns surgery and cosmetic surgery. It often put on a burn 
wound site and sticks to the wound and stays there until the wound is healed. This 
provides an ideal environment for promoting tissue healing. Figure 1.1 shows before and 
after medical photography of a paediatric patient who presented with partial thickness 
burns and was treated with biobrane.   
                
Figure 1.1: A paediatric patient with partial thickness scald injury was cured by Biobrane.  
Left: the patient with scald injury was treated with biobrane; right: the patient made a full recovery with 
no scarring after treatment (Frenchay hospital). 
 
However, dressings designed to encourage cell growth also assist microbial growth. 
Dressings such as Acticoat 
TM





a more controlled and prolonged release of nanocrystalline silver to the wound area. 
This mode of silver delivery allows the dressings to be changed with less frequency to 
reduce risk of nosocomial infection, cost of care, further tissue damage and patient 
discomfort.
10-11
 Although silver products have been recognised as useful antibacterial 
agents for burn wound treatment, recent findings indicate that the compounds might 
delay the wound-healing process
12
 and that silver may have serious cytotoxic activity on 
various host cells.
13 
Furthermore, silver-containing dressings allow microorganisms on 
the wound to be continually exposed to a silver-containing environment, which would 
increase the rate of bacteria evolving resistance.
13
 Therefore, there is a need to develop a 
‗smart‘ wound dressing which can respond to the microbiological environment of the 
wound and give a color response in the presence of pathogenic bacteria and which will 
release an antimicrobial to kill/inhibit the growth of pathogenic bacteria only when 
required.   
 
1.2  Bacteria  
Bacteria comprise a large group of single celled prokaryotes with a variety of sizes in the 
range of a few microns (10
-4
 – 10-7 meters). Bacteria have neither a membrane-enclosed 
nucleus nor membrane-enclosed organelles like mitochondria and chloroplasts.  
 
Bacteria are ubiquitous on earth and grow in soil, rock, water, and in organic matter and 
live bodies of plants and animals. There are approximately 40 million bacterial cells in 
every gram of soil and millilitre of water. It has been estimated that there are 
approximately 5×10
23 
bacterial cells in the entire planet.
14
 The numbers of prokaryotic 
cells are approximately more than ten times than human eukaryotes on the planet. 
Eukaryotes with a size range of 10
-3
 – 10 -5 meters are around two orders of magnitude 
than prokaryotes (10
-4
 – 10-7 meters).15  Bacteria are extremely adaptable and have 
adapted over billions of years to survive in extremely unlikely conditions including 
radioactive waste, volcanic springs and even the surface of the moon. Bacteria can 
colonise objects and remain dormant. However, they can change very much viable when 
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that environment changes to be more accommodating. When it comes to surgical and 
dental equipment, this may be colonised prior to use and once the bacteria are supplied 
with a constant supply of warmth and nutrients, the dormant bacteria grow and some 
pathogenic bacteria may cause an infection which is life threatening. 
 
1.2.1  Classification of Bacteria  
Most bacteria are collected, identified and grouped based on their sizes and shapes, 
requirement of oxygen for respiration, role of temperature for their growth, intake of 
nutrients for their survival and by gram staining of bacterial cell wall. Therefore, correct 
identification of bacteria is important for precise diagnosis and effective treatment in 
case of diseases due to bacterial infection.  
 
Based on cellular morphology, bacteria display a range of shapes. Most bacteria are 
either spherical (coccus), or rod-shaped (bacillus). Some rod-shaped bacteria can be 
further divided by different variants. Some rod-shaped bacteria are slightly curved or 
comma-shaped (vibro); others can be spiral-shaped (spirillum) or tightly coiled 
(spirochaetes) and some other less common forms for example, tetrahedral or cuboidal 
shapes.
16-17
 This wide range of variety is controlled by the bacterial cell wall and 
cytoskeleton and is important as it can influence the ability of bacteria to acquire 
nutrients, attach to surfaces, swim through liquids and escape predators.
18-19
 Bacterial 
cells naturally aggregate on surfaces and this gives another classification and 
identification. When cellular division occurs along a single axis and the bacteria grow in 
chains or pairs, these bacteria are called Streptococci, the shape of which are like a chain 
or twisted chain, while Staphylococci forms grapelike clusters. Staphylococcus aureus 
which are gram negative bacteria is clinically important. 
 
Most bacteria are classified as gram-positive and gram-negative in the laboratory. The 
classification relies on the positive or negative results from Gram‘s staining method 
which uses a purple dye and iodine. The staining method was developed by Hans 
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Christian Gram in 1884 to characterise bacteria based on the structure of their cell 
wall.
20
 Both gram-positive and gram-negative bacteria have a cell wall made up of 
peptidoglycan and a phospholipid bilayer with membrane-spanning proteins. The thick 
layers of peptidoglycan in the ―gram-positive‖ cell wall stain purple, while 
―gram-negative‖ bacteria have a unique outer membrane with a thinner layer of 
peptidoglycan, and a periplasmic space between the cell wall and the membrane and the 
cell wall appears pink. In the outer membrane, gram-negative bacteria have 
lipopolysaccharides (LPS), porin channels, and murein lipoprotein, all of which 
gram-positive bacteria lack.  Many species of gram-negative bacteria are pathogenic, 
meaning that they can cause disease in a host organism. This pathogenic capability is 
usually associated with certain components of ―gram-negative‖ cell walls, in particular 
the lipopolysaccharide (also known as LPS or endotoxin) layer which blocks antibiotics, 
dyes, and detergents protecting the sensitive inner membrane and cell wall.
21 
 
1.2.2  Bacterial Cell Wall Structure   
The cell walls of gram-positive bacteria are made up of many layers of peptidoglycan 
and teichoic acids, whilst gram-negative bacteria have relatively thin cell walls 
containing a few layers of peptidoglycan. Peptidoglycan in gram-negative bacteria is 
surrounded by a second lipid membrane containing lipopolysacharides and lipoproteins. 
The thick outer layer of peptidoglycan, teichoic acid, polysaccharides, and other proteins 
has many purposes including cell expansion, shape formation and membrane transport 
regulation.
22
 Figure 1.2 shows the structures of cell walls of ―gram-negative‖ and 
―gram-positive‖ bacteria. The difference in structures of cell walls results in the differing 
susceptibilities to antibiotics, e.g. vancomycin was used to fight against gram-positive 








   
Figure 1.2: Construction of the cell walls of Gram-negative and Gram-positive bacterial cell walls.
24 
 
1.2.3  Pathogenic Bacteria  
There are ten times more bacteria inhabiting the human flora than the total number of 
human cells.
25
 Most of bacteria in the body are harmless due to the protection afforded by 
the immune system. These bacteria are known as commensal or ―good‖ bacteria, because 
they perform some vital and useful functions in the human body, for example, 
Escherichia coli are found in the gut and play an important role in maintaining efficient 
digestion.
26 
However, some species of bacteria are pathogenic and are capable of causing 
infectious diseases, including cholera, syphilis, anthrax, leprosy and bubonic plague. The 
pathogenic bacteria can be divided into two groups---opportunistic pathogens and 
primary pathogens. Opportunistic pathogens do not normally cause disease as the host 
immune system will prevent this from happening, but will if a patient has a compromised 
immune system, bacteria which are part of the natural flora e.g. E. coli are allowed to 
multiply and cause disease and therefore are considered opportunistic. The pathogens that 
are able to cause infection and disease in healthy individuals are recognised as primary 
pathogens.
27
 Humans are most interested in the species of pathogenic bacteria which 
affect humans although humans and animals share a common susceptibility to certain 
pathogens. Pathogenic bacteria including Streptococcus, Staphylococcus, Tuberculosis 
and Escherichia coli are most studied by researchers, because these bacteria account for 
many illnesses and disease epidemics. 
Gram-negative  Gram-positive  
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Infection during hospital infection, known as nosocomial infection, is a global concern
28
 
and has become far more dangerous with the emergence of antibiotic resistant strains of 
many pathogens, with the most notable being methicillin resistant Staphylococcus 
aureus (MRSA).
29-30  
It is reported that at least half of all cases of nosocomial infections 
are associated with medical devices.
31 
The medical consequences of device-related 
infections can be disastrous; they include potentially life-threatening systemic infections 
and device malfunction that may require device removal, often complicated by tissue 
destruction. As described bacteria can colonise many items prior to use and then 
inoculate a patient with the bacteria. Inoculation can also occur from a patient‘s skin or 
orifice during procedures, for example, nasogastric intubation may transfer bacteria 
occupying nasal cavity further into the patient which will allow colonisation of the 
mucosal membrane. Urinary catheters may also transfer bacteria from a patient‘s skin 
and allow migration from the urethral fissure toward the bladder causing consequent 
infections.
30
 Sterilised surfaces may also be colonised by bacteria. When the nutrition 
requisite for cell proliferation is not present, the bacteria can depress metabolism and 
await inoculation to a host. This causes a biotransfer threat and generally occurs in 
hospitals (MRSA) and in the food industry (Salmonella enterica, Escherichia coli).
32
 
Urinary tract infection resulting from catheterization accounts for over 40% of all 
nosocomial infections. Removal and replacement of soiled catheters generally requires a 
further invasive procedure and expense.
33
 P. aeruginosa (PAO1), S. aureus (MSSA 476) 
as pathogenic bacteria are used in this work and E. coli (DH5α) as a control system, 
hence the three species of bacteria will be presented in the thesis in chapter 2. 
1.2.4  Pathogenic Toxins  
It is known that pathogenic bacteria secrete an array of virulence factors such as lipases 
and toxins which cause local tissue breakdown, by damaging cell walls. This is 
illustrated in figure 1.3. Pathogenic bacteria cause harm to their eukaryotic hosts by 
secreting enzymes and toxins that damage cells and connective matrix material of the 
tissues. They include adhesins that allow them to attach to tissues and enzymes that 
degrade tissue matrix proteins and allow deep tissue penetration such as hyaluronidase 
10 
 
or lipase. Other virulence factors such as leukocidin, leukotoxin and staphylysin act as 
cytotoxins, directly killing host cells allowing further tissue invasion and suppressing 
their own immune destruction. Proteins such as coagulase and protein A further act to 
suppress the host immune system. It should be noted that the secretion of virulence 
factors can essentially alter the properties of the host environment which is common to 
all pathogenic bacteria.
 
Knowledge of the enzymes and toxins secreted by specific 
pathogens and their mode of attachment onto eukaryotic cells provides an opportunity 
for detecting the presence of pathogens. For example, the lysis of red blood cells around 
bacterial colonies on agar plates has long been used as a clinical microbiology 
diagnostic for the detection of certain common human infections (such as Streptococcus 











Figure 1.3: Schematic of array of membrane bound bacterial cell and secretion of proteins/toxins that 
pathogenic bacteria can deploy against healthy tissue.  
 
 
1.2.4.1  Endotoxins  
Endotoxins are a component of the outer membrane of the cell wall of gram-negative 
bacteria. They are associated with gram-negative bacteria whether the bacteria are 
pathogenic or non-pathogenic.
34
 Endotoxins mainly refer to lipopolysaccharide (LPS) 
which is a part of outer membrane of gram negative bacteria such as Escherichia coli, 
Salmonella, Shigella etc. The typical molecular weight of LPS is about 10 kDa but can 
be up to 1000 kDa because they can form into aggregates. The role of endotoxins in the 
11 
 
outer membrane of bacteria is to act as a permeability barrier preventing large molecules 
and hydrophobic compounds from external environment. It also acts as a barrier to 
lysozyme and many antimicrobial agents. In addition, endotoxins may play a role as 
adhesins when they it colonise on the host. LPS consists of lipid A and a polysaccharide 
chain. Lipid A is responsible for causing toxic effect on host and polysaccharide is 
responsible for immunogenicity. Both lipid A and the polysaccharide side chains which 
are nontoxic but immunogenic portion of LPS are determinants of virulence in 
gram-negative bacteria.
35 
 LPS is responsible for a large number of clinical infections 
and even at low concentrations, LPS can cause extreme immune responses such as 
activation of inflammation and coagulation by the host.
36
 Therefore, such immune 
reaction during the infection by gram-negative bacteria may cause toxic shock syndrome 




1.2.4.2  Exotoxins  
Exotoxins are usually secreted by bacteria. They are released in soluble monomeric 
forms and act at a site away from bacterial growth. They can also be released by lysis of 
the bacterial cell. Exotoxins are usually proteins and rarely polypeptides. Proteins 
contain one or more polypeptides folded in a biologically functional way such as 
globular or fibrous form. Exotoxins can act enzymatically or through direct action with 
host cells and stimulate a variety of host responses.
38
 Their actions against hosts are 
different depending upon the individual exotoxin. Some act as adhesins to colonise the 
host, while others act as invasins. Exotoxins are known to cause physiological and 
pathological damage to the host cells. Physiological damage refers to impairing 
particular functions of the host but without killing any cells e.g. cholera enterotoxin (Ctx) 
of Vibrio cholera promotes water and electrolyte secretion from enterocytes, causing 
diarrhea.
39
 Some other exotoxins cause pathological damage to the host e.g. diphtheria 
toxins (Dtx) of Corynebacterium diphtheria
40 
and exotoxin A of Pseudomonas 
aeruginosa. They cause the death of the target cell of the host by inhibiting protein 
synthesis. Some exotoxins have very specific cytotoxic activities and they only attack or 
12 
 
target specific cells. Other exotoxins produced by clinical pathogens such as S. aureus 
have broad cytotoxic effects.
41 
These toxins have ability to damage the cell 
non-specifically and lead to apoptosis or necrosis. 
 
1.2.4.3  Pore Forming Toxins (PFTs) 
Pore-forming toxins belong to the group of protein exotoxins produced by pathogenic 
bacteria. The toxins can disrupt the selective influx and efflux of ions across the plasma 
membrane by inserting a transmembrane pore. At the molecular level, the toxins have an 
affinity to bind to membrane proteins, cholesterol or lipids to insert and form a pore to 
exert their virulent effects. Some toxins have a specific affinity to bind to cholesterol to 
insert and form a pore and this group of toxins is called cholesterol binding toxins 
(CBTs). Streptolysin of Streptococcus pyogenes, pneumolysin of Streptococcus 
pneumoniae, perfringolysin O of Chlostridium perfringenes and listeriolysin of Listeria 
monocytogenes belong to CBTs group. CBTs consist of three to four domains in their 
monomeric state and one of these domains is responsible for binding to cholesterol. 
Therefore the toxins are more likely to bind/insert to cholesterol-rich regions of the cell 
membrane and the resulting transmembrane pores are quite large with 24 to 48nm in 
diameter.
42
 Some PFTs do not specifically bind to sites in the cell membrane. Monomer 
insertion with subsequent transformational changes results in hydrophobic pore 
formation. The PFT group is classified into two groups: α-PFTs and β-PFTs. The two 
groups are based on the differences in mechanisms of interaction with membrane.
43
 
α-PFTs insert helices into the membrane to form the pores while β-PFTs insert β-barrel 
in the membrane to form the β-barrel pores including aerolysin of Aeromonas 





There are roughly two types of toxins: pore forming toxins and translocation toxins.
45
 
The pore forming toxins generally reside in the plasma membrane and form an ion 
channel conformation. The ion channel is mainly responsible for the toxicity either by 
13 
 
permeating through the membrane or by activating signal transduction pathways. The 
α-toxin of S. aureus and E.coli haemolysin are members of this family. The translocation 
toxins are known as ―A-B type toxins‖ as they are made up of two subunits: the A 
domain carries the enzymatic property such as ribosylation (Diphtheria toxin, cholera 
toxin), adenyl cyclase (edema factor of B. anthracis) etc; 
46
 B domain binds to a receptor 
on a cell surface and plays an important role in translocation. These two domains are 
either connected to each other such as diphtheria toxin and cholera toxin or separated 




1.2.4.4  Exoenzymes  
Exoenzymes, also known as extracellular enzymes, are secreted by many pathogenic 
bacteria and are associated with the process of cell degradation and invasion. 
Collagenase for example can break peptide bonds in collagen which is the supporting 
component of the extracellular matrix of eukaryotic cells.
49
 Hyaluronidase degrades 
hyaluronic acid which is the anionic glycosaminoglycan found in connective, epithelial 
and neural tissues.
50
 Some other enzymes such as phospholipases can recognise and 
degrade different types of phospholipids by hydrolysis. Different phospholipases 
recognise different sites of cleavage in different phospholipids (figure 1.5). 
 
1.2.4.5  Superantigens  
Some bacterial toxins can directly act on the T cells and trigger the immune system of 
the host. Several human diseases are associated with impairment of the immunologic 
functions of these cells by toxin. A large number of known and identified bacterial toxin 
superantigens belong to pyrogenic exotoxins which are produced by staphylococcal 
bacteria and streptococci. Their biological activities include potent stimulation of the 
immune system, pyrogenicity and enhancement of endotoxin shock. Superantigens have 
the ability to trigger the immune system and this immunostimulatory property is potent 
and triggered by extracellular binding of superantigens onto specific receptors of T-cells 
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and major histocompatibility molecules (MHC) which are expressed on the surface of 
antigen presenting cells.
51
 The binding results in a massive proliferation of peripheral T 
cells followed by a massive release of cytokines from lymphocytes and monocytes. 
Cytokins are small proteins mainly responsible for cell signalling secreted by the glial 
cells of the nervous system and by the cells of the immune system. Over secretion of 
cytokines can trigger a dangerous syndrome called ‗cytokine storm‘, which can cause 
several dangerous diseases such as toxic shock syndrome. The cytokines
52
 are mediators 





1.2.5  Mode of Action of Bacterial Toxins  
Many bacterial pathogens produce toxins which are considered as primary virulence 
factors. The mode of action of bacterial toxins depends on different toxins secreted by 
pathogens. The main barrier for the toxins to go through or interact with is the plasma 
membrane which is the primary defence of eukaryotic cells from the extracellular 
environment. Some toxins need to bind to cellular receptors on a membrane to exert 
their function and hence cause lysis; while some toxins need to insert into membranes to 
form a pore allowing water, ions, and small organic molecules pass through the 
membrane to cause the host cell death. In either case, toxins necessarily interact with the 
host cell membrane. Common modes of toxicity against the host cells include cell 
membrane damage, protein synthesis inhibition, pore formation, second messenger 




1.2.5.1  Transmembrane Pore Formation 
Membrane binding  
The modes of interaction with target cells depend on different types of toxins. The 
mechanism of action of α-toxin secreted by S. aureus is detailed here as S. aureus is the 
bacterium that is used as a pathogenic model in the work. The dosage of α-toxin can 
result in two different modes of activity.
55
 Low concentrations (< 50 mM) of toxin 
specifically bind to an unidentified cellular receptor and form the heptameric pore. This 
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pore allows the exchange of monovalent ions which results in DNA fragmentation and 
apoptosis.
56
 Binding is saturable and displays an optimum at 22-26 
o
C. Higher 
concentrations (> 200nM) will result in the toxin absorbing nonspecifically in to the 
lipid bilayer and this accounts for its permeabilizing action on cells lacking the receptor 
(e.g. human erythrocytes) and on protein-free lipid bilayers (liposomes and planar lipid 
membranes). This will form large, Ca
2+
 permissive pores and result in massive necrosis 




   
 
Streptolysin O (SLO) secreted by streptococcal is a haemolytic exotoxin. SLO interacts 
primarily with cholesterol molecules in target bilayers.
58
 The C-teminus plays a key role 
in binding.
59 
In biology, C-terminus is the end of an amino acid chain which is 
terminated by a free carboxyl group (-COOH).  
 
In contrast to α-toxin and SLO, it appears that HlyA does not interact with any specific 
acceptor molecule in target membranes. Binding is independent of the presence of 
proteins or cholesterol in the membranes. 
60
 In fact, the functional domain of HlyA has 
not been clearly identified. It is speculated that the hydrophobic sequence in HlyA forms 
at least part of the primary binding site and this domain possibly can spontaneously 
insert into lipid bilayers without any specific acceptor molecules. 
 
Pore Formation  
When bacterial toxins insert into a lipid membrane, toxins will generate hydrophobic 
domains to match the low polar character of the lipid acyl chains. The strategy is the 
oligomerization of toxin protomers to form partially or fully circularized protein 
complexes. This mechanism is applicable in the case of α-toxin 53 and SLO.61 The 
energy required for pore formation depends on conformational changes in the toxin 
molecules themselves. It is proposed
62
 that HlyA also forms oligomers in membranes 
but the detailed mechanism and supporting data are unknown. The mechanism of 
α-toxin formation has been studied in the greatest detail. The structure of the 
α-haemolysin heptameric complex which probably represents the pore has been studied 
by Song et al.
63
 Each protomer mainly consists of a β-sheet structure. The heptameric 
complex has a mushroom shape of 100 Å in height and 100 Å in diameter, the stem of 
which forms the pore forming domain
59
 (figure 1.4a). The structure is divided into three 
domains: the cap, the stem and the rim. The cap is composed of seven β-sandwiches, 
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interconnected by the first 18 N-terminal amino acids forming a latch, extending from 
one protomer to the next. The stem forms the true transmembrane channel. Each 
protomer contributes with two antiparallel β-strands. The rim interacts with lipid bilayer. 
Once the bulk of the oligomeric structure lies on the membrane surface, the portion will 
penetrate into the membrane and a series of changes will occur. The β-hairpin of the 
stem is quite small and can be fully internally hydrogen bonded. Within each strand, non 
polar and polar residues alternate which make the outside of the barrel hydrophobic and 
the inside channel hydrophilic, while the bottom of the rim is rich in aromatic residues 
with four tryptophans and two tyrosines per protomer, which are also important for 
membrane anchoring.  
 
Once the pore is formed, only the stem inserts into the lipid matrix of the cell membrane 
while the cap heptamer stays above the membrane on the side where it is inserted. The 
channels have no control on transport of solutes, molecules etc and will cause lethal 
permeability changes in the membrane. 
 
 
           
Figure 1.4: Ribbon diagram of the α-haemolysin of S. aureus.  
Top/bottom (a,b) and lateral (c) views of the α-haemolysin oligomer.58 
 
1.2.5.2  Lipid Damaging  
Lipid damage can be caused either by some lipid-degrading extracellular enzymes or by 
endotoxins LPS. 
47-48 
The damage not only may result in the direct lysis of cells but also 
  100Å 
70 Å  
52 Å  





52 Å  
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can facilitate bacterial spread through tissues. Bacterial hyaluronidases, collagenases, 
and phospholipases are able to degrade cellular membranes. There are some examples of 
this type of toxin including α-toxin of Chlostridium perfringens, which possesses 




Phospholipases (PLs) are common extracellular enzymes produced by many human 
pathogenic bacteria.
67
 PLs are highly site specific and they can bind to a wide range of 
lipids including phosphatidylcholine(PC), phosphatidylinositol(PI), phosphatidylethanol 
(PE), phosphatidylserine(PS), phosphatidylglycerol(PG), lysophosphatidylcholine(LPC), 
lysophosphatidylinositol(LPI) and sphingomyelin(SM).
57 
Cellular damage caused by 
PLs is quite considerable because phospholipids are the main component of human cell 
membranes, constituting more than 75% of lipids (% mol) in human cells.
68 
The 
mechanism is based on the sites of phospholipids at which particular PLs 
hydrolyse.(figure 1. 5)  
 
There are four main categories, termed A, B, C and D, which are classified by different 
type of reaction they catalyse. Phospholipase A includes phospholipase A1 (PLA1) and 
phospholipase A2 (PLA2). PLA1 and PLA2 can recognise sn-1 and sn-2 acyl bonds of 
phospholipids respectively and hydrolyses the fatty acids.
69
 Phospholipase A2 is an 
enzyme which is present in the venom of the bees and viper snakes.
70
 Phospholipase B 
(PLB) cleaves both sn-1 and sn-2 acyl chains. It is also known as a lysophospholipase. 
Phospholipase C (PLC) and phospholipase D (PLD) hydrolyse the bonds before and 
after the phosphate group respectively.
71
 Lipid catalysed by PLC will release 
diacylglycerol and a phosphate-containing head group, while PLD breaks the lipid down 






















Figure 1.5: Cleavage sites of different phospholipases (shown with red dashed line) 
 
1.2.5.3  Inhibition of Protein Synthesis  
This group of toxins consists of A-B subunits: the A subunit is responsible for enzymatic 
activity, while the B subunit is designed to target a specific receptor on the host cell and 
then translocate the enzyme across the membrane to intracellular targets.
73
 Subunit A 
enters the host cell either by pore forming or receptor-mediated endocytosis (RME). In 
the first mode of the action, subunit B binds to the specific receptor on the target cell and 
induces the formation of a pore where subunit A will translocate.
74
 In the second mode, 
binding to a specific receptor on target cells triggers the formation of an endosome 
which is a process of an enclosed vesicle budding inward from the plasma membrane. 
Endosome carries the whole toxin and the change of pH in the cell will separate the 




Corynebacterium diphtheriae is a human pathogen that generally colonises the human 
throat. Diphtheria toxin (DT) secreted by the bacterium is a potent toxin which is one of 
the most well studied and understood bacterial toxins.
75-76 
The toxin can cause the 
disease diphtheria in humans by entering into the cell cytoplasm and inhibiting protein 
synthesis.
77 
The DT catalytic domain belongs to a family of mono-ADP 
ribosyltransferases, which bind to NAD and transfer the ADP-ribose group to a specific 
residue on the target protein. The active site is conserved among the bacterial 
ADP-ribosylating toxins and forms the NAD-binding cavity which plays a major role in 
catalytic activity. The ADP-ribosylation of diphamide by DT prevents the binding of 
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Pseudomonas exotoxin A (ExoA),
79
 Shiga toxin (ST)
80 
and E. coli verotoxin (VT) enter 
cells via the Golgi apparatus and the endoplasmic reticulum (ER). Exotoxin A uses as 
similar mechanism of action as DT does, while ST and VT impair ribosomal RNA 
function by cleaving an N-glycosidic bond in the 60S subunit. Pore forming toxin (PFT) 
such as C. perfringens enterotoxins (CPE) inhibit protein synthesis by inducing leakage 
of nucleotides, amino acids and other small molecules. 
 
1.2.5.4  Activation of Secondary Messenger Pathways  
Many bacterial toxins have the ability to kill the target cells indirectly by altering the 
function of a variety of cellular proteins. These toxins can activate and modify 
secondary messengers and result in the change of signal transduction pathways which 
play a key role in maintaining a variety of cellular functions.
81
 Cholera toxin of Vibrio 
cholerae, heat-liable, heat-stable toxins and cytotoxic necrotizing factors (CNFs) of 
E.coli 
82
 and pertussis toxin of Bordetella pertussis all belong to this group of toxins. 
These toxins can affect the secondary messenger pathways and target guanine 
nucleotide-binding proteins (G-proteins) and Rho G-proteins.
83
 The mechanism of 
action is similar to the toxins inhibiting protein synthesis. Both cholera and pertussis 
toxins utilise RME modes of translocation to enter the target cells. The cholera toxin is 
an oligomeric complex consisting of six protein subunits: a single copy of the A subunit 
which is an enzymatic part, and five copies of the B subunit, responsible for receptor 
binding.The five B-subunits form a five-membered ring, while subunit A carries 
enzymatic activity which ADP-ribosylates G proteins.
84 
The pentameric part B of the 
toxin molecule binds to the targeted cells, while A subunit detaches from the pentameric 
part and enters the cell via receptor-mediated endocytosis. It ribosylates the Gs alpha 
subunit of the heterotrimeric G protein inside the cell, resulting in the production of 
cyclic adenosine monophosphate (cAMP). This leads to the secretion of fluid and 




1.2.5.5  Inhibition of the Release of Neurotransmitters 
Some toxins affect the nerve cells of peripheral nervous system (PNS) and central 
nervous system (CNS). This group of toxins is classified as neurotoxins and their modes 
of action include interfering with the ion transport function of many voltage gated ion 
channels and inhibiting the release of neurotransmitters of the nerve cells.
85
   
1.2.6  Biofilms  
A biofilm is a complex aggregation of microorganisms that can be attached to a 
non-living or living surface in the presence of sufficient nutrients.
86
 More than one type 
of bacteria may be present in this sessile system and these adhered cells are usually 
embedded within a self-produced matrix of extracellular polymeric substance (EPS). 
Biofilm EPS is a polymeric conglomeration normally composed of extracellular DNA, 
proteins and polysaccharides. This matrix plays an important role in protecting the cells 
within it and facilitating communication among them through biochemical signals. 
Biofilms can form single-species films under certain conditions. However, biofilms 
often contain many different types of miroorganism, e.g. bacteria, archaea, protozoa, 
fungi and algae.  
 
Biofilms are often characterised by surface attachment, structural heterogeneity, genetic 
diversity, and complex community interactions. Biofilms have altered phenotype and 
bacteria living in biofilms usually have different properties from planktonic 
microorganisms as the dense and protected environment of the films allow them to 
cooperate and interact in various ways. This leads to increased resistance to 
antimicrobial agents and the host‘s immune system.87-88 In some cases, antibiotic 




1.2.6.1  Biofilm Formation  
It was previously assumed that all bacteria are planktonic.
90
 Microbial communities 
were found in the 1970s 
91
 and more work has been done to understand the mechanism 







Initially, free-floating microorganisms attach to a substrate through reversible 
attachment via van der Waals forces to condition the surface for further bacterial 
attachment.
90
 The initial bacterial colonists can anchor themselves more permanently 
using cell adhesion structures such as pili 
90
 if the bacteria are not separated from the 
surface immediately. The early stage of biofilm formation is coordinated by unknown 
cues, bacteria use flagellar, twitching, and gliding motility mechanisms to grow together 
in nascent clusters.
94
 Biofilms then grow by further addition of bacteria through more 
diverse adhesion sites and begin to build the matrix that holds the biofilm together. More 
bacteria either attach to the matrix or directly to earlier colonists. The cells are able to 
communicate through quorum sensing which is a process bacteria coordinate gene 
expression and communicate with each other based upon the density of their local 
population by using products such as N-acyl homoserine lactone (AHL) during this 
stage.  
Biofilms then grow through the reproduction of bacteria and twitching motility. The 
final stage of biofilm formation is known as development. In this stage biofilms are 
established and may only change in shapes and sizes. 
95 
A schematic of biofilm 
formation is illustrated in figure 1.6.  
 
          
Figure 1.6: Stages of biofilm formation with corresponding photomicrographs.
96
  
(1) initial reversible attachment via weak attractive forces; (2) irreversible attachment; (3) maturation: 
reproduction and recruitment of bacteria and production of exopolymers matrix; (4) maturation; (5) 
dispersion. (image credit: D. Davis) 
22 
 
1.2.6.2  Antimicrobial Resistance of Biofilms  
Biofilms have proved to resist various antibiotics and human immune system 
responses.
97-98
 Besides the familiar mechanisms of resistance such as efflux pumps, 
modifying enzymes, and target mutations, other possible factors may account for the 
protection of bacteria in a biofilm. Several defence mechanisms of bacterial 




The biofilm matrix can slow the diffusion of antibiotics, resulting in slow or incomplete 
penetration of the antibiotic into the biofilms.
99
 Antibiotics that are absorbed into the 
biofilm matrix could also have a retarded penetration. This is might account for the slow 
penetration of aminoglycoside antibiotics.
100-101
 The inherent negative charge in the 




Bacteria living in biofilm structure are nutrient deficient and exist in a slow/non-growing 
or ‗starved‘ state. This makes the bacteria communities not susceptible to antimicrobial 
agents.
104
 Cell viabilities reduce from around 100% in the planktonic phase to around 
10% in a biofilm.
104
 However, slow growing P. aeruginosa cells have shown no greater 
resistance to antibiotics than do stationary phases of planktonic cells.
105
 Experimental 
work has proved that the planktonic form of P. aeruginosa is less affected by antibiotics 
in the stationary phase compared to biofilm core cells.
106
 The resistance to antibiotics in 
both stationary cells and biofilms is probably due to the presence of persister cells 
96 
which are a small subpopulation of microbial cells. The presence of persister cells can 




Furthermore, the structural heterogeneity of biofilms ensures cells are in a variety of 
metabolic states and thus deny metabolically directed action. It is also possible that at 
least one species of bacteria living in biofilms are resistant to antibiotic attack. Therefore, 





Additionally, the altered chemical environment within biofilms may result in the 
antibiotic resistance of biofilm. Some studies have shown that oxygen in the surface 
layers of a biofilm can be completely consumed, causing an anaerobic environment in 
the deep layer of the biofilms.
108
 Aminoglycoside antibiotics are less effective against 
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the same bacteria in anaerobic rather than in aerobic conditions. Alternatively, some 
local accumulation of acidic waste products may cause the changing of pH greater than 
1 between the bulk fluid and the biofilm interior. This would cause the deactivation of an 
antibiotic.
108
 In addition, the change of osmotic environment within biofilms which 
results in the induction of an osmotic stress response. This response could change the 




   
1.2.6.3  Biofilm Related Infectious Diseases  
Biofilms have been found to be related to a large variety of microbial infections in the 
body
110 





 coating contact lenses,
112
 etc. Most biofilms are comprised of a 
variety of organisms, i.e. polymicrobial. Biofilms are best known for their role in foreign 
device-related infections including infections of catheters and other biomaterials used in 
medicine. However, recent studies have shown that biofilms may impair wound healing 
and reduce topical antibacterial efficiency in the treatment of burn wound 
infection.
113-114
 Pseudomonas aeruginosa is an environmental organism that regularly 
causes infections in burns and other wounds. The study of P. aeruginosa pathogenicity 
can explain the molecular mechanisms responsible for the switch from planktonic 
growth to a biofilm phenotype and the role of inter-bacterial communication in 
persistent disease.
115
 Again, the increased resistance to antimicrobial agents and 





1.3  Pathogenesis of Burn Wound Infection 
Not all of burn injuries will cause infection by pathogenic bacteria and the majority of 
burn injuries affect only the epidermis for example sun burn. However, the length of 
hospital stay, scarring, and pain will be increased when the open wounds are infected by 
pathogens. Human skin, as the first line of defense against invading microbes, is covered 
with a series of immune mediators which are able to clear invading bacteria and 
fungi.
16-117
 Therefore, immune failure in a burn patient who has lost the skin barrier 
renders them vulnerable to bacterial infection. Bacteria can rapidly colonise open skin 
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wounds after burn injury even if burn wound surfaces are sterile immediately following 
thermal injury.
118-119 
Microorganisms that colonise the burn wound originate from 
gastrointestinal and endogenous skin and also respiratory flora.
120-121
 Gram-positive 
bacteria from patient‘s endogenous skin or external environment such as staphylococci, 
predominantly colonise the wound surface within the first 48 h unless specific topical 
antimicrobial agents are used for wound injury.
122
 After an average of 5 to 7 days, these 
wounds are subsequently colonised with other microbes including gram-positive 
bacteria and gram-negative bacteria. Wound colonisation by yeast and fungi may occur 
later depending on whether broad-spectrum antibiotic therapy is used.
123-125
   
 
Streptococcus pyogenes (beta-hemolytic streptococci) was once the most serious 
pathogen which can cause burn wound infections and was a major cause of death in 
severely burned patients. 
126-127
 With the introduction of penicillin G in the early 1950s, 
Staphylococcus aureus became the major pathogens which could result in severe wound 
infection. However, Pseudomonas aeruginosa from the patient‘s endogenous 
gastrointestinal flora or environmental source is the most common causes of wound 
infections in many burn wound centers.
128
 Pseudomonas aeruginosa will be detailed in 
chapter 2. Table 1.1 shows the most common pathogenic bacteria colonising and 
infecting burn wounds.  
 




















Data are from references 126, 129 and 130. 
 
Antimicrobial resistance among a wide variety of human bacterial burn wound 
pathogens has been a major concern for many years and has had a negative effect on 
effective treatment of burn wound infections.
128,131
 Hospitals often harbour 
multi-resistant strains of pathogens and microorganisms transmitted from the hospital 
environment tend to be more resistant to antimicrobial agents than those from patients‘ 
normal flora because of the transfer from patient to patient.
132-133
 In addition, a high 
percentage of patient mortality and morbidity make MRSA, methicillin-resistant 
coagulase-negative staphylococci, vancomycin-resistant enterococci, and multiple 
resistant gram-negative bacteria with several types of beta-lactamases, including 
extended-spectrum beta-lactamases (ESBL), ampC beta-lactamases, and 
metallobeta-lactamases serious pathogens in hospitalised patients. β-lactamases are 
enzymes secreted by some bacteria and the enzymes are responsible for the resistance to 
various β-lactam antibiotics such as penicillin, methicillin and carbapenem. Data from 
Centre for Burn Treatment in Poland
134
 show that both Pseudomonas aeruginosa and 
Staphylococcus aureus are the major strains isolated from burn wounds and are two 



















1.4  Antimicrobial Agents Used for the Treatment of Burn Wound 
Infection  
1.4.1  Introduction to Antimirobials  
Current treatment for burn wound infections relies on the use of antimicrobials. The 
proper use of antimicrobial agents is a strategy to overcome the microbial invasion 
135
 of 
the host. Antimicrobial agents are molecules that are selectively toxic to microorganisms 
by interfering with essential microbial processes. This is due to the differences in cell 
membrane constituents and ribosome structure between the host and microbial cells. The 
presence of a microbial cell wall is usually a target for antimicrobial drug action. 
136
 
(The description of the eukaryotic cell membrane will be presented in section 1.5) The 
different classes and mechanisms of actions are listed in table 1.2.  
 
Table 1.2: Classes of antimicrobials and their mechanisms of action to the host 
137 
           Antibacterial               Mechanism  
 
           β – Lactams  
 
                      
          Sulfonamides  
 
 
          Macrolides  
 
                      
          Chloramphenicol  
 
 
            Polypeptides  
 
           Glycopeptides  
 
                   
          Aminoglycosides 
 
Inhibit cell wall synthesis through 
inhibition of peptidoglycan crosslinking 
 
Interfere with folic acid synthesis by 
competing with p-aminobenzoic acid  
 
Inhibit protein synthesis by binding to 50S 
unit of ribosome 
  
Inhibit protein synthesis by binding to 
peptidyl transferase  
 
Disrupt cell membrane  
 
Inhibit cell wall synthesis by binding to 
precursors  
 






            Quinolones  
 
                 
                   
            Tetracyclines  
 
 
unit of ribosome and distort membrane 
integrity through cationic character  
 
Inhibit microbial topoisomerases, inhibits 
DNA relaxation and increases DNA 
breakage 
 
Inhibit protein synthesis by binding to 30S 
unit of ribosome  
 
Topical antimicrobials cover a wide range of compounds that are all applied directly 
onto the external site of infection in the form of creams. They are most commonly used 
for the treatment of bacterial infections. The ideal properties for an antimicrobial are 




- Broad spectrum of activity                     - Easy to apply  
- Painless                                    - No wound healing retardation 
- Long lasting                                 - Inexpensive 
- Non-toxic                                   - Easy to store 
- Good eschar penetration                        - No systemic absorption 
 
1.4.2  Topical Antimicrobial Agents 
1.4.2.1  Silver Products  
The use of topical chemotherapy has helped to improve the survival of patients with 
major burns and to minimise the incidence of burn wound sepsis, a main cause of 
mortality and morbidity in these patients. 
139
 One of the strategies for preventing 
bacterial infection is the use of metal antimicrobials, the most common of which is 
silver.
140
 Siver has been known to possess bactericidal properties and silver compounds 
have been used for their medicinal properties for centuries as well.
141
 Silver has been a 
viable treatment option for infections in burns, open wounds, and chronic ulcers. Several 
products incorporating silver have been used as topical antibacterial agents, such as 
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silver nitrate and silver sulphadiazine (SSD) Flammazine 
TM
, (Smith & Nephew Health 




 (Westaim Biomedical Inc., Fort 
Saskatchewan, Alberta, Canada) and Silverlon
®
 (Argentum Medical, L.L.C., Lakemont, 
Georgia) are newly developed products which have a more controlled and prolonged 
release of nanocrystalline silver to the wound area. This mode of silver delivery allows 
the dressings to be changed with less frequency to reduce risk of nosocomial infection, 
cost of care, further tissue damage and patient discomfort.
10-11
 Although silver products 
have been recognised as useful antibacterial agents for burn wound treatment, recent 
findings indicate that the compounds might delay the wound-healing process 
12
 and that 




Silver sulfadiazine (Ag-SD) has been clinically used as a standard treatment for burn 
wound infection over decades since silver sulfadiazine was first synthesized. Ag-SD was 
reported to be effective as a topical antimicrobial agent for the control of Pseudomonas 
infection in burns.
140
 However, Cho Lee‘s12 previous study showed the cyto-toxic effect 
of Ag-SD on HaCaT cells and delayed epithelisation process in a second-degree burn 
animal model.
144
 Wound healing is a complex process involving several cell types 
including the processes of epithelisation and wound contraction, which is defined as 
closure of open wound by inward movement of the surrounding integument. 
145
 The 
process of re-epithelialization is generally keratinocyte dependent, while the process of 
contraction is fibroblast dependent. Therefore, impaired proliferation of these two cell 
types could lead to the delayed and complicated wound healing. 
146
 Thus, the use of 
Ag-SD is not recommended any more because of its reported wound healing inhibition. 
 
1.4.2.2  Mafenide Acetate 
Mafenide is a methylated sulphonamide available commercially as a 10% preparation in 
a water-soluble, hygroscopic cream base. It can interfere with the kidney‘s role in 
hydrogen ion excretion, resulting in metabolic acidosis. It has a large spectrum of 
activity against both the common gram-negative burn related pathogens such as 
Pseudomonas aeruginosa and the gram-positive pathogens.  
 
Mafenide is usually used to treat the second and third degree burns and is not suitable to 
use as the first-line. 
147
 It should be reserved for infections that require rapid penetration 
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of the eschar for control and when other antimicrobials have failed. It may cause toxic 
effects and careful monitoring is necessary.
148
 The agent is applied using open 
techniques. Mafenide can cause pain on application to partially burned areas, possibly 
because of its high osmolarity. It can also inhibit epithelial regeneration. Mafenide can 
be readily absorbed from burn wounds, so the actual therapeutic wound concentrations 
cannot be maintained unless the agent is reapplied.   
 
1.4.2.3   Nitrofurazone  
Nitrofurazone is another topical antimicrobial used in burn wound care. It inhibits 
bacterial enzymes and is used against S. aureus, Streptococcus, E. coli, Clostridium 
perfringens, Enterobacter aerogenes, and Proteus organisms. Nitrofurazone has a 
relatively more limited role in burn wound care and it is used as the treatment of second 
and third degree burns when resistance to other agents is a real or potential problem.  
  
1.4.2.4  Povidone-Iodine 
Povidone-iodine (PVP-I) is a complex of polyvinylpyrrolidone and iodine as an 
antiseptic for use on normal skin (e.g., surgical scrubs) and mucous membranes. Iodine 
has been broadly used for the treatment of skin infections and has been recognised as an 
effective broad-spectrum bactericide. This complex was then found to be less toxic and 
anti-bacterially effective in vitro tests.
149 
The complex has a wide antimicrobial spectrum, 
but protein binding of iodine in the open wounds may result in decreased antimicrobial 
effect in vivo. The agent can be used with both the open and semiclosed techniques. It 
frequently causes pain on application to burned wound areas. This may be due to the 
acidic cream (pH 2.43) or to other side effects. It is also reported that povidone-iodine 




1.4.2.5  Gentamicin Sulfate  
Getamin sulphate is an aminoglycoside, bactericidal antibiotic used in the treatment of 





 Its mechanism of action is to disrupt bacterial protein synthesis. 
Although being gram-negative, E. coli shows some resistance to gentamicin. The use of 
gentamicin is not recommended in the treatment of E. coli infections. Therefore, the use 
of alternative broad-spectrum antibiotics has been increased, which may lead to the 
prevalence of antibiotic resistant bacterial infections by Gloden Staph and other 
so-called ―superbugs‖. 137 
 
The drug is readily absorbed when applied to open wounds. Gentamicin is useful for 
invasive infection. It should be applied for brief periods to the smallest possible areas. 
The drug has some adverse effects including nephrotoxicity, auditory or vestibular 
ototoxicity and impairment of neuro muscular transmission and hypersensitivity 
reactions. Such toxicity remains a major problem in clinical use. 
137 
Therefore, blood 
levels of the drug should be carefully monitored. Superinfection with resistant bacterial 
strains will quickly occur with its protracted use.   
1.4.2.6   Silver Nitrate Solution (0.5%)  
Silver nitrate solution (0.5%) is an effective prophylactic agent for burns of less than 
50% total surface area if properly used. 
152
 It can coagulate and precipitate bacterial 
proteins to inhibit bacterial growth. The diluted silver nitrate can be used in the 
treatment of common bacterial and fungal burn infections. Silver nitrate solution is not 
widely used clinically nowadays because it leaves black stains and has a limited scope of 
efficacy. In addition, silver compound probably inhibit tissue healing by several 
mechanisms and evidence suggests silver is cytotoxic.
143
   
 
Silver nitrate solution is applied to thick cotton dressing (40-ply). These dressings must 
be wetted every 2 hours to ensure a constant source of silver ions at the wound site, the 
purpose of which is to prevent the wound from drying because the drying of the wound 
will lead to increased concentration of silver ions to injurious levels (>2%), and to 






1.4.2.7  Chlorhexidine  
Chlorhexidine is a chemical antiseptic effective on both gram-positive and 
gram-negative bacteria.
154
 It has both bactericidal and bacteriostatic mechanisms of 
action, the mechanism of action being membrane disruption.
155
 Here the definition of 
bactericidal and bacteriostatic agents should be distinguished. Bactericidal agents kill 
bacteria and it includes disinfectans, antiseptics and antibiotis, whereas bacteriastatic 
agents interfere with the reproduction of bacteria and do not necessarily harm them. 
Chlorhexidine is harmful in high concentrations, but is used safely in low concentrations 
in many products including mouthwash and contact lens solution. 
 
1.5  Biomembranes  
1.5 .1  Basics of Lipid and Cell Membrane Structures  
Cell membrane, which is also referred to as the plasma membrane, maintains a strictly 
balanced internal environment. Cells are surrounded by cell membranes. The major 
constituents of a cell membrane are amphiphilic biomolecules called phospholipids. 
Many different types of lipids, proteins, carbohydrates, cholesterols and all of their 
complexes are embedded in the lipid bilayer of cell membranes. All the constituents are 
held together by non-covalent, hydrophobic interactions within the cell membrane 
(figure 1.7). The type and composition of lipids, proteins, carbohydrates and cholesterols 
in cell membranes vary from cell to cell which depend on different properties of 
individual cells and the specialized functions that they perform. In most cell membranes, 
proteins constitute the largest fraction by weight and the ratio of lipid to protein is 
usually taken as an index of functional activity, comprising the higher ratio, the lower 
the activity and vice versa. In addition, the cell membrane is a platform for 
communication for inside and outside of the cells and involved in many cellular 
functional processes such as signal transduction, cell division and ion channel 
conductance.
156 
Cellular organelles such as mitochondria, endoplasmic reticulum and 
Golgi complex (of the eukaryotic cell) are membrane-bound and all the intracellular 
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communications and the transport of components within the cell are also associated with 
the lipid bilayer membranes. Cell membrane becomes the primary target of the foreign 
invasions such as bacterial toxins and infection as it controls all possible means of 
access into the cell. 
157
 The compositional complexity and different varieties of 
membrane constituents make it a challenge to study, despite the detailed information on 
membrane-bound processes at the molecular level is crucial to understand the living 
organisms. This causes the development of simplified artificial model--lipid bilayers or 
lipid vesicles, comprising one or a few types of lipid molecules. The model lipid vesicles 
can mimic the cell membrane in several ways and allow the integration of membrane 
proteins by creating natural cellular environment, they allow not only the possibility to 
study the functional processes of cell membrane constituents but also become a potential 




      
Figure 1.7: Basic construction of a typical eukaryotic cell membrane.  
The phospholipid bilayer (shown in red) makes up the framework of the membrane. Cholesterol (yellow) 
fills any gap in the structure to aid in membrane strength and increase permeability to essential organic 
components 
 
1.5.1.1  Glycerophospholipids  
Glycerophospholipids are biological molecules which occur in all eukaryotic cells and 
are the most common membrane lipids. The 3 hydroxyl group of the glycerol is linked to 
a polar phosphate group and the 1 and 2 position hydroxyls linked to apolar acyl groups. 
The momenclature of glycerides is in terms of stereospecific numbering (sn), 1,2 
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di-myristoyl-sn-glycero-phosphatidylcholine, for example, is shown in figure 1.8. These 
glycerol esters are most abundant lipids in eukaryotic and most prokaryotic cellular 
membranes. Phosphatidylcholine is predominant in animals and 
phosphatidylethanolamine in bacteria. The length of the fatty acid tails can vary 
depending on different organisms but most commonly C16, C18 and C20. Incorporation 
of unsaturation in these fatty acids helps to increase fluidity of a membrane and the most 
common unsaturated tails are 18:1, 18:2, 18:3 and 20:4. The natural alkene bond in these 
fatty acids is cis- which causes disruption in the packing of fatty acid tails in a 
membrane resulting in less densely packed ‗fluid‘ membrane. A combination of 
saturated and unsaturated fatty acid tails are incorporated into membranes to provide the 
optimal fluidity for that membranes function.
44
 Due to their amphiphilic properties, 
phospholipids have ability to spontaneously form lipid bilayer (figure 1.8). This ability 
is resulting from the amphiphilic nature of phospholipids with a polar head and 
hydrophobic tails. The major driving force for this process is from the minimisation of 
unfavourable non-polar/polar interactions (fatty acid tails and water molecules) and the 
maximization of polar/polar solvent interactions (hydrogen bonding between the 



















Figure 1.8: Lipid bilayer containing hydrophilic head and hydrophobic tail.  





Because of the amphiphilic property of phospholipids, they have the ability to form 
supramolecular structures spontaneously in vitro such as micelles, vesicles or liposomes 
and crystalline structures. The liposome and lipid bilayer sheet are quite similar to that 
observed in vivo but much more basic. The bilayer is a way in which the lipids minimise 
their energy grouping hydrophobic tails together away from the water. This also 
provides separation of two volumes of water inside and outside of the liposome and 
either side of the bilayer sheet. The lipid bilayer sheet is useful for studying 
electrochemical responses across a membrane to stimuli interacting with the biomimetic 
lipid structure. Liposomes or vesicles not only provide this separation but they can 
encapsulate a different fluid inside the vesicles which can be used in drug delivery.  
 
1.5.1.2  Membrane Fluidity  
The interior of a lipid bilayer is usually highly fluid and in the liquid crystal state, 
hydrocarbon chains of phospholipids are disordered and in constant motion. At lower 
temperature, a membrane containing a single type of phospholipid undergoes phase 
transition to a crystalline state. Fatty acid tails are fully extended in this state, packing is 
highly ordered, and van der Waals interactions between adjacent chains are maximal 
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(figure 1.9). In addition, double bonds in fatty acid chains interfere with packing of 
lipids in the crystalline state and lower the phase transition temperature.  
 
                             
               
Figure 1.9: Structure of liquid-crystal phase of lipid bilayer 
 
1.5.1.3   Cholesterol  
Cholesterol is an important constituent of cell membranes. It has a rigid ring structure 
and a short branched hydrocarbon tail. Cholesterol is largely hydrophobic but it has one 
polar group, hydroxyl which makes it amphipathic. Cholesterol inserts into bilayer 
membranes with its hydroxyl group oriented toward the aqueous phase and its 
hydrophobic ring adjacent to fatty acid tails of phospholipids. The hydroxyl group of 
cholesterol forms hydrogen bonds with polar phospholipid head groups. Cholesterol 
plays a key role in maintaining the integrity of the lipid bilayer. The presence of 
cholesterol in a phospholipid membrane interferes with close packing of fatty acid tails 
in the crystal state. Interaction with relatively rigid cholesterol decreases the mobility of 
the hydrocarbon tails of phospholipids. Therefore, insertion of cholesterol inhibits 
transition to the crystalline state, for example, phospholipid membranes with a high 
concentration of cholesterol have a more tendency to stay in liquid crystalline state.  
1.5.2  Description of the Background for Lipid Vesicles  
Liposomes are microscopic vesicles, generally spherically shaped, which are formed 
from one or more lipid walls. The walls are prepared from lipid molecules, which have 
the tendency both to form bilayers and to minimise their surface area. The lipid 
molecules that make up a liposome have hydrophilic and lipophilic portions (figure 
1.10). Upon exposure to an aqueous solution, the lipid molecules form a bilayer 
membrane wherein the lipid ends of the molecules in each layer are directed to the 
Crystal  Liquid crystal  
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centre of the membrane, and the opposing polar ends form the respective inner and outer 
surfaces of the bilayer membrane. Thus, each side of the membrane presents a 






                       
                                   
Figure 1.10: Basic structure of lipid vesicles with hydrophilic head and hydrophobic tail.  
 
Liposomes can be divided into several categories based on their overall size and the 
nature of the lamellar structure. The classifications include small unilamellar vesicles 
(SUV), multilamellar vesicles (MLV) and large unilamellar vesicles (LUV) (also called 
as giant unilamellar vesicles, GUV). SUVs range in diameter from approximately 
twenty to fifty nanometres and consist of a single lipid bilayer surrounding an aqueous 
compartment. A characteristic of SUVs is that a large amount of the total lipid, about 
70%, located in the outer layer of the bilayer. Among theses liposome, the most 
frequently encountered and easily prepared liposomes are the multilamellar vesicles. 
Where SUVs are single compartment vesicles of a fairly uniform size, MLVs vary 
greatly in diameter up to about 30,000 nanometers and are multicompartmental in their 
structure wherein the liposome bilayers are typically organised as closed concentric 
lamellae with an aqueous layer separation each lamellar from the next. Large unilamellar 
vesicles are so named because of their large diameter which ranges from about 600 




It is not common for SUV‘s to be used due to their thermodynamic instability. Their 
small size and high surface area are a driving force to coagulation, being only kinetically 
stable for a relatively short time. GUV‘s make good cellular approximation, and 
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functional molecules can be either embedded into their membrane architecture (such as 
cholesterol) or encapsulated inside the plasma membrane itself (including the compound 
in the buffer during the hydration phase). 
 
1.5.3  Introduction to Polydiacetylene Vesicles  
1.5.3.1  Polydiacetylene Vesicles  
Polydiacetylene (PDA) is a conjugated polymer with optical properties that are usually  
used for the detection of biological molecules. Due to its unique colour changing 
properties upon stimulation, PDA based sensors for the detection of biologically species 
have been intensively studied.
162-164
 Closely packed and properly designed certain 
diacetylenes can undergo polymerisation via a 1,4-addition reaction to form an ene-yne 
alternated polymer chain upon UV irradiation with 254 nm as shown in figure 1.11. The 
diacetylene polymerisation occurs only when the material is in a highly ordered state. It 
requires an optimal packing of the diacetylenic units to allow propagation of the linear 
chain polymerisation through the ordered phase. The packing of monomers in a 
crystalline lattice is determined by the side groups attached to the diacetylene units and 
therefore can be controlled by choosing the appropriated substituents or headgroups, in 
the case of lipids. 
165-166
 The resulting polydiacetlenes appear to be intense blue colour to 
the naked eyes. The blue-coloured polydiacetylenes can be prepared in form of 
liposomes in aqueous solutions or as thin films using Langmuir-Blodgett or 
Langmuir-Schaefer methods due to their amphiphilic properties. 
167
 The main advantage 
of polydiacetylenes as biosensors comes from the fact that a visible colour change from 





 and ligand-receptor interactions
171-172
 or mechanical stress. The 
mechanism of colour transition is not clear, but it has widely been accepted that colour 
change is associated with a conformational change of the polydiacetylene backbone. The 
polydiacetylene in its blue form has extended conjugation of p-orbital in the main chain 
of the polymers. The conjugated p-orbitals undergo distortion by environmental stimuli, 
which leads to a partial twist, decreasing the overlap of the p-orbital. Therefore, the blue 
colour of the polymers can gradually shift to the red colour irreversibly depending on the 









                                  B 
Figure 1.11: Schematic of polydiacetylene vesicle formation.  
(A) Schematic representation of polymerisation of molecularly assembled functional diacetylenes by UV 
irradiation; (B) Schematic representation of the liposome prepared with 10, 12- tricosadiynoic acid 
(TCDA) 
 
Diacetylene monomers for self-assembled materials consist of two parts: a polar 
headgroup and a hydrophobic tail containing the diacetylene moiety. Some 
representative monomers are shown in figure 1.12. The hydrophobic portion of the 
amphiphile is generally composed of a single alkyl chain, but can also have multiple 
chains with a diacetylene group in one or more chains. Each tail can be broken down 
into three parts: the diacetylene group, a spacer between diacetylene and the headgroup, 
and the terminal alkyl chain.
173
 Each part of the diacetylene amphiphile plays an 
important role in deciding if the amphiphile can form self-assembled material or not. 
Headgroup chirality strongly influences colloidal structure; amphiphilic monomers with 
achiral headgroups usually form spherical liposomes, while chiral amphiphiles often 
form non-spherical structure such as helices and tubules. The number and the length of 
the tails influence the range of conditions under which an amphiphile will undergo 
self-assembly and the temperature of the melt transition (Tm) from ‗crystalline‘ chain 
1Molecular Assembly  1 UV irradiation 
2 Polymerisation 
 Redesigning 
Self -assembly  
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packing to ‗liquid‘ chain packing.  
 








   
 
Figure 1.12: Diacetylene structures 
 
1.5.3.2  Mixed Lipid/PDA Liposomes   
One feature of PDA that makes it a promising biomimetic model is the rigid framework 
allowing incorporation of varied lipid constituents. Polydiacetylene vesicles are thermal 
stable at certain conditions after UV irradiation. This colorimetric platform consists of 
supramolecular aggregates of physiological lipid molecules such as DMPC embedded 
within a polydiacetylenic (PDA) lipid matrix (figure 1.13). One particularly important 
feature of lipid/PDA vesicle systems is the feasibility for incorporating a significant 
concentration of lipid constituents within the PDA matrix – up to 50% (mole ratio).174 
This construction is designed to better mimic the cell surface and is different from PDA 
systems both in structure and functionality. In fact, such mixed vesicle systems comprise 
distinct lipid domains embedded within the polymer framework that still retains its 
structural and chromatic properties.
175-176
 Figure 1.13 presents a schematic description of 
lipid/PDA vesicles. Kolusheva
175
 indicated that the lipids and polydiacteylene most 
likely form interspersed microscopic phases within the vesicles. The phospholipids 
incorporated in the PDA matrix adopt a bilayer structure, the dominant lipid organization 
within cellular membranes. The lipid components in the mixed vesicle system that form 
distinct bilayer domains are significant in the context of biological applications. Such 
vesicles could closely mimic the membrane surface of a cell. The utilisation of 
lipid/PDA vesicles for biological applications can be enhanced by incorporating within 
   m, n               Abbreviation            
   
   0,15               2,4-HCDA 
       3,13               5,7-DCDA 
       4,12               6,8-DCDA 
       0,17               2,4-TRCDA 
       8,9               10,12- TRCDA 
       3,15              5,7 – TCDA  
       2,17              4,6 – PCDA 
       4, 15             6,8 – PCDA   
       6,13              8,10-PCDA 
       8,11              10,12-PCDA 
       10,9              12,14 – PCDA 
      8,13             10,12 - HPCDA 
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the vesicles varied synthetic and natural phospholipids, glycolipids, lipopolysaccharides, 
cholesterol, or total membrane extracts, which can essentially mimic the lipid 




                 
 
Figure 1.13: Structure of mixed lipid/PDA vesicle.  




1.6  Application of Liposomes --- As Drug Carriers  
1.6.1  Lipid Vesicles/Liposomes 
Antimicrobial treatment plays a major role in the treatment of patients‘ infection for 
decades. However, the failure of antimicrobial treatment is often encountered in the 
immunocompromised patients. There are several causes of failure of antimicrobial 
therapy including sub-effective drug concentrations at the infected site or the presence of 
barriers, low susceptibility of the microorganism to the applied antimicrobial agent, 
growing number of immunocompromised patients and sub-optimal treatment regimen 
because of unknown disease. A possible way to improve antimicrobial treatment is to 
formulate drugs into liposomes. Drug delivery could improve the therapeutic index by 
increasing control over the time, duration and site of drug action and by reducing side 
effects of potentially toxic antibiotics.
178-180
 The ideal drug carrier should ensure the 
timely release of drug at the appropriate site and is neither toxic nor immunogenic, is 
biodegradable or easily excreted after action and is relatively cheap and stable upon 




There have been several reports about the application of drug delivery based on 
liposomes.
183-184
 These systems are known as nanocapsules and may include synthetic 
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elements to the leaflets. One example is the incorporation of polymers into the leaflets. 
Nanopartical systems responding to their local environments have been described with 
respect to certain applications. For example, a pH sensitive polymer-nanopartical which 
responds after the environment changes from pH 7.4 to pH 5; the polymers hydrolyse 
and the particles swell. The swelling compromises the membrane integrity and the 
encapsulated drug is then released, in this case paclitaxel, a chemotherapeutic agent used 
to indicate for lung cell carcinoma.
183
 Another example is to use chitosan with the 
encapsulation of silver sulfadiazine. In this case the chitosan bursts and the antimicrobial 
is slowly released into the wound.
184
 However, it is no longer advisable to use silver in 
such a way because recent research shows that to achieve a sufficiently antimicrobial 
environment a concentration of silver is required greater than the threshold for 
cytotoxicity.
12-13
 The concept of encapsulating materials for the prevention of biofilm 
formation has been described, however, the use in wound dressings as an active response 
system was not addressed.
161
 Liposome systems have shown to deliver drugs 
transdermally and to the lungs.
184-185
 Liposomes in vivo have been shown to be less 
successful. They have to contend with the host immune systems which invariably 
recognise vesicles as a xenotopic entity.  
 
1.6.2   Polydiacetylene Vesicles as Drug Carriers  
The applications of liposomes for long-term, sustained release have been plagued by 
their insufficient morphological stability, susceptibility to acids, bases, or surfactants, 
and the resulting poor sustained- and controlled-released efficiency. Due to these issues, 
various polymerised vesicles with surfactant or lipid type have been investigated to 
overcome the instability problem.
186
 The polymerised vesicles could maintain the shapes 
for an extended period of time, less susceptible to surfactant-induced disruption, and 




Self-organised π-conjugated polydiacetylenes (PDA) are usually used as a platform for 
detection of biological analytes such as microorganisms, viruses and proteins. The 
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environmentally responsive chromic properties of the polymer, combined with 
self-assembled material formats, make these materials particularly attractive for 
biosensing applications. So far, the use of polydiacetylene vesicles alone or blended with 
liposome as drug carriers has rarely been studied. Compared with conventional 
liposomal formulations, polydiacetylene-phospholipid vesicles exhibit various 
advantages: (1) photoinduced polymerisation results in higher stability; (2) the 
conjugated backbone of polydiacetylene can be distorted upon exposure to pH, 
temperature and biorecognition, which can be used for stimuli-responsive drug 
controlled-release systems; (3) the degree of polymerisation along with the release of the 
entrapped drugs can be regulated by altering the proportion of diacetylene monomers.
188
  
Qin and his group developed partially polymerised liposomes composed of 
polydiacetylene lipids and saturated lipids.
189
 The results showed that cross-linking of 
the diacetylene lipids prevents the drug leakage even at 40 
o
C for days and more than 
70% of the encapsulated drugs can be instantaneously released by a laser that matches 
the plasmon resonance of the tethered gold nanoparticles on the liposomes.  
 
1.7  Problem Statement & Aims  
The re-emergence of bacterial infection of burn wound as a clinical problem in the late 
20
th
 century, after it was reportedly defeated by the widespread use of antibiotics, has 
triggered a growing interest in developing systems that either kill bacteria or prevent 
bacterial attachment and growth. Many bacteria can attach to surfaces, where they 
colonise and form complex communities (defined as biofilms) which are notoriously 
resistant to antibiotics. This has led to the development of antimicrobial coatings 
containing agents such as silver or quaternary ammonium cations (QCAs) that prevent 
or limit bacterial attachment and biofilm formation. However, it should be pointed out 
that there are some reports that the presence of silver ions in wounds can actively reduce 
wound healing, and that silver is cytotoxic at concentrations required for it to be an 
effective antimicrobial. Although they are functional in essence, they do not respond to 
their local environment, and operate whether bacteria are present or not. Therefore, there 
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is a need to develop a ‗smart‘ wound dressing technology which can respond to the 
microbiological environment of the wound and give a colour response in the presence of 
pathogenic bacteria and will release an antimicrobial to kill/inhibit the growth of 
pathogenic bacteria only when required. 
 
There are a number of drug delivery approaches that utilise nanocapsule technology. 
Vesicles have shown to be able to transfer drugs through skin 
184
 and to the lungs 
190
 as 
biomimetic model as their structure is similar to the structure of plasma membrane and 
they potentially have no harm to host cells. However, there are some critical issues for 
current liposomal carriers in clinical applications such as morphological instability, 
susceptibility to acids, bases, or surfactants, and the resulting poor sustained and 
controlled-release efficiency. In this work, a new liposomal system to achieve stability 
has been developed. The system is based on the polymerisable molecule, 
10,12-tricosadiynoic acid  (TCDA) (figure 1.11), in liposomes composed of 
phospholipids (DMPC,DMPE). The polymerisation of TCDA monomers occurs by UV 
irradiation, resulting in the formation of polydiacetylene-linkages. The focus of the 
stability study is to regulate the degree of polymerisation, hence the degree of stability 
of vesicle system by altering the TCDA proportion.  
  
In this thesis, a microbiologically responsive nanocapsule system has been investigated 
for the potential use in burn wound dressings. Figure 1.14 outlines the experimental 
approach explored in this work. Two pathogenic bacteria have been used to be the agents 
of their own destruction by releasing toxins that rupture vesicles containing an 
antimicrobial agent and/or fluorescent dye. Non-pathogenic bacteria E. coli EH5α has 
been used for control system as it does not secrete any toxins. Pathogenic bacteria 
secrete membrane damaging toxins/enzymes that lyse the lipid membrane of vesicles 
which are attached to a treated surface. Antimicrobial agents and/or fluorescent dye will 
be released outside the vesicles to kill/inhibit bacteria growth. Meanwhile, vesicles 




           














Figure 1.14: Schematic of responsive antimicrobial system showing an immobilised vesicle with 
encapsulated antimicrobial/fluorescent dyes.  
Toxins secreted by pathogenic bacteria lyse the vesicle and release the antimicrobial, concomitantly 











(a) Non-woven polypropylene textile 
material used in burn dressings: 
plasma/photografting modified the 
surface. Vesicles sprayed on and bound 
to fibers.  
  
(b) Vesicles or partially polymerised vesicles 
attached to the modified surface covalently 
containing ‗switched off‘ dye and 
antibiotic/antimicrobial.  
(c) Pathogenic bacteria secrete toxins 
and enzymes, some of which lead to 
lysis of vesicle wall.  
 
(d) Antimicrobial kills bacteria or 
encapsulated dye released  
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Chapter 2  Instrumentation and Theory 
2.1  Fundamentals of Plasma Polymerisation and Surface 
Modification 
 
Plasma polymerisation is a unique technique to fabricate thin polymer films (100 Å-1 
µm) from a variety of organic and organometallic starting materials. Plasma polymerised 
films are highly crosslinked and therefore are insoluble, thermally stable, chemically 
inert and mechanically tough. In addition, such films are often highly coherent and 
adherent to a variety of substrates including conventional polymer, glass and metal 
surfaces. Due to excellent properties they have been used in last few years for a variety 









 and adhesion promoters
8 
, plasma polymerisation technique 
is employed in this work for surface modification, on which the vesicles can covalently 
bonded.  
 
Low-pressure plasma polymerisation is an ultimately green process, in which a 
minimum amount of material is used and actually no effluent results from the process. 
Low-pressure plasma polymerisation is a useful and economical tool for nanofilm 
coatings which is quite friendly to the environment. It is reported that the 
functionalisation of solid surfaces for biocompatibilisation has been a challenging task 
for interdisciplinary research bordering between materials and life sciences. While 
plasma polymers have commonly been associated with protective coatings, diffusion 
barriers, optical applications, and abrasion resistance, more recently there has been 
increased interest in the chemistry of these coatings with the aim to maximise the 




2.1.1  Main Sources of Gas Discharge Plasmas 
The plasma state is a mixture of electrons, negatively and positively charged particles, 
and neutral atoms and molecules. Plasmas have been described as the fourth state of 
matter, which is more highly activated than in solid, liquid or gas state. Three factors are 
required for plasma generation: (1) an energy source for ionisation, (2) a pumping 
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system to maintain the plasma state; vacuum or atmospheric, (3) and a reaction chamber. 
This energy source can be used to initiate polymerisation. The mechanism of plasma 
polymerisation is complex and is not well understood.
10
 However the use of plasma in 
this study is to deposit an activating layer of grafting compounds onto a fabric which 
means that the explicit processes of plasma initiated organic gas polymerisation is 




Plasma can also be created by other conditions by transferring power from an electric 
field to electrons or by applying intense heat to a state of matter.
1, 12-14
 In most cases, a 
direct current (DC) glow discharge is attained by passing electric current through a gas 
under low pressure. The cathode is bombarded with positive ions, resulting in the 
generation of secondary electrons. These electrons are accelerated away from the 
cathode until they gain sufficient energy to ionise the gas molecules or atoms that collide 
with the electrons.  
 
Another way to create glow discharge is by using alternating current. The frequency of 
alternation is important. At a low frequency, it can be regarded as a DC discharge with 
changing polarity. The positive ions become immobile upon increasing the frequency of 
the applied voltage since they can no longer follow the periodic changes in field polarity, 
and therefore respond to time-averaged fields. A frequency of about 50-100 kHz is 
sufficient to provide a continuous discharge. At radio frequency (rf, 13.56 MHz), no 
contact between the electrodes and the plasma is required. The plasma can be initiated 
and sustained by external inductive electrodes. 
 
2.1.2  The Plasma Polymerisation Mechanism 
The concept of this polymerisation is that elemental reactions occurring in plasma 
polymerisation are the fragmentation of monomer molecules, the formation of active 
sites (radicals) from the monomer, and recombination of the activated fragments to form 
a polymer. H. Yasuda described this process as the rapid step growth of polymers due to 
fragmentation of monomers, which occurs in a glow discharge region.
1, 15-16
 This process 
is attributed to the various types of collisions simultaneously or separately in the 
reaction chamber. The starting molecules for plasma polymerisation are not restricted to 
unsaturated compounds. Saturated compounds can also deposit plasma polymers. The 
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fragmentation of starting molecules in plasma is represented by two types of reactions, 
namely the elimination of the weakly bonded hydrogen atom and the scission of the C-C 
bond. 
 
(a) Hydrogen elimination                                     
 
                           
 
 
(b) C-C bond scission 
 
                    
 
 
Hydrogen elimination is considered to contribute greatly to the polymer-forming process 
in plasma polymerisation. The gas phase of a closed system after plasma polymerisation 




Figure 2.1 shows an essential polymer forming process as proposed by H. Yasuda, which 
can be related to the elimination of hydrogen and scission of C-C bonds. When hydrogen 
atoms are eliminated from monomer molecules by plasma to form mono-radicals Mi·, 
and bi-radicals ·Mk·, and therefore, the addition of the radicals to monomer and the 
recombination between two radicals proceeds to make large molecules with or without 
radical. Mono-radicals Mi· add to the monomer to form a new radical Mj-M·. 
Mono-radical Mi· may combine Mj· to form a neutral or stable molecules Mi-Mj. A 
bi-radical can also attack the monomer to form a new bi-radical ·Mk-M·, or recombine 
with another bi-radical to form a new bi-radical ·Mk-Mj·. The new monomer Mi-Mj is 
activated by plasma to form mono- or bi-functional activated species. The cycle (i) is the 
repeated activation of the reaction products from mono-functional activated species, 








Plasma polymerisation in this work was done using a home-made reactor which belongs 
to the A.T.A.Jenkins research group at the University of Bath and can be seen in figure 
2.2.  
 
          
Figure 2.2: Home-made plasma reactor  
 
The reactor is schematically represented by figure 2.3. The reaction chamber (centre) is 
kept under high vacuum (10
-2
 mbar), with organic vapour allowed to flow from the 
Youngs flask. The substrate is immobilised in the reaction chamber and the plasma is 
ignited using RF power via the copper wire wrapped around the chamber (blue). Oxygen 





Figure 2.3: Diagram of a plasma reactor.  
The Plasma Reactor can be used to form an oxygen plasma for cleaning gold electrode surfaces. The 
general procedure is detailed in the appendix. The reactor can also be used to oxidise a gold surface or to 
form polymers on a surface (the monomeric unit being introduced via the Young‘s Flask) 
 
The structure of the deposition is determined by many factors. The input power can be 
oscillated on and off during deposition, thus a lower incidence of bombardment from 
ions and radiation provides an overall lower particle temperature. The off time cycle 
allows for recombination processes that are unavailable in the high energy continuous 
wave mode allowing more time for binding to substrates.
11, 18-19
 The flow of the 
monomer from the Youngs flask to the reaction chamber also impacts on film chemistry. 
Homogenous films are obtained at higher flow rate (low pressure) and heterogeneous 
films with lower flow rate (high pressure). Flow rate can be calculated by measuring the 
change in pressure over a time when the vacuum chamber is isolated via equation 2.1. 
This equation also provides an indication of the volatility of a monomer. In addition 
some empirical parameters also have impacts on the film chemistry which include 
position in reactor, flow rate under the vacuum, volume of plasma glow and substrate 
temperature. It is found that positioning substrates downstream of the centre of the 







    
   
                                             (2.1) 
 
In this equation, χ is the flow rate in cm3 sec-1 when Δt is time in seconds, V the volume 




2.1.3  Plasma Reactor  
Home-made plasma reactor was used in this work with help from Dr. Stuart Fraser of the 
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University of Sheffield based on the design explained by Bullett et al 
20
 (figure 2.2).  
  
The reactor comprises a Pyrex cylindrical tube, 30 cm long and 10 cm in diameter. The 
reactor had a round stainless steel flange at either end. Substrates were positioned at an 
optimised point for deposition according to the conditions and monomer used. The 
system was kept under vacuum by an Edwards RV5 pump (ca. 10
-2
mbar). Gases for 
reactor cleaning or film tailoring (e.g. oxygen) were fed in via a gas control valve and 
monomer vapour allowed to flow from the Youngs tap. The rate of gases was controlled 
by adjustment of the tap and/or external heat applied to the monomer chamber. Power 
was supplied by a 13.56 MHz RF coaxial system and connected to the reactor via a coil 
of solid copper wire of 2 mm diameter and was earthed through the electrodes or 
vacuum line. A manual matching network was used to adjust input impedance so that 
maximum power was transferred from the generator to the load. The RF power supply 
was introduced in CW or pulse mode by using a pulse generator. An oscilloscope was 
used to alter the width and amplitude of the pulse which allows high levels of control 
over reaction conditions.  
  
2.2  Fluorescence 
21
  
2.2.1  Principles of Fluorescence  
Luminescence is the emission of light from any substance and is divided into two 
categories, fluorescence and phosphorescence. Both fluorescence and phosphorescence 
involve a transition from an electronically excited state to the ground state.
21
 In a singlet 
excited state the excited electron has the opposite spin to an electron in the ground state 
orbital, therefore when the excited electron moves to the ground state the transition is 




); this is fluorescence 
and has a life time of about 10 ns. In phosphorescence an electron is in an excited triplet 
state and has the same spin as an electron in the ground state orbital. The transition for 
the electron to move back to the ground state is spin forbidden and therefore occurs over 










Fluorescence is a well described and exploited phenomenon. Fluorophores often exhibit 
strongly delocalised electrons in conjugated double bonds or aromatic systems. The 
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schematic Jablonski energy level diagram is the usual way to explain the absorption and 
emission of fluorescence and phosphorescence. A Jablonski diagram is shown in figure 
2.4.  
                                                                   
VR = Vibrational Relaxation                            T = Triplet State 
ISC = Inter System Crossing                            S = Singlet State  
IC = Internal Conversion          
      
 
Figure 2.4: Excitation and relaxation of molecules due to absorption and emission of light.  
Absorption of light is followed by vibrational relaxation (VR) or radiationless internal conversion (IC) 
between electronic states. The superscripts of the electronic states represent the vibrational quantum 
numbers of the various vibrational sublevels. Return to the ground state from 
0
1
S can be proceed by 
internal conversion, fluorescence (F) or intersystem crossing to the lowest triplet state (T 1). The triplet 
state is deactivated by phosphorescence (P) or radiationless intersystem crossing.  
 
Excitation of a fluorophore is induced by absorption of electromagnetic wave energy of 
specific quanta. An electron can be excited to the higher excited energy levels of S1 or S2 
and rapidly relaxes and returns to the ground state (S). An electron at an excited state 
will undergo vibrational relaxation (VR) from a vibrational level returning to the lowest 























non radiative decay pathway. This process generally occurs in 10 
-12
 s or less which is 
much more quickly than fluorescence (10 
-8
 s). Therefore, fluorescence occurs from the 
lowest excited state ( 0
1
S ) (Kasha‘s law). From this exited state ( 0
1
S ) the molecule can 
decay to any of the vibrational states of the ground electronic state ( 1 2 3
0
, , ......S ) by emitting 
photons at a rate of
F
 .  
 
The transition between two states of the same spin multiplicity is a quantum 
mechanically allowed process and the rate of emission is typically high at  10-8 s. 
Stokes‘ shift, the spectra of fluorescence emission to a lower wavelength (red shift) 
relative to absorption, is a way to compare the difference between absorption and 
emission in energy.  This shift can be explained by energy losses between the two 
processes due to the rapid internal conversion in the excited states (S1, S2) and the 
subsequent decay of the fluorophore to higher vibrational levels of S0. The Stokes‘ shift 
allows differentiation between excitation and emission energies such that discrete 
wavelengths can be used to excite systems and measure emission allowing isolation of 
the emitted photons and exciting photons (figure 2.5). 
                                                         
 
Figure 2.5: Spectra of Stokes‘ shift.  
The peaks occur at the 
0 1
x yS S transition energies, the difference in energy illustrates the Stokes‘ shift of 
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a fluorophore. The specific transition between 
0 0
0 1
S S  would be expected to be at the same energy as 
no vibrational relaxation occurs. However if energy is lost due to solvent collisions and the surroundings, 
in the gas phases this energy difference is reduced.
 21-22 
(Image source is from free Wikipedia)  
 
Generally the fluorescence emission spectrum appears to be a mirror picture of the 
absorption spectra due to the same transitions that are involved in both processes and the 
similarities among the vibrational levels of S0 and S1. However, exceptions do exist due 
to excited state reactions and geometric differences between electronic ground states and 
exited states. Kashsa‘s law explains this: all excitation from 0
0
S  to any level greater 
than 0
1
S will decay extremely rapidly to 0
1
S and so all emission will occur from this level. 
Again there are some exceptions in molecules with different absorption/emission in 
different ionised forms. Some molecules also fluoresce from the 0
2
S state, but these 
molecules are rare and have not been found in biological systems.  
 
Quantum yield and fluorescence lifetime are two main characteristics that describe a 
fluorophore. The quantum yield is defined as the ratio of emitted photons to the number 
of photons put into the system. Starting from the excited state S1 the fluorophore can not 
only dissipate its energy by fluorescence emission with the rate
F
 , but several other 
radiationless decay channels can be found that lead to a depopulation of S1. Electronic 
transition to triplet states by intersystem crossing (ISC) as well as quenching processes 
(
Q
 ) and resonant energy transfer ( ET ) result in a decrease of the fluorescence 









                                                   (2.2) 
In this equation, Q  is quantum yield, F  is the rate of fluorescence and 0  
is the 
rate of internal conversion from the first electronic excited state to the ground state. 
 
This is equivalent to the ratio of the number of emitted photons over absorbed ones. The 
rate constant 
0








0 ISC IC Q ET
                                                 (2.3)  
 
Fluorescence lifetime   is defined as the average time that a molecule spends in the 
excited state before return to the ground state. The general value for this property is 









                                                  (2.4) 
  
In addition the environment of the fluorescent species such as polarity of the solvent or 
pH may influence intensity and the wavelength of emitted fluorescence. The interaction 
with the fluorophore‘s dipole and chemical reactions between the dye and solvent 
molecules such as hydrogen bonding, charge transfer and ionisation can also have 
impact on fluorescence intensity. The solvent effects are used to explore the environment 
in which the fluorophore exists particularly in complex biological systems. Some heavy 
atoms such as iodine and bromine can result in poor quantum yields. In the following 
section, quenching will be discussed.  
2.2.2  Fluorescence Quenching  
Fluorescence intensity can be reduced by a number of processes, for example complex 
formation, energy transfer, excited state reactions or collision of molecules. The energy 
that has been absorbed can be dissipated without fluorescence occurring. Such processes 
are called fluorescence quenching and can occur via multiple mechanisms. Collisional 
quenching occurs when the excited-state fluorophore is deactivated upon contacting with 
other molecules in solution, which is called quencher. Static quenching happens when 
the fluorophore and the quencher form a nonfluorescent complex through collisional 
quenching. The decrease in intensity is described by Stern-Volmer equation. 
  








In this equation, I and I0 are the fluorescence intensities of the quenched and unquenched 
fluorophore respectively. 
D
 is the Stern-Volmer quenching constant,
Q
  is the 
bimolecular quenching constant, 
0
 is the unquenched lifetime and  Q is concentration 
of quencher. Quenching data are usually plotted as I0/I versus  Q . The ratio of such 
value is expected to give a linear dependence. However, if a quencher forms a non 
fluorescent complex with fluorophore, this is known as static quenching. Deviations 
from linearity can be described by equation 2.6. 
 




                                                    (2.6) 
 
In this expression, 
S
 is the association constant for the fluorophore-quencher complex. 
Mechanisms of energy transfer, chemical reaction and oligomerisation can lead to 
quenching and the exact process varies between systems. For example, 
carboxyfluorescein which is used in the thesis will self quench at high concentrations.  
 
2.3  Instrumentation for Characterisation and Visualisation of 
Vesicles 
2.3.1  Fourier-transform Infra-red Spectroscopy 
Following synthesis of plasma polymerisation in this work, identification of polymer 
composition is required. In this section, FT-IR will be employed to detect the 
characterisation of plasma deposition for pp-MA and to provide an evidence of vesicles 
attachment onto deposited films.  
 
FTIR requires the change in dipole moment of a molecule upon vibration. The 
compound is recognised if an antisymmetric stretch occurs, or the bending of a bond 
results in departure of the dipole moment from zero. An infrared spectrum represents a 
fingerprint of a sample with absorption peaks which correspond to the frequencies of 
vibrations between the bonds of the atoms making up the material. Hence such bonds as 




IR spectroscopy is based on specific absorption of a photon by photo-excitation. If a 
photon of infra-red radiation of frequency ν is absorbed which matches the separation in 
vibrational levels, the molecule is excited to a higher vibrational level. Bonds vibrate at 
certain energy and therefore an IR spectrum may be obtained by measuring percentage 
transmission or absorption of an IR beam against wavenumber after data processing 
(Fourier-transform). The chemical composition may then be determined by from this 
spectrum.
23-24
 Therefore the frequency of the vibrations can be associated with a 
particular bond type. A Perkin-Elmer FT-IR spectrum 100 spectrometer with an ATR 
attachment was used during this work to indentify the covalent bond formation after 
vesicles attached to pp-MA modified non-woven polypropylene.   
 
2.3.2  Fluorescent tagging  
A fluorescent dye may be encapsulated in both phospholipid vesicles and 
polydiacetylene/phospholipid vesicles in order to identify their presence and/or their 
interaction with pathogenic bacteria over time. Such dyes utilise the principle of 
fluorescence which has been described in section 2.2. 
2.3.2.1  Fluorescence Spectroscopy  
A spectrofluorometer is an instrument which can both excite fluorophores and detect 
emission of fluorescence. The emission is normally recorded as the intensity versus 
wavelength which is called emission spectra. A sample is bombarded by a high intensity 
of light source which allows the maximum number of molecules to be in the excited 
state at any point in time. The light is passed through either a filter or a monochromator 
to select a fixed wavelength to use as the exciting light. The emission is collected at 90 
degree to the exciting light and beam is then passed through either a filter or a 
monochromator before being detected. A BMG Labtech microplate reader was used as 
the spectrofluorometer in this work which is shown in figure 2.6. The multifunctional 
plate reader covers a full range of wavelength from 230 to 900 nm for both excitation 
and emission by integrating a high intensity xenon flash lamp. It can detect both 
fluorescence intensity and UV/Vis absorbance. The emission/excitation maximum for 
the fluorescence used in this work is 488/510 nm. This technique was employed for 
measuring vesicle leakage when bacteria were inoculated in vesicle solution 
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(self-quenched fluorescent dye encapsulated) in terms of fluorescence intensity 
increasing over time.  
 
                       
Figure 2.6: FLUOstar Omega microplate reader  
 
2.3.2.2  Fluorescence Microscopy  
Light microscopy can be adapted to utilise fluorescence in visual representation of cell 
viability. Ultraviolent is the light source in fluorescence microscopy. Fluorophores are 
excited similarly to fluorescence spectroscopy and emit photons which can be viewed 
optically. 
25
 The excitatory light is passed from above (or for inverted microscopes, from 
below), through the objective and then onto the specimen instead of passing it first 
through the specimen. The fluorescence in the specimen gives rise to emitted light which 
is focused to the detector by the same objective that is used for the excitation. A filter 
between the objective and the detector filters out the excitation light from fluorescent 
light. Since most of the excitatory light is transmitted through the specimen, only 
reflected excitatory light reaches the objective together with the emitted light and this 
method therefore gives an improved signal to noise ratio (figure 2.7). This method was 
used to take images of giant unilamellar vesicles attaching onto plasma- and non-treated 
surfaces post bacterial attachment. The fluorescence microscope used here was a Nikon 




                                                                
                                                      




2.3.3  Scanning Electron Microscopy (SEM) 
The scanning electron microscope (SEM) was used to visualise the surface structure of 
the vesicle conjugated plasma deposited surface. SEM uses a focused beam of 
high-energy electrons to generate a number of signals at the surface of solid specimens. 
Theses signals result from interactions of the electron beam with atoms at or near the 
surface of the sample. These signals of interactions reveal information about the sample 
such as external morphology (texture), chemical composition, and other properties such 
as conductivity. Data are generally collected over a selected area of the surface of the 
sample. Areas ranging from approximately 1 cm to 5 microns in width can be imaged in 
a scanning mode with conventional SEM techniques which allows magnification 




There are many types of signals produced by an SEM such as secondary electrons, 
back-scattered electrons (BSE), characteristic X-rays, visible light 
(cathodoluminescence) and heat. Secondary electrons are the main means of viewing 
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images in SEM and can produce high resolution images of a surface sample which can 
reveal details less than 1 nm in size. The SEM micrographs can produce a characteristic 
three-dimensional appearance which provides a useful tool to understand the surface 
structure of a sample due to the very narrow electron beam, thus having a large depth of 
field. Back-scattered electrons (BSE) are beam electrons that are reflected from the 
sample by elastic scattering. The images produced by BSE can provide information 
about the distribution of different elements in the sample because the intensity of BSE 
signal is associated with atomic number (Z) of the sample. Therefore, BSE are often 
used in analytical SEM along with the spectra made from the characteristic X-rays. 
Characteristic X-rays are produced when the electron beam removes from the sample to 
an inner shell electron and cause a higher energy electron to fill the shell and release 
energy. X-rays are often used to identify the composition and measure the abundance of 
elements in the sample. 
25
 A scanning electron microscope (SM6480LV) was used in this 
work to explore the structure after polydiacetylene vesicles have been attached onto a 
pp-MA polypropylene surface. Diagrams of typical electron microscopes are detailed in 
figure 2.8.  
 
                
                                  
Figure 2.8: Schematic diagram of a SEM;  
A vacuum source is generally provided to reduce the free path of electrons. The source of electrons is 
generally a tungsten filament or lanthanum hexaboride. Sample should be coated with an electrically 
conductive material e.g. gold.  
74 
 
2.3.4  UV-Vis Spectroscopy  
UV-Vis spectroscopy refers to absorption spectroscopy or reflectance spectroscopy in 
the ultraviolet-visible spectral region. In this region of the electromagnetic spectrum, 
molecules will undergo electronic transitions from one energy level to higher energy 
level. When molecules are exposed to light having an energy which matches a possible 
electronic transition within the molecule, some of the light energy will be absorbed as 
the electron is promoted to a higher energy orbital. An optical spectrometer will record 
the wavelength at which absorption occurs with degree of absorption at specific 
wavelength. The resulting spectrum may be presented as a graph of transmittance (T = I 
/I 0) or absorbance (A = log I0/I ) versus wavelength. If no absorption occurs, T=1.0 and 
A = 0. A corrected absorption value as the molar absorptivity is often used to compare 
the spectra of different compounds using Beer-Lambert law:  
 
 A= log 10 (I0/I) = ε c L                                          (2.7) 
(Where A = absorbance, I0 = intensity of the incident light at a given wavelength, I = 
transmitted intensity, L = the length of light path through the sample in cm, c = the 
sample concentration in moles/litre, ε = molar absorptivity or extinction coefficient)  
 
Molar absorptivity is a fundamental molecular property in a given solvent, at a particular 
temperature and pressure and is useful when comparing the spectra of different 
compounds and determining the relative strength of light absorbing functions 
(chromophores).  
The spectrometer used in this work to determine the absorbance of conjugated 
polydiacetylene/phospholipid vesicles at specific wavelength was BMG Labtech 
microplate reader which has been introduced in section 2.3.2.1. This technique was also 
used to determine bacterial viability/growth in terms of optical density when they were 
inoculated in vesicle solution (antimicrobial/fluorescent dye encapsulated within the 
vesicles), which will be described in microbiological assay.  
2.4  Microbiology   
Microbiology refers to the study of organisms that are too small to be seen by naked 
eyes.
32
 This includes eukaryotes such as fungi and protista, and prokaryotes, which are 
bacteria and archaea. Microbes can be grouped into three categories according to DNA 
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structure: Bacteria, Archaea, and Eukarya. The former two kingdoms have prokaryotic 
cell structure, which has been presented in previous chapter, the latter eukayotic cell 
structure having a more advanced form of cell. Three main methods for detecting 
bacterial growth will be presented in this section. 
 
2.4.1  Bacteria Used in the Work  
Pseudomonas aeruginosa (PAO1), Staphylococcus aureus (MSSA 476) are used in work 
and Escherichia coli (DH5α) as a control system, hence the three species of bacteria will 
be detailed in the thesis.  
 
2.4.1.1  Pseudomonas aeruginosa  
Pseudomonas aeruginosa (P.aeruginosa) is a gram-negative, aerobic rod measuring 0.5 
to 0.8 µm by 1.5 to 3.0 µm which belongs to the family Pseudomonadaceae (figure 2.9). 
The bacterium is commonly found in soil and water, or regularly on the surfaces of 
plants or occasionally on the surfaces of animals. Typical Pseudomonas bacterium in 
nature is found in a biofilm which is attached to some surfaces or substrates, or in a 
planktonic form. This bacterium is quite tolerant to a wide range of physical conditions, 
including temperature, for example, its optimum temperature for growth is 37 degrees, 
and it is also able to grow at temperature as high as 42 degrees. In addition, it is resistant 
to high concentration of salts and dyes, weak antiseptics, and many commonly used 
antibiotics. P. aeruginosa isolates may produce three colony types according to 
published results. Natural isolates from soil or water generally produce a small, rough 
colony, while clinical samples generally produce one or another of two smooth colony 
types. One is a fried-egg appearance which is large, smooth, with flat edges and an 
elevated appearance; another type has a mucoid appearance which is generally from 
respiratory and urinary tract secretions. It is estimated that the smooth and mucoid 
colonies play a role in colonisation and virulence. P.aeruginosa produces a variety of 
pigments, including the fluorescent pigment pyoverdine, blue pigment pyocyanin, and 
red-brown pyorubin. Pyocyanin is produced a lot in media of low-iron content and 
functions in iron metabolism in the bacterium. Pyocyanin is also a characteristic of 




      
                    A                          B                                       
Figure 2.9: P. aeruginosa colonies on an agar plate and its micrograph in SEM.  
(A) P.aeruginosa colonies on agar; 
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 (B): False colour SEM (9560 x) of Pseudomonas aeruginosa (Image 
Source: Carr J. H., in MRSA_PHIL #10046 and PAO1_PHIL#10043, Public Health Image Library.) 
 
P. aeruginosa has been increasingly considered as an emerging opportunistic pathogen 
of clinical relevance. Pseudomonas aeruginosa is an opportunistic pathogen which 
means that it almost never infects uncompromised tissues, but it can cause infection if 
the tissue defenses are compromised in some manner. It generally causes urinary tract 
infections, respiratory system infections, dermatitis, soft tissue infections, bacteremia, 
bone and joint infections, gastrointestinal infections and systemic infections, especially 
in patients with severe burns and in cancer and AIDS patients who are 
immunosuppressed.  It is found that almost one in ten hospital-acquired infections are 
from Pseudomonas, for example the infection is a serious problem in patients 
hospitalised with cancer, cystic fibrosis, and burns. This major nosocomial pathogen has 
a low antibiotic susceptibility and is intrinsically resistant to a great number of 
antibiotics including all penicillins with the exception of certain ureidopenicillins.
34
 This 
resistance results from the action of multi drug efflux pumps with genetically encoded 
antibiotic resistance as well as the low permeability of the cellular envelope. P. 
aeruginosa also acquires resistance by the action of genetic mutation and horizontal 
gene transfer of antibiotic determinants. Biofilms of P. aeruginosa can cause chronic 
opportunistic infections. This kind of infection is a serious problem for medical care, 
particularly in immunocompromised patients and the elderly. The infection is hard to 
treat effectively with traditional antibiotic therapy because biofilms as presented above 
seem to protect these bacteria from adverse environmental factors. This will require 
better clinical management of chronically infected patients and should lead to the 






P. aeruginosa (PAO1) is used in the study as the gram-negative model.  
 
2.4.1.2  Staphylococcus aureus  
Staphylococcus aureus (S. aureus) is a gram positive, facultative anaerobic and cluster 
–forming coccus (figure 2.10). S. aureus is nonmotile and non-spore forming, catalase 
and coagulase positive.
35
 Typical colonies are yellow to golden yellow in colour. S. 
aureus can cause haemolysis when grown on blood agar plates.
35
 Gram-positive means 
that the bacterium retains crystal violet dye because of its cell wall construction. This 
type of bacterium lacks the outer lipopolysaccharide wall which can be normally found 
in gram negative but has thicker peptidoglycan layer. S. aureus is mainly present in nasal 
passages and regularly can be found on skin surfaces, oral cavity and gastrointestinal 
tract. Although it is usually harmless at these sites, it may get into the body through 
breaks in the skin such as abrasions, cuts, wounds et al. and cause infection. Therefore, S. 
aureus is considered as an important nosocomial and community – acquired pathogen 
and is the most common cause of hospital acquired infection. It is responsible for a 
range of illnesses from skin infections (impetigo, boils and sores) to lethal infections 
such as cellulitis, meningitis, endocarditis, toxic shock syndrome (TSS) and bacteremia 
to name a few. Toxic shock syndrome is a severe systemic illness and a complication of 
burn injury. It is a rare but serious type of blood poisoning caused by toxin-producing 
Staphylococcus and Streptococcus bacteria. TSS has a high risk of patient mortality, 
particularly in paediatric patients. It is known that unrecognised and untreated TSS in 
paediatric burn patients can lead to extremely high mortality which is up to 15-20%.
36
 
Some strains of S. aureus are usually responsible for TSS because they produce exotoxin 
TSST-1 which is the causative agent of toxic shock syndrome. 
 
The treatment for S.aureus infection is penicillin. However, most strains of S. aureus are 
now resistant to β-lactam antibiotics including penicillins, carbapenems and 
cephalosporins.
37 
This is because S. aureus can produce a substance called 
―β-lactamase‖ which can degrade penicillin and destroy its antibacterial property. 
Following the introduction of methicillin (a new type of penicillin antibiotic which was 
not degraded by β-lactamase and was used as an effective antibiotic to treat infections), 
certain strains of S. aureus showed resistant to methicillin. These methicillin–resistant 
S.aureus became known as ―MRSA‖ for short although methicillin is no longer 
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prescribed and have been replaced by fluocloxacillin, which is a better penicillin-type 
antibiotic that is also not affected by β-lactamase, and the term ―MRSA‖ continues to be 
used.  Figure 2.10 shows a colony of MRSA under scanning electron microscope and 
MRSA infection on a patient skin.  
 
Methicillin susceptible S. aureus (MSSA 476) is used in the study as the gram positive 
model.      
 
Figure 2.10: Micrograph of S.aureus in SEM and wound infection caused by MRSA.  
Left: scanning electron micrograph (SEM) of a colony of MRSA magnified 2381 times. Right: an abscess 
is shown on the knee of a prison inmate caused by MRSA 
38 
(image source: Centre for Disease Control 
and Prevention, http://phil.cdc.gov/phil) 
2.4.1.3  Escherichia coli   
Escherichia coli (E.coli) is a gram-negative, non-sporulating, facultative anaerobic 
bacterium with an average size of 2 µm by 0.5µm 
39
 (figure 2.11). The bacterium can 
survive on a wide variety of surfaces but is commonly found in the lower intestine of 
warm-blooded organisms in endotherms. Most of E.coli strains are harmless and they 
are a part of gut flora and can benefit their hosts by production of vitamin K and also 
they can prevent the establishment of pathogenic bacteria within the intestine.
40-41
   
However, some virulent strains of E. coli are responsible for a range of illnesses, such as 
gastroenteritis, urinary tract infections, and neonatal meningitis. In some cases, virulent 
strains can even cause haemolytic-uremic syndrome, peritonitis, mastitis, septicaemia 
and gram-negative pneumonia.
42
 Pathogenic strain O157: H7 is notorious for causing 
serious and even life-threatening complications such as haemolytic-uremic syndrome. 
The mechanism of infection includes the common pilus attachment and then the release 







It is comparatively simple to culture and manipulate the genetics of E. coli which makes 
it a popular prokaryotic gram negative model. E. coli DH5α is a non-pathogenic 
bacterium to normal healthy individuals and has been used in the laboratory for many 
years and most of its virulent factors have been removed, leaving no virulence factors. 
Therefore, E. coli DH5α is used in this work as non-pathogenic control bacteria. 
 
Figure 2.11: False colour SEM (× 22,000) of hemorrhagic E. coli O256:H7 
43 
 
2.4.2  Methodology of Detection for Bacteria  
Bacteria can be cultured in aqueous or solid media by inoculation of the media with a 
small amount of cells. Most bacteria have individually defined minimum, maximum and 
optimum growth temperatures which range from -10
o 
C to over 80
o
C. The majority of 
pathogenic bacteria tend to have an optimum of 37
o
C, or human body temperature. 
Equally, bacteria can grow in a range of oxygen concentrations, pH and water content. 
Also, bacteria can be tagged with a fluorescent dye in order to identify their presence 
and/or viability. Such dyes utilise the principle of fluorescence, which is evidenced by 
decay of short lived excited states in an atom or molecule through the emission of a 
photon.  
 
2.4.2.1  Basics of Bacterial Growth 
Bacteria grow to a fixed size and then reproduce by a process of binary fission, which is 
a form of asexual reproduction.
44
 The nutrient and the temperature play an important 
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role in the growth and reproduction of a bacterium. Therefore, with sufficient nutrients 
and optimum temperature, bacteria can grow and reproduce very well. It is estimated 
that bacteria can grow and divide rapidly and bacterial populations can double as 
quickly as every 9.8 minutes under optimal conditions.
45
 In laboratories, bacteria are 
generally grown or cultured using solid (agar plates or slopes) or stirred liquid medium 
(broth) in an incubator at 37 
o
C. Solid media such as agar plates are used to isolate pure 
cultures of a bacterial strain. Liquid growth media are used when large amount of cells 
are required. As bacteria reproduce, the resulting cells are genetically identical to their 
mother cells if no mutation occurs during growth. 
Under ideal conditions, the growth of a population of bacteria occurs in several stages 
termed lag, log (exponential), stationary, and death. During the lag phase, active 
metabolic activity occurs involving synthesis of DNA and enzymes, but no growth. 
Geometric population growth occurs during the log or exponential phase, when 
metabolic activity is most intense and cell reproduction exceeds cell death. The 
measurement of an exponential bacterial growth curve in batch culture was traditionally 
a part of the training of all microbiologists; the basic method requires bacterial 
enumeration (cell counting) by direct and individual (microscopic, flow cytometry),
46
 
direct and bulk (biomass), indirect and individual (colony counting), or indirect and bulk 
(most probable number, turbidity, nutrient uptake) methods. Following the log phase, the 
growth rate slows and the production of new cells equals the rate of cell death. This 
period, known as the stationary phase, involves the establishment of an equilibrium in 
population numbers and a slowing of the metabolic activities of individual cells. The 
stationary phase reflects a change in growing condition such as a lack of nutrients and/or 
the accumulation of waste products. When the rate of cell deaths exceeds the number of 
new cells formed, the population equilibrium shifts to a net reduction in numbers and the 













     
Figure 2.12: Foure stages of bacterial growth.  




2.4.2.2  Colony Counting  
Plate counting is widely used and suitable for enumerating bacteria in appropriate media. 
Typically serial dilutions are prepared for each sample with vesicle solution 
(antimicrobial encapsulated) and several replicate plates are prepared from each dilution. 
Agar plate containing nutrients necessary for growth is used to allow bacterial growth to 
be monitored quantitatively in terms of growth colony counting followed incubation at 
an optimal growth temperature. After a strain-dependent period of time (usually 18h) 
visible cell colonies appear on the agar surface (figure 2.13). The visible cells 
correspond to an initial cell which has reproduced sufficiently. Although the labour 
required to prepare, inoculate, and count the plates are not insignificant, it is a relatively 
reliable way to estimate a quantity of bacteria which were present in the original solution, 




 This is the ‗gold 
standard‘ of bacterial detection as it provides both an estimation of cell quantities and 
shows any contamination within the culture e.g. other micro-organisms.   
























         
Figure 2.13: S.aureus (MSSA 476) colonies on an agar plate grown from individual cells 
 
2.4.2.3  Solution Turbidity  
Solution turbidity is a more straightforward but slightly more inaccurate and indirect 
way to determine cell quantification. Because cell reproduction results in a less 
transparent solution than pure media alone, the difference in light absorption can be 
measured and related back to the initial bacterial concentration.
36
 This is normally 
measured by a UV-vis spectrophotometer, with the transmission of light through a 
known path length reduced by cells in terms of optical density reading (OD) for the 
sample which is shown in figure 2.14. 
 
                                          
                   
Figure 2.14: UV-vis measurement to determine the optical density of bacterial culture 
where I0 = incident beam intensity, I = transmitted beam intensity and wavelength of incident light 
(typically 600 nm).  
  
c , ε 
Cuvette containing bacterial solution 
I 0 I   
L 
OD λ = log 10   I / I 0 
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Optical density can be associated with CFU mL
-1
 when the same bacterial solution is 
colony counted at various known dilution factors to yield a calibration plot. The 
calibration plot is used to determine the bacterial concentration at specific OD 600. The 
plot is highly strain specific. Therefore a calibration plot must be done for every single 
bacterial strain under particular experimental conditions. In addition the limit of 






 due to the fact that the light 
cannot pass through with large amount of bacterial cells. The UV-Vis spectrophotomer 
used in this work to determine the concentration of bacteria was FLUOstar Omega 
microplate reader which has been presented in 2.3.2.1. 
 
2.4.2.4  Optical Density-CFU Relationship of Bacteria 
The relationship between optical density at 600nm (OD 600) against CFU mL 
-1
 is shown 
in figure 2.15 which elucidates the relationship as a quick reference for indentifying 




 CFU mL 
-1
 which has been explained in section 2.4.1.3.  
 





(reproduced with permission from MPhil thesis of A. Loftus, 2010). 
 
2.4.3  Sterilisation  
The maintenance of sterile conditions is necessary to work safely with bacterial sample. 
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All work was carried out with Class II pathogens (MSSA 476, PAO1) in a class II safety 
cabinet in this work. Bleach or 70% alcohol was used to disinfect the surfaces outside of 
the cabinet.  
 
Media and equipment were sterilised by the use of heat, which is in the form of an 
autoclave. Autoclaving is a decontamination process of materials at depressurised steam 
which must run at 121ºC and 15 psi for 15 minutes.
32
 All pp-MA treated non-woven 
polypropylene samples were sterilised by using a quick and dry method of UV/ozone 
treatment as an ultraviolet light source can attack bacteria on contaminated surface by 
bombarding chemical bonds within the cell via high energy light.  
 
2.4.4  Antimicrobial Evaluation Assays  
In order to evaluate antimicrobial property of vesicles both in solutions and on surfaces, 
the methods used in this work were chosen according to their applicability and are 
presented here. All potential antimicrobials against a non-treatment control system must 
be carried out in this work.  
 
2.4.4.1  Solution Assays 
This assay would investigate the antimicrobial ability of vesicle solution if 
antimicrobials are encapsulated inside. A known concentration of bacteria (by measuring 
it optical density) mixing with antimicrobial vesicle solution was tested either in 
microplate reader overnight in terms of optical density at wavelength of 600 nm or 
through use of colony counting. Due to the high concentration of bacterial cells in some 
solutions, multiple dilutions are required when doing the colony counting.  
  
2.4.4.2  Surface Assays ---JIS  
The measurement of antimicrobial activity from vesicle modified nonwoven is based on 
using the Japanese Industry standard (JIS 1902) to determine antimicrobial efficacy on 
treated surface, the experimental procedure of which will be detailed in experimental 
section. Typically, the surface is lightly rinsed and votexed to remove surface-attached 
bacteria. These bacteria can then be assessed by colony counting.  
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2.4.4.3  Minimum Inhibitory Concentration Assays  
This assay aims to determine the bacterial susceptibility to free antimicrobials in 
solution. The principle of such assay is that the lower MIC in mg mL
-1
 the more 
sensitive the bacterial isolate is to the antimicrobial. There are three general methods of 
determining MIC. Theses are the serial dilution, disc diffusion, and gradient diffusion 
methods. Serial dilution method is commonly used in laboratories. In this method, the 
antibiotic solution is diluted to various concentrations. The broth or agar containing the 
dilution multiples are then inoculated with bacterial isolated of interest and incubated 
overnight at 37 °C. The broth dilution tubes or agar plates are then inspected to 
determine the lowest concentration of antibiotic that prevents of turbidity (dilution tubes) 
using UV-Vis spectrophotometer. The data reported by UV spectrophotometer will be 
plotted and the concentration of an antimicrobial can be determined constructing a 
dose-response curve. The common assessment is based on the ability of the 





2.5  Estimation of Minimum Encapsulation Volume  
In this work, vesicles are used as antimicrobial/fluorescence carriers for killing/detecting 
the presence of pathogenic bacteria. The estimated concentration of encapsulated 
dye/antimicrobial should be taken into consideration to ensure appropriate concentration 
of fluorescent dye/antimicrobials encapsulated in the vesicles to kill/inhibit the growth 
of bacteria. The assumption is on the basis of estimating the total internal volume of 
vesicles when all the vesicles are ruptured in solution. The most straightforward way to 
measure this is to consider a uniform size population of vesicles sphere with an outer 
diameter and an inner diameter. Due to the size differences, the GUVs and 
polydiacetylene vesicles is discussed separately.  
 
2.5.1  Structure and Organisation of Lipid Bilayer  
Lipid bilayers consist of two single-molecule layers of an amphiphilic substance. Lipid 
bilayers are held together by non-covalent forces. This is because lipids can 
self-assemble into this structure due to hydrophobic effect, which creates an 
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energetically unfavourable interaction between the hydrophobic chains and surrounding 
aqueous medium.  
 
Lipid bilayers consist of several chemical regions across its bilayer arrangement. 
Hydrophilic headgroup which is located on either side of the bilayer is the first region. 
This region is completely hydrated and is typically around 0.8-0.9 nm thick. In 
phospholipid bilayers the phosphate group is located within this hydrated region and is 
approximately 0.5 nm outside the hydrophobic core.
51 
The hydrated region can be 
extended much further in some cases when larger proteins or a longer sugar chain are 
grafted onto the region, for instance the lipopolysaccharide coat on a bacterial outer 
membrane.
52 
Such grafted substance can help maintain an aqueous layer around the 
bacteria to prevent dehydration. The intermediate region is next to the hydrated 
headgroup and is partially hydrated. This region is approximately 0.3 nm thick.
53-54 
The 
length of hydrophobic region of bilayer varies with chain length and temperature, 
especially near a phase transition.
55-57
 The hydrophobic part of the bilayer is 
approximately 3-4 nm thick. A schematic structure of a typical lipid bilayer with three 
chemical regions is shown in figure 2.16.  
       
 
 
Figure 2.16: A typical lipid bilayer with several chemical regions.  
There are three distinct regions: a fully hydrated phosphate group in phospholipids; a partially hydrated 
intermediate region; a completely dehydrated region of alkane tails.  




2.5.2  GUVs  
GUVs were formed based on rotary evaporation and thus the sizes of vesicles are much 
larger than that of polydiacetylene vesicles which was made by the extrusion method. 
The assumption of outer diameter and inner diameter should be taken into account in 
order to calculate the total encapsulation volume. The assumption of outer diameter is 1 
μm and this was measured by fluorescence microscopy. To estimate the diameter of 
inner sphere, the approximate length of lipid bilayer should be considered. The length of 
lipid bilayer is assumed to be 5 nm in this work 
58
 based on the discussion of section 
2.5.1. The diameter of inner sphere can be calculated to be 990 nm (figure 2. 17).  
 
                 
                                                                                                                                                                                                      
          
                      
Figure 2.17: Simplified vesicles with estimation of inner and outer diameter.  
 
                                  




and the lipids are highly 
packed in a bilayer configuration,
60
 the number of lipids in one vesicle with internal 
volume can be calculated. The detailed estimation of volume calculation is presented as 
follows:  
 
Outer diameter: 1000 nm  
Area of outer sphere = 4 π r2 = 3.14 x 10 -12 m2  
Inner diameter: 990 nm 
1 μm 
5 nm 990 nm 
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Area of inner sphere = 4 π r2 = 3.08 x 10 -12 m2 
Area of a DMPC head group = 60Å
 2 






Number of lipids:   
Outer sphere = area of outer sphere/area of a DMPC head group = 5233333 lipids  
Inner sphere = area of inner sphere/ area of a DMPC head group = 5133333 lipids 
Total number of lipids in one vesicle = 5233333 + 5133333 = 1.04 x 10 
7 
lipids/ vesicle  
 
Total number of vesicles per mL  
In GUVs: 0.041g DMPC was used to form GUVs = 6.05 x 10 
-5
 moles (Mr DMPC = 
677.93 g/mol) 
 Total number of lipid molecules 
 = moles of DMPC formed in the vesicles x NA = 3.64 x 10 
19 
  
Total number of vesicles = total number of lipids in GUVs solution / number of lipids in 
one vesicle = 3.5 x 10 
12   
in experiment (6.65 mL)  
Number of vesicles per mL = total number of vesicles/ experiment (6.65 mL) = 5.26 x 
10 
11
 vesicles/mL  
 
Total encapsulated volume 
Volume encapsulated in one vesicle = (4/3)πr 3 = 5.08 x 10 -15 m 3   
Total encapsulated volume in 6.65 mL = volume in one vesicle x total number of 
vesicles = 2.67 mL  
The encapsulated volume per mL = 400 μL  
  
2.5.3  Polydiacetylene Vesicles  
Polydiacetylene vesicles were formed by the extrusion method with 100 nm pore size of 
polycarbonate filters. The size of resulting vesicles were quite uniform with outer 
diameter of 110 nm and an inner diameter 100 nm assuming a bilayer thickness of 5 nm. 
Therefore, the encapsulated volume in polydiacetylene vesicles can be considered in the 
same manner as the GUVs did.  
 
Outer diameter: 110 nm  
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Area of outer sphere = 4 π r2 = 3.80 x 10-14 m2  
 
Inner diameter: 100 nm  
Area of inner sphere = 4 π r2 = 3.14 x 10 -14 m 2 
Area of a DMPC head group = 60Å
 2 






Number of lipids:   
Outer sphere = area of outer sphere/area of a DMPC head group = 63333 lipids  
Inner sphere = area of inner sphere/ area of a DMPC head group = 52333 lipids  
Total number of lipids in one vesicle = 63333 + 52333 = 1.15 x 10 
5
 lipids/vesicle  
 
Total number of vesicles per mL  
 
In polydiacetylene vesicles: 30 mol% TCDA for example: approximate 3.26 mg   
DMPC was used to form 30 mol% TCDA vesicles= 4.81 x 10 
-6
 moles (Mr DMPC = 
677.93 g/mol) 
  
Total number of lipid molecules 




Total number of vesicles = total number of lipids in GUVs solution / number of lipids in 
one vesicle = 2.52 x 10 
14
 vesicles in experiment (5 mL) 
 





Total encapsulated volume 
Volume encapsulated in one vesicle = (4/3)πr 3 = 5.24 x 10 -22 m3  
Total encapsulated volume in 5mL = volume in one vesicle x total number of vesicles = 
1.32 x 10 
-1 
mL  
The encapsulated volume per mL = 2.64x 10 
-2
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Chapter 3   Experimental Methods  
 
In this chapter, a detailed description of the establishment, optimisation and 
development of the experimental set-up are presented. The different experimental 
procedures for the formation of nanocapsules (GUVs and PDA vesicles) with 
fluorescent dye/antimicrobial are presented, followed by a description of the 
experimental methods employed.  
 
3.1  Material Science  
3.1.1  Synthesis and Purification of Giant Unilamellar Vesicles 
All chemical used in this work were purchased from Sigma-Aldrich, UK, and not 
purified further. The 1,2-dimyristoyl-sn-Glycero-3-phosphocholine (DMPC) and 
1,2-dimyristoyl-sn-Glycero-3-phosphoethanolamine (DMPE) lipid were purchased from 
Avanti Polar Lipids, USA. Sephadex columns of NAP-10 and NAP-25 for vesicle 
purification were purchased from GE Health Care.  
 
3.1.1.1  Formation of GUVs 
 
Aqueous bulk solutions were prepared before vesicle synthesis for encapsulation 
purpose. A bulk solution was prepared containing one of fluorescein, sodium azide or 
gentamicin sulphate. Carboxyfluorescein was encapsulated in the GUVs to detect the 
purification efficiency between NAP-10 and NAP-25 in the later work. The 










Table 3.1: Encapsulated agents used in this work and the concentration prepared in different buffer 
systems 
Compound Buffer   Concentration   Structure /Formula 
 








                
NaN3 





Saline   




















is detailed in 




The encapsulated concentration of gentamicin sulfate varies according to different 
vesicle system. 
 
GUVs were synthesised according to the work of Moscho et al: 
1
 The mixture of 0.041g 
of DMPC and 0.002g of DMPE with 0.013g cholesterol was added to a vial with 1mL 
chloroform (Fischer). A 200μL aliquot of this solution was added to a 50mL 
round-bottomed flask containing 980μL chloroform and 150μL methanol (Fisher). To a 
clean vessel, 6650 μL aqueous bulk was carefully added into the flask along the sides of 
the glass wall. The resultant mixture was rotary-evaporated for 2 minutes at 40 ºC. Two 
major boiling events were noticed to occur (the first due to the chloroform, the second 
due to the methanol). After 2 minutes, the liquid in the round-bottom flask was observed 
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to be a faint milky-white opalescent fluid which contained GUVs in high yield (which 
was the GUV stock solution). When not in use, the GUV solution was kept sealed in a 
refrigerator for no longer than a week. They were sonicated and briefly vortexed each 
time before use.  
3.1.1.2  Purification of Giant Unilamellar Vesicles (GUVs)  
There is a specific eluent buffer for each aqueous bulk. The eluent buffers are shown in 
table 3.2: 
 
Table 3.2: Eluent buffer systems for different encapsulating compounds 
      
1 Eluent Buffer for Sodium Azide  (50 mL) 
        Constituent           Concentration  
      Tris-HCl (pH 7.4)             0.05 M 
       
2 Eluent Buffer for Gentamicin Sulfate (50 mL) 
Constituent Amount 
Phosphate Buffered Saline 0.25 Tablet 
 
3 Eluent Buffer for fluorescein (50 mL) 
Constituent Amount 
Tris-HCl (pH 7.4) 0.05M 
 
In this work, two types of columns were used for the purification of vesicle solution. 
These were GE healthcare NAP-10 and NAP-25 sephadex columns which were used 
based on size exclusion. These are disposable columns prepacked with Sephadex G-25 
DNA grade and require only gravity to run. NAP-10 columns were mainly used for the 
purification of giant unilamellar vesicles and NAP-25 for polydiacetylene/phospholipid 
vesicles. The only difference between the columns is that NAP-25 columns allow greater 
volume to be purified. The columns were secured in a clamp stand and the storage 
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solution was drained. Excess buffer was passed through the column in order to 
equilibrate it. Once the equilibration buffer had drained from the column, the sample 
was then placed in the reservoir and allowed to load onto the column. Once the sample 
was loaded onto the column the eluent buffer (same composition as the equilibration 
buffer) was added to the reservoir and collection of the chromatographic eluent began. 
The purified vesicle solution was collected either in 15 mL plastic tubes or a 96 well 
microtiter plate, into each well 4 drops (approx 155 µL) were collected. The purified 
vesicle solution was kept in refrigerator at 4 
o
C for further use. The information of the 
columns is shown below in table 3.3.   
 
Table 3.3: Description of two types of columns used in the purification of vesicles including the 
parameters for sample and eluent volumes 
Columns  Equilibration volume(mL) Sample volume(mL) Eluent (mL) 
NAP-10            10           0.5   2  
NAP-25             15           2    2.5-3  
 
 
In this work, 5(6)-carboxyfluorescein was encapsulated in giant unilamellar vesicles to 
investigate the better purification system. The bulk solution and eluent buffer system for 
carboxyfluorescein are shown in table 3.7 and 3.8.   
 
3.1.2  Synthesis and Purification of Polydiacetylene/Phospholipid Vesicles  
3.1.2.1  Preparation of Stock Lipid Solution (SLS) 
Before vesicle synthesis, the lipids DMPC and DMPE, diacetylene monomers TCDA, 
cholesterol was first separately dissolved in 1mL chloroform and stored in glass vials at 
-20 
o









Table 3.4: Vesicle stock solutions 
Compound Mr (g mol 
-1
) Mass (mg) Concentration (mol L
 -1
) 
TCDA 346.55 35 0.11 
DMPC 677.93 73 0.11 
DMPE 635.85 18 0.03 
Cholesterol 386.65 39 0.10 
3.1.2.2  Compositions of Phospholipid/PDA Vesicles  
TCDA stabilised vesicles with varying TCDA concentrations were formed referred to 
table 3.5  
 
Table 3.5: Constituents of 20,30,40,50,60 mol % TCDA vesicles 
 mol% TCDA  TCDA (µL) DMPC (µL) DMPE(µL) Cholesterol(µL) 
20 20 58 2 20 
30 30 48 2 20 
40 40 38 2 20 
50 50 28 2 20 
60 60 18 2 20 
 
3.1.2.3  Synthesis of Polydiacetylene/Phospholipid vesicles 
As previously described, aqueous bulk solutions were prepared before vesicle synthesis 
for encapsulation purpose. A bulk solution for such system was prepared containing one 
of carboxyfluorescein, gentamicin sulphate, silver nitrate, chlorhexidine. The 
compositions are shown in table 3.6. The composition of aqueous bulk solution for 
carboxyfluorescein is listed separately due to the complexity of the constituent of the 
buffer system.  
 
Table 3.6: Compositions of aqueous bulk solution for encapsulation, solvent is distilled water 
Compound Buffer   Concentration   Structure /Formula 
 Silver Nitrate  Distilled water 1 mg mL
-1
     AgNO3 





Buffered Saline  








 Chlorhexidin  
 
 Distilled water 
     







on will be detailed 
in table 3.7  
 
50 mM  
 
 
Table 3.7: Composition of aqueous bulk solution system for 5(6)-carboxyfluorescein (50mM) in 50mL 







The vesicle system comprises 20 mol% cholesterol, 2 mol% 
1,2-dimyristoyl-sn-glycero-3-phosphatidylethanolamine (DMPE) and various fractions 
of 1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine (DMPC) and 10, 12-tricosadiynoic 
acid (TCDA). Lipids, cholesterol and TCDA were mixed in chloroform, dried under 
nitrogen. Following evaporation, 5 mL HEPES buffer (pH 7.4) containing 
5(6)-carboxyfluorescein/antimicrobials was added and votexed vigorously. The 
suspension was then heated up at 75 °C to ensure all lipids were mixed well due to 
different phase transition temperatures of the different lipids. The resultant vesicle 
solution was then subjected to freeze-thaw cycles at least 3 times to enhance 
encapsulation efficiency if any drugs/dyes are encapsulated within the vesicles. The 
resultant vesicle solution was cooled at 4 °C overnight to allow lipid head groups to 






3.1.2.4  Polymerisation  
The vesicles were then purified using NAP-25 columns to separate non-encapsulated 
dye/antimicrobials from vesicles before being exposed to UV light (254 nm) for a total 
of 60 seconds from a high intensity of UV source (Hamamatsu photonics). Overnight 
hydrated un-polymerised vesicle solution in quartz cuvette (1 mL) was irradiated by 
hard UV point by point with each point of 10-second irradiation (totally three points per 
side) (Figure 3.1B). The partially polymerised vesicle solution was then mixed well and 
subjected to UV radiation in the same manner, each point with 10 second of irradiation. 
The resultant vesicle solution was votexed again and kept in regrigerator at 4 
o
C prior to 
















                
 
Figure 3.1: Details of polymerisation of polydiacetylene/phospholipid vesicle induced by UV irradiation 
and experimental setup in the A.T.A.Jenkins group.  
(A) procedure of how the polymerised vesicles form under UV irradiation by giving a colour transition 
from transparent to blue depending upon different concentrations of diacetylene monomer incorporation.; 
(B) Experimental setup: a quartz cuvette containing vesicle solution was stabilised by a stabilizer and was 
irradiated by hard UV light point by point for total 1 minute to form blue coloured polymerised vesicle 
solution.  
 
Vesicle solution was irradiated 
by hard UV with each point for 
10 seconds 
 1st UV irradiation 1
st








was votexed to 
mix well 
Partially polymerised vesicle 
solution was irradiated by 
UV for another 30 seconds 










3.1.2.5  Purification of Phospholipid/PDA Vesicles  
Vesicles were purified using illustra 
TM
 NAP-25 columns to remove un-encapsulated 
carboxyfluorescein/antimicrobials. The procedure of purification has been detailed in 
section 3.1.1.2. The eluent buffer for 5(6)-carboxyfluorescein is shown in table3.8. 
 
Table 3.8: Eluent buffer (pH 7.4) for 50mM 5(6)-carboxyfluorescein (50 mL) 






3.2  Physical Science  
3.2.1  Characterisation of Chromatic Property for Phospholipid/TCDA 
vesicles   
UV-Vis spectroscopy used here was to detect the colorimetric properties of 
phospholipid/TCDA vesicles. Samples were prepared at a concentration of 0.1 mM total 
lipid. The blank system was HEPES buffer (eluent buffer system which can be referred 
to table3.8). Samples with various concentrations of TCDA were measured at room 
temperature using the Thermos Helios Gamma single beam spectrophotometer, with a 1 
cm optical path cell.  
 
Quantification of the extent of the blue-red colour transition is given by the colorimetric 
response (% CR), which is defined as follows:  
 
PB = A blue / (A blue + A red)                                       (3.1) 
  
%CR = [(PB0 – PBI) / PB0] × 100%                                (3.2) 
 
In these two equations, A is the absorbance measured at either ‗blue‘ component (640 
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nm) or the ‗red‘ component (500 nm) of the visible spectrum. PB0 is the value of the 
control sample. PBI is the value of the vesicle solution after appearance of the colour 
change.  
 
3.2.2  Colorimetric Detection of Bacteria-Vesicle Interactions 
This measurement was carried out in 96-well plate. The absorbance of vesicle solution 
was measured using a BMG Labtech fluorostar microplate reader in absorbance mode at 
600nm for 1 cm path length before addition of bacteria as the control system. A 190µL 





was incubated at 37 
o
C overnight. The absorbance spectrum was then recorded after 
leaving overnight.   
3.2.3  Carboxyfluorescein Fluorescence – Concentration Analysis 
5(6)-carboxyfluorescein was dissolved in HEPES buffer (eluent buffer system table 3.9) 
at a concentration of 95 mM, which is a concentration above the threshold of 
concentration induced self-quenching. A factor of 10 serial dilutions was made and each 
diluted solution (200 µL) was placed in a Costar 96-well plate and analysed for 
fluorescence intensity with excitation at 485nm and emission at 520 nm by using a BMG 
Labtech fluorostar fluorimeter. The resultant figure was then plotted with fluorescence 
intensity versus various concentrations of carboxyfluorescein containing unquenched 
and quenched concentrations. The result is shown in figure 5.9. The HEPES buffer 
system for dissolving carboxyfluorescein to make a concentration of 95 mM is listed in 
table 3.9. All the measurments were measured at room temperature.  
 
Table 3.9: HEPES buffer system for 95mM carboxyfluorescein 









3.2.4  Carboxyfluorescein Photobleach Analysis  
The experiments were carried out in a Costar 96-well plate reader to detect the 
fluorescence intensity after photobleach by hard UV source. All the samples were placed 
in a quartz cuvette for UV irradiation. Carboxyfluorescein samples (1 mL) dissolved in 
appropriate HEPES buffer with the concentrations of 50 mM, 500 μM, 50 μM were 
exposed to UV radiation using Hamamatsu UV-Vis Fiber Light Source L10290 fibre 
optic for 10 minutes. The way of irridating the sample is similar to the vesicle 
polymerisation. The UV fiber source was pointed one side of the quartz cuvette (1 
min/side) and was then mixed well. This was done for at least 10 times for total 10 min. 
The fluorescence would be identical to a control sample (before UV irradiation) if the 
radiation had no effect on the samples. All measurements were measured at room 
temperature.  
3.2.5  Stability Study of Phospholipid/PDA Vesicles–Dehydration & 
Rehydration Assay 
The measurement aims to find out the optimal vesicle system which could survive in dry 
condition. 50 µL of polymerised vesicle solution containing self-quenched 
carboxyfluorescein with varying concentrations of TCDA (0, 10, 20, 30, 40, 50, 60 
mol%) was placed in a Costar 96-well plate. The plate was then dried in a Class II flow 
hood for 24 hours. After overnight the dehydrated vesicles were then rehydrated with 
appropriate HEPES buffer (pH 7.4, eluent buffer system) and the 96-well plate was then 
measured in a fluorostar fluorimeter with exciting light at 485 nm, and emission at 520 
nm to measure the fluorescence intensity of the rehydrated vesicles. Vesicles with more 
diacetylene incorporation would retain their structures and will not lose their whole 
payload of fluorescence. All experiments were repeated 3 times for a given set of 
conditions and all the mearsuments were measured at room temperature.    
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3.2.6  Sensitivity Study of Phospholipid/PDA Vesicles to Lytic Agents  
In order to ascertain the sensitivity of vesicles with varying molar concentrations of 
TCDA to lytic agents, a set of compounds were selected and assessed for their ability to 
disrupt lipid bilayers. Triton X-100 was used as the positive control in experiments, 
which can cause total lysis of the bilayer membrane of vesicles. These compounds are 
listed in table 3.10.  
 
Table 3.10: List of lytic agents for their ability to lyse vesicle membrane and hence release the contents 
Compound Concentration  
Triton X-100 1/10 (distilled water) 
Phospholipase A2 0.1mg mL 
-1
 




The first measurement was based on fluorescence intensity measurments of different 
concentrations of TCDA vesicles after lysis by Trition X-100.The measurement was 
placed on a Costar 96-well plate using a BMG Labtech fluorimeter with exciting light at 
485nm and emission light at 520nm. 100 μL vesicle solutions with various TCDA 
concentrations (0%, 10%, 20%, 25%, 30%, 40%, 50%, 60%, 100%) were measured in 
the fluorimeter for 5.5 hours. The plate was then taken out of the fluorimeter and 20 μL 
of Triton was added into each well containing different concentrations of TCDA vesicles. 
The plate was put the fluorimeter to measure the fluorescence release overnight.  
 
Phospholipase A2 used in this work was purchased Sigma Aldrich and is extracted from 
honey been venom as the lyophilized powder of 600-2400 units/mg protein. Haemolysin 
and PLA2 was dissolved in PBS buffer with a concentration of 0.1 mg/ mL and freezing 
below -8 
o
C   before use. All the experiments were carried out in a Costar 96-well. 
Vesicles with TCDA concentrations of 0%, 20%, 30%, 40% (100 μL) were measured in 
the 96-well plate in terms of fluorescence intensity before the lysis by the lytic agents 
listed above. After that an aliquot of 20 μL of each of the compounds (Triton, PLA2, 
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-Haemolysin) was transferred to wells containing 100 μL of freshly made vesicle 
solution with different TCDA concentrations of 0%, 20%，30%，40%. 0% TCDA vesicle 
was used as a positive control system to give an indication of maximum fluorescence 
after lysis by Triton. The plate was then measured in a fluorostar plate reading 
fluorimeter with exciting light at 485 nm, and emission at 520 nm. All experiments were 
repeated 3 times for a given set of conditions and all measurements were measured at 
room temperature.  
 
3.2.7  Plasma Polymerisation  
Plasma reactor was employed here to deposit a thin film of maleic anhydride as supports 
for both GUVs and PDA vesicles. The aim is to immobilise the vesicles onto various 
textiles such as glass slide, non-woven polypropylene or polystyrene petri dishes and 
thus vesicles are attached onto pp-MA treated surface via covalent bonding.  
  
The use of the reactor for plasma polymerisation required loading of substrate to the 
main chamber, then adding monomer to the Young‘s flask. The detailed procedure can 
be seen in the appendix.  In brief, the chamber was evacuated, allowed to reach a 
suitable base pressure, the monomer tap was opened and either continuous wave or pulse 
plasma was ignited using the radio frequency source. Pulse plasma deposition was 
operated using the standard monomer deposition procedure. Duty cycles of 1/40 (T= 
41ms) were employed by altering on/off times on the oscilloscope to give an equivalent 
input power of 1.2W at a peak power of 50W. 100 mg maleic anhydride powder was 
loaded in the Young‘s flask and was freeze-dried three times just prior to deposition to 
remove adsorbed water and then deposited using low power 1/40 at 50W input power to 
afford a high retention of anhydride and ring structure in the deposited film.  
3.3  Microbiological Assays 
All microbiological work was undertaken in Class II flow hood in the Department of 
Chemicstry, the University of Bath. Safety precautions should be taken when working 
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with microbes including lab coat, gloves and use of a flow hood. Prior to flow hood use, 
the interior was sterilised with 70% ethanol. All equipment used for contact with 
microbes (e.g. pipette tips, tubes) was either pre-sterilised or autoclaved at 121°C. 
3.3.1  Bacterial Culture   
Three strains of S.aureus (MSSA 476), P. aeruginosa (PAO1), and E. coli DH5α were 
used as model microorganisms. Cultures were prepared by inoculation of an agar plate 
with desired bacteria using a sterile loop and incubated at 37 °C for 48 hours to allow 
growth. A single colony was transferred from the stock plate to 10 mL of LB/TSB broth 
and was incubated overnight (18 h) at 37
o
C with shaking at 200 rpm to agitate growth by 
using aseptic technique. Also, a negative control of LB/TSB was set up to check for 
contamination. The overnight cultures are in the static phase of bacteria growth. 100 μL 
of the overnight culture was re-suspended in 10 mL of clean LB/TSB and incubated at 
37
o
C for 4 hours. The re-suspended culture was in the exponential phase in which 
virulence factors were produced by pathogenic bacteria. This procedure is called 
sub-culture. The sub-cultured bacteria were used in experiments unless otherwise stated. 
Tryptic soya broth (TSB) was used as medium to grow S .aureus (MSSA 476) in the late 
period of the work as it provided greater environment for MSSA 476 growth and more 
toxins could be produced by MSSA 476 when grown in TSB.  
 
3.3.2  MIC Assays   
Culture Preparation:   
The three strains of bacteria were grown overnight in 10 mL LB, 37 
o
C, 200 rpm. A total 
of 100 μL of the overnight culture was subcultured in 10 mL of LB, 37 oC, 200 rpm and 
grown to exponential phase (OD 600 = 0.3-0.4).  
 
Assay Method: 
MICs of four different compounds were determined in this work: sodium azide, 
gentamicin sulphate, silver nitrate and chlorhexidine. An initial dilution series of these 
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test compounds were made up in distilled water over a suitable concentration range by 
serial dilution.  
 
Initially, a range-finding test was performed with 1 replicate that tested 8 different 
concentrations (e.g. 1/10 dilutions from 0.1 μg mL-1 to 10 mg mL-1 ) to gauge a rough 
indication of sensitivity to the compound. Triplicates using a narrow range of 
concentrations were then performed once a good indication of range finding test has 
been confirmed. The serial dilutions of concentrations should contain the concentrations 
which show no effect on growth through to total inhibition of growth. 9.7 mL LB was 
then transferred to clean, sterile glass universals and 200 µl of antimicrobial at varying 
concentrations were followed to add to LB medium. 100 µl of fresh sub-culture were 
then added to each glass universal. Also, a negative control was set up only to check for 
contamination. The cultures were grown with shaking 200 rpm at 37 
o
C overnight 
(16-18 h). The OD 600 of the cultures was measured by using UV-Vis spectroscopy. 
Results of this assay provided an estimation for the minimum concentration required to 
inhibit bacterial growth. Each parallel experiment was carried out in triplicate.  
3.3.3  Antimicrobial Analysis 
3.3.3.1  Colony Counting  
Three strains of bacteria were grown and sub-cultured as described in MIC assay. 100μL 




in LB was added to a suspension of 
900 μL of GUVs. Every 20 min, the bacteria concentration was determined by standard 
plating assays and colony counting. The bacteria solution containing vesicles 
(antimicrobial inside) was made 10-fold serial dilutions. After overnight incubation, 
colonies were then counted and scaled up (multiplied by 10 x dilution factor) to give an 
estimation of viable cell count, in terms of colony-forming units per millilitre (CFU mL 
-1 
)  
The number of colonies was determined by the equation:  
CFU/ mL = CFU/plate x dilution factor x 10 (to get back to 1 mL)       (3.3)  
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Bacteria colonies, theoretically originating from a single bacterial cell termed ‗colony 
forming unit‘ (CFU), were counted and the original bacterial concentration determined.  
3.3.3.2  Solution Turbidity Assay 
The assay was performed on a 96 well plate using a BMG Labtech fluorostar plate in 
absorbance mode with a software correction factor to plot absorbance data at 600 nm for 





) in LB culture media or Tryptic Soy Broth on a 96 well plate, allowing all 
experiments to be repeated 3 times for a given set of conditions. The plate was incubated 
at 37 
o
C and shaken before measurement. The optical density was recorded over time.  
 
3.3.3.3  JIS Assays –Antimicrobial Test on Modified Surface 
The assay was based on the Japanese Industry Standard (JIS 1902) for determination of 
the antimicrobial efficacy of fabrics. Maleic anhydride was plasma deposited onto 
non-woven polypropylene, which were subsequently cut into four pieces of 2 cm x 2 cm 
squares; the pp-MA treated fabrics were then immersed into the vesicle solution for 1 h 
and were then rinsed with appropriate buffer (the buffer system applied here depending 
on different compounds encapsulated within vesicles) to remove non-binded vesicles 





 in LB with exponential phase. pp-MA treated fabrics were 
used as control systems and were sterilised by UV exposure and were treated in an 
identical way. The fabric squares were either incubated at 37 
o
C for 4 hours or analysed 
immediately to determine the concentration of adherent bacteria. The negative for 
growth controls was analysed immediately after inoculation. The treated samples and 
further controls were incubated for 4 hours for further analysis.  
After 4 hour period, the fabrics were rinsed in physiological saline (0.9% NaCl w/v), 
placed in 5 mL of physiological saline and vigorously vortexed for 5 x 5 s to remove the 
adherent bacteria. The saline/bacterial solution was then spread on LB agar to obtain 
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proper concentrations: 1.5 x 10
-2
, 2.5 x 10
-3
, 1.25 x 10
-4
, 6.25 x 10
-6
, 3.125 x 10
-7
.  
These six concentrations were made by a serial dilution with 20 dilution factor. Each 
concentration of saline/bacteria was spread to an LB agar plate. The plates were then 
incubated at 37 
o
C overnight. The colonies were then counted after following day and 
the number of colony forming units (cfu) per millilitre (concentration) was then 
determined.                    
3.3.4  Fluorescence Response Assay ---Pathogenicity Assay in Suspension  
The basis of the detection assay is that at high concentration, carboxyfluorescein is 
non-fluorescent. Following breakdown of the lipid vesicle containers by bacterial toxins, 
the dye becomes diuted and ‗switches on‘. Experiments were performed on a 96-well 
plate using a BMG Labtech fluorostar plate reading fluorimeter. A 150 μL vesicle 
solution was added to 50 μL of bacteria with starting concentration of 105 CFU mL -1 on 
a 96 well plate. S.aureus (MSSA 476) was grown in TSB medium, while P.aeruginosa 
(PAO1) and E.coli (DH5α) were grown in LB medium. All experiments were repeated 6 
times for a given set of conditions. The dye was excited with light at 485 nm, and 
emission measured at 520 nm. Plates were incubated at 37 
o
 C and shaken every 30 
seconds for 2 seconds prior to measurement. Fluorescence was recorded every 4 minutes 
and plotted both vs. time and as a histogram at a fixed time point, showing both the 
absolute value of fluorescence and increase following addition of Triton X-100 to lyse 
the vesicles.  
3.4  Attachment of Vesicles to Treated Fabrics  
Vesicles can be attached on various treated fabrics. Pulse plasma polymerised deposition 
is the most commonly used in the thesis for attaching vesicles via covalent bonding. 
Poly (acrylic acid) photochemically grafted non-woven polypropylene was given from 
Dr Thet Naing Tun, in the Jenkins‘ group. Vesicles are attached to these fabrics via 
hydrogen bonding. Hydrogels were used or incorporated in the modified surface in order 
to improve the hydrophilicity of the surface hence maintain vesicles intact and stable for 
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long term use.  
3.4.1  Pulse Plasma Polymerisation 
Polymers were deposited onto several substrates including polystyrene petri-dishes,   
and non-woven polypropylene fabrics (purchased from Boots, the chemist).  
Preparation of polymeric surfaces for the acceptance of plasma films or for use as 
controls in microbiological assays was achieved using either oxygen plasma or UV/O3 
treatment. 
 
Freshly prepared pp-MA modified nonwoven polypropylene fabrics, polystyrene Petri 
dishes were removed from the reactor and immediately placed in 2 mL of vesicle 
suspension. The substrates were left for 1 hour to allow formation of amide linkages 
three times in PBS buffer (GUVs) or appropriate HEPES eluent buffer (PDA vesicles) to 
remove most non-covalently bound vesicles. The vesicle bound surfaces were then used 
for FT-IR analysis.  
 
3.4.1.1  Pathogenicity Assay on pp-MA Treated Fabrics  
Vesicle modified non-woven polypropylene fabrics were cut into 3 cm x 6 cm. The 
experiment was carried out in petri dishes and each sample was placed in one petri dish. 
200 µL sub-cultured bacteria (two pathogenic strains P.aeruginosa and S.aureus and one 
non-pathogenic strain E.coli DH5α) with an initial concentration of 105 CFU mL-1 were 
inoculated on vesicle modified pp-MA non-woven polypropylene. E.coli DH5α was 
used as a control system. The bacterial bound fabrics were incubated at 37
o
C overnight. 
The photograph was taken under a low power UV lamp the following day. All 
experiments were repeated 3 times for a given set of conditions.  
3.4.2  Surface Photografting of Poly (acrylic acid) on Non-woven 
Polypropylene 
The Poly (acrylic acid) photochemically grafted non-woven polypropylene was offered 
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by Dr. Thet Naing Tun of the Jenkins‘ group. The detailed procedure will not be shown 
here. Generally, the non-woven polypropylene was primed with the photo-initiator BP to 
provide high concentrations of photo-initiator. The systems were then dried and 
monomer solution was then loaded onto the primed surface and temporarily sealed with 
adhesive tapes. The treated non-woven polypropylene was then exposed to UV radiation 
for 20 minutes. After UV exposure the monomer solution was flushed out and the 
system was thoroughly rinsed prior to use. 100 µL of vesicle solution was then placed on 
the treated fabric for further use.  
3.4.2.1 Pathogenicity Assay on UV-Induced PAA Grafed Non-woven 
Polypropylene  
Vesicle modified UV induced PAA grafted non-woven polypropylene fabrics were cut 
into 3 cm x 3cm. The experiment was carried out in petri dishes and each sample was 
placed in one petri dish. 100 µL sub-cultured bacteria (two pathogenic strains 





 were inoculated on vesicle modified fabrics. E.coli 
DH5α was used as a control system. The bacterial bound fabrics were incubated at 37oC. 
The photograph was taken under a low power UV lamp after 4 hours. The plates were 
then put back in the incubator and measured overning. All experiments were repeated 3 
times for a given set of conditions.  
3.4.3  Gelatine 
Pork gelatine sheets were used in this work and purchased from AB World Foods. 
Gelatine sheets were hydrated using appropriate HEPES buffer (eluent buffer for 
carboxyfluorescein) prior to use. The vesicle solution with total 100 µL was then placed 
on hydrated gelatine sheets. Double layered sheets were most commonly used with 
vesicles sandwiched between the two sheets in order to maintain a moist environment. 
Vesicle solution was generally placed on hydrogels by transferring one drop (20 µL) five 
times to different distributed locations on the fabrics as shown in figure 3.2. 
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Figure 3.2: Representation of the positions that vesicles were placed 
 
3.4.4  Collagen Grafted pp-MA Non-woven Polypropylene 
Collagen solution used in this work was made by mixing 0.2 g gelatine (Sigma-Aldrich) 
and 0.05 g Catrix
®
 in 5 mL appropriated HEPES buffer (pH 7.4). Catrix
® 
is collagen 
based powder for use in wound management and was purchased from Cranage 
Healthcare. 
Vesicle mediated pp-MA fabrics were immersed in the collagen solution for 1 hour to 
ensure high concentrations of grafted collagen. Double layered sheets were most 
commonly used to maintain vesicles intact and stable.  
 
3.4.4.1  Pathogenicity Assay on Collagen Grafted pp-MA Non-woven 
Polypropylene 
 
The modified fabrics were cut into 3 cm x 3 cm and the pathogenicity test on the 




3.5  Visualisation of Vesicles   
Vesicles (fluorescent dye encapsulated inside) or the interaction of vesicles and bacteria 
can be visualised either by microscopy or under low power UV light.  
3.5.1  Visualisation of GUVs with bacteria by Using Fluorescent 
Microscopy  
Plasma polymer (maleic anhydride) was deposited onto petri dishes before visualisation 
under microscope. The treated petri dishes were sterilised by exposing to UV/O3.  The 
GUVs containing fluorescein were subsequently attached onto the pp-MA treated petri 
dishes. The GUVs were imaged using a Nikon eclipse TE2000-S epi-fluorescence 
microscope followed by the inoculation of 200 μL of bacteria (ca. 109 CFU mL-1) onto 
the vesicles attached surfaces.  
 
3.5.2  Visualisation of Phospholipid/PDA Vesicles on pp-MA Treated 
Fabrics by Scanning Electron Microscopy   
SEM images of phospholipid/TCDA vesicles on pp-MA treated non-woven 
polypropylene were obtained using JEOL JSM-6480LV scanning electron microscope. A 
drop of vesicle solution to be tested was applied to a 1 x1 cm pp-MA modified 
non-woven polypropylene and the tested system was then placed in dessicator overnight 
for drying and was vacuum-coated with gold the following day prior to use.  
3.6  References: 
1 Moscho A., Orwar O., Chiu D. T., Modi B. P., Zara R. N., Rapid preparation of giant 




Chapter 4  Giant Unilamellar Vesicles as 
Response System for Killing/Inhibiting 
Growth of Pathogenic Bacteria 
 
In the previous chapters, the instrumentation and experimental were described which 
laid a foundation for the following evaluation of responsive nanocapsule system. This 
chapter presents an initial microbiologically responsive nanocapsule system, giant 
unilamellar vesicles covalently attached to plasma polymerised maleic anhydride 
(pp-MA) modified non-woven polypropylene. The system shows that pathogenic 
bacteria can be used to be the agents of their own destruction by releasing toxins that 
degrade or damage vesicles containing an antimicrobial agent. This is shown for two 
strains of pathogenic bacteria, P. aeruginosa (PAO1) and S. aureus (MSSA 476). A 
non-pathogenic strain of E. coli (DH5α) was used as the control system. Antimicrobial 
assays (solution assay and JIS) show that antimicrobial GUVs have the ability to kill 
pathogenic bacteria.  
 
This chapter is organised as follows: In section 4.1, the compositions of vesicles and 
their theory of formation and purification are described. The phase transition 
temperature of different phospholipids is also detailed.  In section 4.2, a novel method 
for attaching GUVs onto pp-MA treated non-woven polypropylene is presented.  
Section 4.3 outlines vesicles antimicrobial efficacy containing an antimicrobial both in 
suspension and on pp-MA modified fabrics using Japanese Industry Standard (JIS 1902). 
Section 4.4 further investigates vesicle lysis by bacteria by using fluorescence 




4.1  Formation and Purification of GUVs  
4.1.1  Materials  
Giant unilamellar vesicle in this work is a hybrid composed of two types of lipids and 
cholesterol. The main functions of these three constituents are described as follows. 
4.1.1.1  DMPC  
1,2-dimyristoyl-sn-glycero-phosphocholine (DMPC) is a phospholipid which is a major 
component in animal cell membranes. The primary role of phosphatidylcholine (PC) is 
to provide a structural framework for the membrane and maintain the permeability 
barrier. It also plays a role in membrane mediated cell signalling. The lipid has four 
distinct regions which are anchor, spacer, linkage and lipid tails (figure 4.1). Anchor unit 
is made of a quaternary ammonium salt containing the N, N, 
N-trimethylethanolammonium cation. The spacer unit consists of phosphate group which 
provides an aqueous space. The linkage is actually a glycerol which one of hydroxyls is 
linked to a polar phosphate-containing group and the other two hydroxyls are linked to 











Figure 4.1: Chemical structure of 1,2-dimyristoyl-sn-glycero-phosphocholine. (DMPC, C36H72NO8P, PC: 
(14:0/14:0), mw: 677.933, Tm: 23 
o
C ).  
The charged polar groups and lipophilic hydrophobic tails are situated away from each other allowing 




4.1.1.2  DMPE 
1,2-dimyristoyl-sn-Glycero-phosphoethanolamine (DMPE) is normally present in 
bacterial membranes. Similarly, DMPE contains four different moieties which are 
anchor, spacer, linkage and hydrophobic tails. The only difference of DMPE is that the 
phosphate group is linked to ethanolamine as indicated in figure 4.2. The anchor part 
(ethanolamine) plays a major role in immobilisation of the lipid vesicles by anchoring 
onto plasma treated surface via covalent bonding which will be described in section 4.3.  
 
           
 
Figure 4.2: Chemical structure of 1,2-dimyristoyl-sn-glycero-phosphoethanolamine.(DMPE, C33H66NO8P, 
PE: (14:0/14:0), mw: 635.853, Tm:50 
o
C).  
The charged polar groups and lipophilic hydrophobic tails are situated away from each other allowing 
supramolecular interaction of polar and apolar moieties.  
 
4.1.1.3  Cholesterol 
Cholesterol is the major sterol found in animal cell membranes which regulates 
membrane permeability and fluidity over a wide range of temperatures. It also plays a 
role in facilitating cell signalling. Cholesterol is a compact, rigid hydrophobic molecule 
with a polar hydroxyl group. The hydroxyl group interacts with the polar head group of 
the membrane phospholipids and phingolipids, the bulky steroid and the hydrocarbon 
chain are embedded in the membrane which aligns the fatty acid chain of the lipids 
(figure 4.3).  Cholesterol makes up approximately 20% of the cell membrane‘s mass.1 
Therefore, cholesterol was used to incorporate into lipid bilayer with 23 w% of the 
whole lipids due to two reasons. Firstly, incorporation of 20% cholesterol into lipid 
bilayers makes the whole vesicle more biomimetic as natural eukaryotic cell membranes 
consisting of cholesterol.
2
 Secondly, cholesterol used here can improve the stability of 
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GUVs at room temperature as it helps maintain liquid crystalline phase of lipid bilayers 
and prevent extremes—whether too fluid, or too firm—in the consistency of the 
membrane. Cholesterol also has some effects on bacterial toxins in direct or indirect 
ways as some of toxins secreted by bacteria may recognise the presence of cholesterol 
on cell membrane e.g. cholesterol binding toxins (CBTs).  
 
 
                     
                          
Figure 4.3：Chemical structure of cholesterol (C27H46O，mw:386.65) and interaction of cholesterol and 
lipid bilayers.  
Cholesterol disrupts long range order which prevents solid phase and enhances short range order which 
increases short acyl chain order in fluid phase.                          
4.1.1.4  Temperature Effect on Lipid Membranes  
Lipids in bilayer membranes undergo different phase transition in response to 
temperature change. This transition exhibits the change from the gel state (―solid‖) to the 
liquid crystalline state (―fluid‖) as surrounding temperature increases. In the gel state, 
the saturated extended acyl chains are closely packed and stabilised by van der Vaals 
forces. As a result, lipids are almost locked in the bilayer membrane with minimum 
lateral movement thus it is relatively unsusceptible to outer environmental changes. In 
the liquid crystalline phase, the acyl chains have less attractive forces on each other and 
able to diffuse laterally and freely at higher temperature. This provides a lipid bilayer 
with sufficient fluidity in the liquid crystalline phase. The phase transition temperature 
(Tm) is at which a lipid changes state from gel phase to liquid crystalline phase. It is 
evident that Tm increases with increasing chain length and decreases with increasing 
unsaturation. This is due to more thermal energy being required to disrupt more 
extensive contact areas with longer chains. The kink introduced into long hydrocarbon 
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chains disrupt this order and thus destabilises the gel phase so less thermal energy is 
required for unsaturated hydrocarbon chains. Table 4.1 shows the Tm of 
phosphatidylcholine as a function of tail length and number of double bonds.  
 
 
Table 4.1：Phase transition temperature with different tail length and number of double bonds2. 
Number of carbon atoms 
in lipid tails  
Number of double bonds Phase transition temperature 
 (Tm in 
o
 C) 
       12           0         -1 
       14           0         23 
       16           0         41 
       18           0         55 
       18           1          1 
       18           2        -53 
       20           0         66 
       22           0         75 
 
Lipids employed in this work are DMPC and DMPE with 14 carbon atoms in each 
hydrophobic region. The use of mixture of DMPC and DMPE improves the biomimetic 
property of lipid membrane. In addition the mixture of phospholipids in vesicles would 
not exhibit a simple ―melting‖ point. The Tm of DMPC and DMPE are 23 
o
 C and 50 
o
 C, 
respectively. The difference of transition temperature of these lipids results from 
differences of head groups. Phosphatidylethanolamine (PE) creates a more viscous lipid 
membrane compared to phosphatidylcholine (PC), thus more heat will be required to 
melt PE compared to the same chain length of PC. It is concluded that the mixture of 
lipids is mostly in the liquid crystalline phase at room temperature as only a small 
amount of DMPE is incorporated in the lipid bilayer in this work. The insertion of 
cholesterol further improves the stability of lipid bilayer which provides both firmness 
and fluidity in lipid bilayers. Therefore, the GUVs are maintained in a sufficiently fluid 





4.1.2  Mechanism of GUVs Formation   
The method of making vesicles used here is based on reference 4, the procedure of 
which requires only standard laboratory apparatus. The GUVs made were around 1 µm 
in diameter that in addition to having high encapsulation efficiencies also can be viewed 
by a light microscope. The process of vesicle formation is presented as follows: initially, 
an ordered monolayer of phospholipids is formed at the interface between the two 
phases (figure 4.4A). In this interfacial region, the polar head groups are located in the 
aqueous phase, whereas the fatty acid chains are present in the organic layer. When the 
organic phase is evaporated under reduced pressure, these ordered structures are 
ruptured into fragments and forced into the aqueous phase; some fragments are 
transported by air bubbles (figure 4.4B and C). Subsequently, these phospholipid 
monolayer fragments fuse into bilayer fragments (figure 4.4E). Alternatively, 
phospholipid bilayer fragments are formed from micellar structures containing the 
organic solvent (figure 4.4D), and as the evaporation progresses, the entrapped liquid 
(organic phase) will undergo a phase transition into a gas, and the micellar structures 
will collapse, yielding bilayer phospholipid fragments (figure 4.4E). These fragments 









Figure 4.4: Diagram of the suggested mechanism of GUVs formation.  
Initially there is an ordered monolayer of phospholipids at the interface between an aqueous and an 
organic phase (A). During evaporation, bubbles form (B) that rupture the phopholipid film into fragments 
(C). The resulting phospholipid monolayer fragments fuse to bilayers (E), which spontaneously vesiculate 
(F). An alternative way for the formation of bilayer phospholipid fragments (D) involves micellar 
structures having entrapped liquid organic solvent. 
4 
(pictures are reproduced with permission from 
reference 4)  
 
4.1.3  Purification of GUVs  
Once vesicles are formed, it is necessary to remove all non encapsulated fluorescent dye 
or antimicrobial agents from the system before it can be used in the further study. In 
order to suspend the vesicles in ‗clean‘ non fluorescent/bacterial buffer, chromatography 
was used to separate the aqueous bulk from the vesicles. The purification is based on 
size exclusion chromatography and due to the size of vesicles (around 1 µm of diameter) 
it can be inferred that the vesicles will elute from the column before the free 
fluorescein/antimicrobials. Figure 4.5 shows the typical traces of the NAP-10 column 
system used on fluorophore containing vesicles. All freshly made vesicles were purified 
in the same way in terms of chromatography. In the case of undetectable 
(non-fluorophore containing antimicrobials agents) vesicles the elution time is inferred 
to be the same as those for fluorescent vesicles and double filtration has to be applied 




Figure 4.5: Typical traces of NAP-10 column used on 5(6)-carboxyfluorescein containing vesicles.  
Grey boxes show the wells which were used for further purification (A) or selection for use in experiments 
(B).  Reduction in fluorescence of carboxyfluorescein was due to the fact that relatively high 
concentration of carboxyfluorescein can quench itself in a range of concentrations (the concentration 
effect of carboxyfluorescein will be described in chapter 5)  
 
NAP-25 columns became available until late in the work of GUVs and were mainly used 
to purify vesicles from unencapsulated fluorophore/antimicrobials. The volume of 
sephadex gel is greater in NAP-25 columns compared to NAP-10 and therefore the 
transverse area of the column allows greater differentiation of elution times. Figure 4.6 
shows the trace graph of NAP-25 and indicates purification by NAP-25 yielded an 
optimal separation. The differentiation in elution of vesicles and free carboxyfluorescein 
is apparent as seen in the graph. The selected well are indicated by the grey box and 
other remarkable events are labelled as well. The double peak shows clear separation in 
the selected wells due to size distribution. From the graph the low fluorescence peak 
indicates elution of pure vesicles with carboxyfluorescein inside, whereas a high 
fluorescence indicates free unencapsulated carboxyfluorescein. The reduction in 
fluorescence in later wells results from the elution of high concentration of 
carboxyfluorescein causing itself quenching.  
 



























































Figure 4.6: Fluorescence intensity change of eluent using NAP-25 column.     
 
This concentration effect can be also mirrored by visual colour of the solution of 
5(6)-carboxyfluorescein in figure 4.7. The solution becomes more orange with increased 
elution volume. The concentration effect on fluorescence intensity only applies in 
carboxyfluorescein in aqueous bulk.  
 
       
     
 
Figure 4.7: Visual images of eluate from NAP-25 column.  
5(6)-carboxyfluorescein vesicles were eluted as a yellow eluate in vial 1, 2, 3. Eluent buffer mixed with 
pure vesicles were in vial 1, whereas some free carboxyfluorescein mixed with pure vesicles were in vial 4. 
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4.2  Surface Design – Pulsed Plasma Deposited Maleic Anhydride 
Thin Films as Supports for Vesicles  
           
The utility of vesicles as encapsulation vehicles for antimicrobial agents in wound 
dressings requires that they can be attached to fabric. The vesicles can either be 
immobilised to fabrics via electrostatic or covalent bonding. Nonwoven fabrics and 
plasma have been of great interest recently. Plasma polymerisation allows fabrics 
functional with a large variety of physicochemical properties such as anti-soiling, 
increased hydrophobicity which repels bacteria, preventing attachment and subsequent 
colonisation. Organometalics have been used to be deposited creating an antimicrobial 
coating which is toxic to P. aeruginosa and S. aureus.
6
 Maleic anhydride is of particular 
interest for the synthesis of functional organic thin films because of the double bond and 
the reactive anhydride group. In the case of maleic anhydride pulsed plasma 
polymerisation (PPP), anhydride functionality incorporation is favoured at short 
on-times and long off-times
6
. The proposed reaction mechanism for PPP using maleic 
anhydride as a model is summarised in figure 4.8. Indeed, the reaction is generated 
during the on-time by radical step-growth as described above, the polymer is deposited 
then a chain-growth mechanism takes over during the off-time.  
  
 
             
 
 
Figure 4.8: Chain growth of a polymer growth during the pulsed off period of PPP 
 
In low power pulsed condition, an open film with retention of the anhydride hetero ring 
structure has been observed.
6
 This ring can undergo nucleophilic attack, a freshly 
polymerised film left in water results in hydrolysis and formation of carboxylic acid 
moieties.
7
 Free amines can attack the ring system forming amides. Free amine moieties 
in a supramolecular structure such as a vesicle can be used to tether the whole 
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suprastructure to the treated fabric via an amide link.
8  
The vesicle based on amine 
attack on the hetero ring is schematically shown in figure 4.9. 
 




Figure 4.9: Schematic diagram & simplified reaction showing GUVs attached to pp-MA treated 
non-woven polypropylene via amide bond.  
Maleic anhydride is grafted to a non-woven polypropylene. The free amine moiety of a 
phosphoethanolamine (2 mol %) can initiate a nucleophilic attack on the hetero ring forming an amide 
linkage.  
 
4.2.1  Chemical Structural Characterisation for Plasma Polymerised Maleic 
Anhydride  
The FT-IR spectrum of the pulsed plasma polymerised maleic anhydride using a plasma 
ON/OFF ratio of 1/40 (ms/ms) shows the film contains both anhydride structures around 
1780 and 1860 cm
-1
, as well as the structures representative of carboxyl groups around 
1730 cm
-1
. Figure 4.8 shows the typical anhydride group of pp-MA deposited on glass 
slides. Interestingly, the pp-MA was not stable enough after overnight at room 
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temperature when exposed to queous solution as can be seen from figure 4.10. The 
shoulder peak at 1860 cm
-1
 disappeared which clearly suggests loss of the anhydride 
structure (1780 and 1860 cm
-1
) accompanied by the appearance of a broad band at 
around 1700 cm
-1 
due to the hydrolysis of anhydride bond and the formation of -COOH. 
Therefore, the pp-MA treated fabrics should be kept in plasma chamber under vacuum 









Figure 4.10: FT-IR spectra of pulsed plasma-polymerised maleic anhydride. Fresh pp-MA is shown in 
black and overnight pp-MA at room temperature shown in red.  
 
4.2.2  Chemical Characterisation for Vesicles Attachment to pp-MA 
Non-woven Polypropylene  
Any surface can be treated by plasma polymerisation. Non-woven polypropylene sheets 
purchased from Boots, the chemist, were used as a substrate for vesicle attachment since 
such non-woven polymers are used extensively in wound dressings, hygiene articles etc. 
FTIR spectra (figure 4.11) show the C-H bond expected for polypropylene. The plasma 
polymerised maleic anhydride deposited fabrics shows typical anhydride group at 1780 
and 1850 cm
-1
. Attachment of vesicles to the pp-MA nonwoven shows a strong, broad 
adsorption at 1630 cm
-1
, which primarily results from ester C=O in the fatty acid chains 
of the phospholipids (both PC and PE) and amide C=O in the reacted MA only 


















Fresh pp-MA on glass slide















Figure 4.11: FTIR data for vesicles attachment onto treated non-woven polypropylene.  
Black, standard polypropylene fabric; Red: non-woven polypropylene was modified with plasma 
polymerised maleic anhydride and shows anhydride group; Green: modified non-woven fabric was 




4.3  Antimicrobial Activity Measurement of GUVs  
In this study, antimicrobial efficacy of GUVs was evaluated both in suspension and on 
modified pp-MA non-woven polypropylene. Sodium azide was initially encapsulated in 
the vesicles as the released antimicrobial to kill/inhibit bacteria. The viable bacterial 
population in terms of CFU mL
-1
 or optical density was then plotted versus time. 
Bacterial susceptibility to antimicrobials was measured before antimicrobial test to 
obtain the information about the MIC50. 
 
4.3.1  Antimicrobials Studied in this Work for killing Bacteria  
4.3.1.1  Sodium Azide  
Sodium azide (NaN3) is commonly used as biocide in hospitals or laboratories.  
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in a process similar to the action of carbon monoxide. The compound is toxic and it may 
cause serious effects on humans such as convulsions, low blood pressure, low heart rate, 




4.3.1.2  Gentamicin Sulfate  
Gentamincin sulphate has been described in section 1.4.2.5.   
 
4.3.2  Pathogens Studied in This Work  
Bacteria studied in this work are specific strains of pathogens belongs to gram-positive S. 
aureus and gram-negative P. aeruginosa. These bacteria are generally present on human 
body in normal conditions but responsible for causing a wide range of infectious 
diseases ranging from minor skin infections to some life-threatening diseases such as 
toxic shock syndrome (TSS). S. aureus (MSSA 476) and P. aeruginosa (PAO1) were 
used as model pathogens in the work as they secrete a large variety of toxins which has 
been described in chapter 2 to cause destruction of membranes of vesicles. E.coli (DH5α) 
was chosen as control system as most of toxic genes has been removed from this strain 
and thus it doesn‘t secrete toxins to lyse vesicles.  
   
4.3.2.1  In-Vitro Haemolysis Test  
Pathogenicity assay on blood agar plate (figure 4.12) illustrates the lysis of haemoglobin 
around colonies of  pathogenic bacteria S. aureus (MSSA 476) and P. aeruginosa 
(PAO1) as they secrete a wide range of toxins, while E.coli (DH5α) does not produce 






Figure 4.12: Blood agar plate showing the lysis of haemoglobin around colonies of typical pathogenic 
bacteria 
S. aureus (MSSA 476) and P. aeruginosa (PAO1). E. coli (DH5 α) is a control system as it does not 
secrete toxins and it does not cause haemolysis; The photograph was taken by Dr. Geraldine Mulley from 
Department of Biology and Biochemistry, University of Bath, UK.  
 
4.3.3  Determination of Bacterial Susceptibility  
4.3.3.1  Minimum Inhibitory Concentration (MIC 50)  
The minimum inhibitory concentrations to kill 50% of the bacterial population (MIC50) 
of sodium azide and gentamicin sulfate against the three bacterial strains, S. aureus 
(MSSA 476), P. aeruginosa (PAO1), and E. coli (DH5α) were determined. Initially, a 
range-finding test was performed to gauge a rough indication of sensitivity to sodium 
azide and gentamicin sulphate.  Table 4.2 and 4.3 show the concentrations of sodium 











E. coli (DH5α) 
   S.aureus 
(MSSA 476) 
P. aeruginosa (PAO1) 
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Table 4.2: Range finding test of NaN3 against three strains of bacteria (where ‗+‘ is positive growth and ‗-‘ 
indicates no growth.) 
 






Table 4.3: Range finding test of gentamicin sulphate against three strains of bacteria (where ‗+‘ is positive 





E.coli DH5α P.aeruginosa (PAO1) S.aureus 
(MSSA 
476) 
0.00001 + + + 
0.0001 + + + 
0.001 + + + 
0.01 - - + 
0.1 - - - 
1 - - - 
 
The results of range finding test indicate at which range of concentration, the 
antimicrobial started to inhibit bacterial growth. Triplicates with a narrow range of 
concentrations were performed once a good indication of range finding test has been 
confirmed. The experiments of narrow range of concentrations of both sodium azide and 
gentamicin sufate against three bacterial strains were further performed on a fluorostar 
fluorimeter in absorbance mode at 600 nm. The concentrations of sodium azide and 
gentamicin sulfate to inhibit the three strains of bacteria are shown as follows: 
 
-  E.coli DH5α  : 0.01 -0.1 mg/mL NaN3 ;   
-               0.001-0.01 mg/mL gentamicin sulphate  
-  P.aeruginosa PAO1 : 0.01-0.1 mg/mL NaN3 
-                    0.001-0.1 mg/mL gentamicin sulphate 
-  S.aureus  MSSA 476 : 0.1- 1 mg/mL NaN3 




P.aeruginosa (PAO1) S.aureus  
(MSSA 476) 
0 + + + 
0.0001 + + + 
0.001 + + + 
0.01 + + + 
0.1 - - + 
1 - - - 
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-                       0.01-0.1 mg/mL gentamicin sulphate 
Based on the range of concentrations analysed above, the value of optical density 
dependent on varying concentrations of the three bacterial strains was then plotted, as 
presented in figure 4.13. 
 
 
Figure 4.13: MIC50 of sodium azide and gentamicin sulfate against the three strains of bacteria.  
The shapes of bacterial optical density-antimicrobials (sodium azide and gentamicin sulfate) graphs give a 
clue that at which concentration of bacteria starts to respond to sodium azide/gentamicin sulfate and at 
which concentration of bacteria would be completely inhibited by these antimicrobials. The error bars 
represent standard deviations based on three measurements of each sample.  
 
Minimum inhibitory concentrations were observed for sodium azide and gentamicin 
sulfate in solution. These are summarised in table 4.4. From the table, it can be observed 
that E.coli DH5α shows the most sensitive strain to both sodium azide and gentamicin 
sulfate meaning that more E.coli DH5α would be killed in comparison with 
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P.aeruginosa PAO1 and S.aureus MSSA 476 with same concentration of these 
antimicrobials. In both cases, S.aureus MSSA was relatively less sensitive to both 
antimicrobials. Also of interest was a much lower MIC for gentamicin versus the three 
strains than sodium azide which was around 100 times less than observed for sodium 
azide.  
Figure 4.13 shows that P. aeruginosa started to respond (declines in concentration) to 
sodium azide and gentamicin sulfate at concentrations of 20 µg mL
-1
, 0.6 µg mL
-1  
and 
was almost completely inhibited at concentrations of 200 µg mL
-1 
, 3 µg mL
-1
; S. aureus  
showed that it became sensitive to sodium azide at 100 µg mL
-1  
and need 500 µg mL
-1
 
for complete inhibition, whereas S. aureus started to respond to gentamicin sulfate at  3 
µg mL
-1  
and was completely inhibited at a concentration of 7 µg mL
-1
; E.coli (DH5α) 
showed most sensitive to both antimicrobials from both graphs and the table listed. The 
MIC provides information for the further studies especially for the study of 
antimicrobial measurement of vesicles containing various antimicrobial agents.  
Table 4.4: MICs determined for sodium azide and gentamicin sulfate versus three strains of bacteria 




S. aureus MSSA 476 







Sodium Azide       4.4 x 10
-2
       1.9 x 10
-1
  3.4 x 10
-2
 
Gentamicin Sulfate      8.9 x 10
-4
       4.5 x 10
-3




4.3.3.2  Minimum Encapsulation Concentration 
In order to avoid any ineffective antimicrobial activity of releasing antimicrobials to 
bulk solution, the minimum encapsulation concentration should be estimated. The idea is 
on the basis of total internal encapsulation volume in section 2.5 and results of MIC 50   
in section 4.3.3.1.   
 




Total internal volume of GUVs per mL :  
 
400 µL (the calculation is referred to section 2.5) 








The minimum concentration of NaN3 to be encapsulated within vesicles:  




Therefore, the calculated concentration of NaN3 is 1.25 mg mL
-1
. A preliminary 
concentration of 15 mg mL
-1
 NaN3 was encapsulated within vesicles to ensure a high 
encapsulated concentration thus can totally inhibit the two strains of pathogenic bacteria. 
Calculations were assumed that 100% of sodium azide was encapsulated and all vesicles 
had a uniform size, which in reality is not the case.  
 
The minimum encapsulation concentration for gentamicin sulfate was calculated in the 
same manner. The calculated concentration is 0.025 mg mL
-1
. A preliminary 
concentration of 5 mg mL
-1
 gentamicin sulfate was encapsulated within vesicles in order 
to ensure a high encapsulated concentration.  
 
4.3.4  Solution Assay  
4.3.4.1  Time Resolved Bacterial Killing by Sodium Azide Vesicles   
Measurments of the bacterial mediated vesicle lysis and subsequent self-destruction 
were based on using conventional plate counting method to obtain the viable bacterial 
population every 20 minute. Figure 4.14 is the plot that viable cells of bacteria in terms 
of colony forming unit per millilitre over 4 hours. The graph shows a decrease in the 
concentration of viable P. aeruginosa and S. aureus over 4 h. P. aeruginosa was reduced 




, while the concentration of S. aureus 
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. The shape of the bacterial optical density 
versus sodium azide concentration graphs (figure 4.13) provides a clue to this behaviour. 
P.aeruginosa showed more susceptible to sodium azide in comparison with S. aureus 
shown on table 4.4. The rate at which P. aeruginosa was inhibited would be greater than 
S. aureus at low concentrations of sodium azide, if sodium azide was being slowly 
released at a constant rate in both cases. This difference in rate appeared to superficially 
correlate with the difference in MIC of the two bacteria. However, other factors which 
affect the rate of concentration decrease should also be taken into account such as the 
expression levels of virulence factors which lyse the vesicles from the two bacterial 
strains, which are not known.  
 
           
 
Figure 4.14: Reduction in the number of viable bacteria (CFU mL
-1
) following exposure to vesicles 
containing sodium azide in aqueous suspension, over a 4 h period.  
The strains tested were the pathogenic P. aeruginosa PAO1 and S. aureus MSSA 476 and the 
nonpathogenic E. coli DH5α. Error bars represent standand deviation based on three measurements of 
each sample. 
 
In contrast, there was a much lower decrease in the number of E. coli, despite this strain 
being the most sensitive to sodium azide. Therefore, it can be concluded that the 
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pathogenic bacteria are rapidly killed/inhibited by sodium azide released from the 
vesicles, which are specifically lysed by membrane-damaging toxins produced by the 
pathogenic strains.  
 
4.3.4.2  Time Resolved Bacterial Killing by Gentamicin Sulfate 
Vesicles   
In this part of study, gentamicin sulfate was encapsulated in the vesicles which are lysed 
by toxins secreted by two pathogenic bacterial strains. The assay was based upon using a 
BMG Labtech plate reader. The resulting graphs shown in figure 4.15 are the viable 
number of bacteria in terms of optical density versus time. Vesicles containing 
gentamicin sulfate were incubated overnight in the presence of pathogenic strains P. 
aeruginosa and S. aureus and non-pathogenic E. coli DH5α. Inhibition of growth should 
be seen in P. aeruginosa PAO1 and S. aureus MSSA 476 as the virulent factors secreted 
by these two strains make a contribution to the lysis of vesicles. E.coli DH5α as a 
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 E.coli (DH5a) + vesicles 
 
               (c)        
Figure 4.15:  Time-course of viable number of pathogenic and non-pathogenic bacteria with GUVs 
containing gentamicin sulfate.  
a) P.aeruginosa (PAO1) was incubated with GUVs overnight. Black squares show normal growth curve of 
P.aeruginosa PAO1; Red squares show P.aeruginosa PAO1 was completely inhibited/killed by gentamicin 
sulfate released from the GUVs after overnight; b) S. aureus (MSSA 476) was incubated with GUVs 
overnight. Black: growth curve of S.aureus MSSA 476; Red: The number of viable of S.aureus MSSA 476 
was decreased by inhibition of getamicin sulfate; c) E.coli (DH5α) shows identical growth curve after it 
was incubated with GUVs after overnight. Error bars represent standard deviations based on three 
measurements of each sample.  
 
The graphs confirm that P. aeruginosa PAO1 and S. aureus MSSA 476 were 
inhibited/killed by gentamicin sulfate released from GUVs as these two pathogenic 
strains secrete a large variety of virulent factors such as phospholipase, exotoxin A by 
P.aeruginosa and α-haemolysin, leucocidin by S. aureus. From the graphs, P. aeruginosa 
PAO1 was completely inhibited/killed by gentamicin sulfate released from GUVs 
overnight, while S. aureus MSSA 476 showing much lower decease with GUVs after 
overnight. The difference in the rate of the viable number decreasing between these two 

























 S.aureus / Vesicles( gentamicin inside)
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strains is due to the difference of sensitivity to gentamicin sulphate of these two strains 
(MIC data) and mechanism of interaction between toxins and membrane of vesicles. 
Similarly to sodium azide, S. aureus MSSA 476 shows less sensitivity to gentamicin 
sulfate which is about 10 times higher than P. aeruginosa PAO1. The rate at which P. 
aeruginosa was inhibited would be greater than S.aureus at low concentrations of 
gentamicin sulphate. In addition, the graph further confirms the description that 
gentamicin is used particularly to treat the infection caused by gram-negative 
organisms.
10
  Furthermore, due to the different modes of action of virulent factors 
secreted by these two strains, the different ways of lysing membrane of vesicles should 
also be taken into consideration. Chapter 1 describes the main toxins secreted by P. 
aeruginosa and S. aureus which would make a contribution to the destruction of vesicles. 
The possible reason is that phospholipase C secreted by P. aeruginosa lyses the 
membrane of a vesicle and would make the whole shell of the vesicle rupture which 
leads to the encapsulated antimicrobials released to the external solution immediately, 
whilst α-haemolysin secreted by S.aureus is a pore-forming toxin which would create 
many holes to insert into the membrane of the vesicles and thus the encapsulated 
antimicrobials would be released gradually to the external environment.  
 
In contrast, the viable numbers of E. coli DH5α with vesicles exhibit indentical growth 
curve although this strain shows the most sensitive to gentamicin sulfate. Therefore, it 
can be concluded that the pathogenic bacteria are inhibited/killed by getamicin sulfate 
released from the GUVs as they produce membrane-damaging toxins which will lead to 
the lysis of vesicles.    
 
4.3.5  Fabric Assay Japanse Industry Standard (JIS)  
Having successfully immobilised vesicles on the pp-MA modified nonwoven 
polypropylene, this part of the study will investigate the antimicrobial performance of 
the modified fabrics against the two pathogenic bacteria (P. aeruginosa PAO1 and S. 
aureus MSSA 476) and a nonpathogenic control E.coli DH5α. The control provides 
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important information on whether the fundamental hypothesis is correct: pathogenic 
bacteria lyse the vesicles and ensure their self-destruction, but nonpathogenic bacteria 
are largely unaffected.  
 
The antimicrobial performance of the vesicles containing sodium azide attached to 
fabrics was initially tested using the methodology described in experimental section. 
Other antimicrobials such as gentamicin sulfate, silver nitrate, chlorhexidine 
encapsulated within vesicles were also tested using JIS which will be demonstrated in 
chapter 7. The results in figure 4.16 show that the vesicle modified nonwoven fabric 
completely inhibits/kills both pathogenic bacteria P. aeruginosa PAO1 and S. aureus 
MSSA 476, while the nonpathogenic E. coli DH5α colonised the vesicle-modified fabric 
to almost the same extent as the non-modified control because it does not secrete 
membrane damaging toxins. There was a decrease in the number of E .coli DH5α due to 
some passive leakage of sodium azide which limited the growth of E. coli to an extent. 
Therefore the E.coli control is useful as a measure of the ‗leakiness‘ of vesicles 






































Figure 4.16: JIS results of lipid vesicles (containing sodium azide) against three strains of bacteria.  
The figures show persistence and growth of two pathogenic (S. aureus MSSA 476 and P. aeruginosa 
PAO1) and one nonpathogenic (E. coli DH5α) strains of bacteria on fabric modified with vesicles 
containing sodium azide (NaN3 vesicles) in comparison to nonmodified, UV sterilised nonwoven (control), 
over a 4 h period. The pathogenic bacteria secrete membrane damaging toxins which lyse the vesicles, 
releasing sodium azide at a concentration that inhibits bacterial growth, with total clearing of S. aureus 
and 2 CFU mL
-1
 of P. aeruginosa being measured after 4 h. Error bars represent standard deviations based 
on six measurements of each sample.  
 
4.4  Visualisation of Vesicle Lysis by Bacteria under Fluorescence 
Microscopy  
The main advantage of GUVs is that their sizes are relatively large which can be easily 
visualised, especially if containing a water-soluble dye such as fluorescein. Fluorescence 
microscopy was used in this work to provide further confirmation of the hypothesis that 
the pathogenic bacteria lyse vesicles, while the nonpathogenic strain does not. The 
results in figure 4.17 show individual immobilised vesicles on pp-MA modified Petri 
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dishes, and subsequent lysis on addition of P .aeruginosa and S. aureus. E. coli DH5α as 
a control system did not lose fluorescence, meaning that the E.coli DH5α does not 
secrete membrane damaging toxins. Interestingly, there are some differences in the 
images of the vesicles being lysed by P .aeruginosa compared with S. aureus.  P. 
aeruginosa appears to have caused the vesicle to initially swell before loosing its 
encapsulated dye; the vesicles exposed to S. aureus gradually lost fluorescence intensity, 
but in a way of slow release of dye rather than swelling. This difference could relate to 
the differences in the modes of action of the different virulent factors secreted by P. 
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Figure 4.17: Fluorescence imaging of surface attached vesicles exposed to the three strains of bacteria.  
Box width 60 µm.  
 
4.5  Conclusion  
In this chapter, an initial microbiologically responsive nanocapsule system for 
controlling bacterial growth and infection has been presented. The synthesis of GUVs is 
relatively easy to manipulate: incorporation of cholesterol in the vesicle system provides 
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vesicles stability at room temperature as well as renders vesicles biomimetic; DMPE 
provides an anchoring site---ethanolamine which would make a contribution to the 
immobilisation of vesicles onto plasma pp-MA treated fabrics. The purification of 
vesicles using NAP-10 and NAP-25 and the efficiency of purification of these two 
columns were also demonstrated. Vesicle immobilisation has been addressed by using 
plasma polymerised maleic anhydride deposited onto nonwoven. FT-IR data further 
proves the successful attachment of vesicles to treated fabrics. The GUVs containing 
antimicrobial agents have the ability to inhibit/kill pathogenic bacteria and are not 
affected by non-pathogenic bacteria. These assays were carried out both in suspension 
and on pp-MA treated fabrics. Two different methods of measuring viable number of 
bacteria against vesicles over time were carried out in this chapter in terms of 
conventional plate counting methodology and optical density. Further microscopy 
images prove the hypothesis---pathogenic bacteria can damage the membrane of vesicles 
to cause the vesicles lysis, while non-pathogenic bacteria are not affected by vesicles 
because they do not secrete virulent factors.  
 
In the case of purification, NAP-10 columns were mainly used in this work to purify 
GUVs and double filtration was applied to encapsulated antimicrobial agents in order to 
obtain pure vesicle solution. NAP-25 became available later in the work and was mainly 
used for the purification of phospholipid/PDA vesicles. However, GUVs were used for 
evaluating the efficiency of these two columns by encapsulating carboxyfluorescein 
(self-quenching at high concentration) and NAP-25 was confirmed to be used for the 
further study due to its greater volume capacity and low cost compared to NAP-10 
columns. 
 
However, the GUVs have some problems for long term use such as susceptibility to 
surfactants, morphological instability and entrapped drug leakage over time. Therefore, 
it is unlikely, for example, that GUVs would be used in a final product. The ultimate aim 
of this work is to attempt to construct a ‗smart‘ wound dressing system that only releases 
an encapsulated antimicrobial agent in the presence of pathogenic bacteria, while not 
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responding to commensal/harmless bacteria. Furthermore, the system would minimise 
the pressure of selected antibiotic resistance by ensuring antibiotics are released only in 
response to pathogenic bacteria and would prolong the efficacy and shelf life of the 
encapsulated antimicrobial.
11
 Also, a simple colorimetric or fluorimetric response could 
be built into the system to provide an early warning of wound infection for patients or 
clinicians. Important problems regarding vesicle stability, tuning of response, 
manufacturability, and immunological response remain to be solved. However, this 
chapter of study provides the possibility of building a prototype of wound dressing for 
detecting/killing pathogenic bacteria. Partially polymerised acetylene fatty 
acid/phospholipid vesicles as an alternative to improve the stability of vesicles will be 
presented in detail in next chapters. Furthermore, the study of tuning of fluorescence 
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Chapter 5  Study of Partially Polymerised 
Polydiacetylene/Phospholipid Vesicles Based 
Upon Construction of a Fluorescence Sensing 
System  
  
The previous chapter was devoted to constructing a new microbiologically responsive 
system for detecting and killing bacteria. The present chapter is based on the idea of 
improving the stability of such a system by insertion of diacetylene fatty acids within the 
lipid vesicles and polymerising. Such a sensing system might be robust enough for 
clinical use. As stated previously, burns and wounds are particularly susceptible to 
bacterial infection especially in young children. Wound swabs, microbiological cultures 
and/or other related tests used to diagnose infection often do not provide clinicians with 
the timely guidance they require which result in inaccurate diagnoses based on the 
child‘s clinical condition alone. Therefore, there is a clinical requirement to diagnose 
infection at early stages and preferably, without the removal of adherent dressings. A 
wound dressing designed to change colour can indicate the change in microbiological 
state, allowing for rapid intervention. A fluorescence sensing system was constructed 
based upon the dilution of a self-quenching fluorescent dye. Carboxyfluorescein was 
used as a dye and was encapsulated within vesicles. The basis of this idea is that at high 
concentration, carboxyfluorescein is non-fluorescent; following breakdown of the lipid 
vesicle containers by bacterial toxins, the dye becomes diluted and ―switches on‖.   
 
The reminder of the chapter is organised as follows: in section 5.1, the methods to 
stabilise phospholipid vesicles by using photo-polymerisable fatty acid moieties are 
presented. In section 5.2, the study of colorimetric property is discussed by using UV-vis 
spectroscopy. A fluorescence sensing system using self-quenching carboxyfluorescein 
within vesicles has been discussed in section 5.3. Section 5.4 elaborates on the study of 
stability and sensitivity of such system by incorporating different molar concentration of 
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TCDA. Section 5.5 further exploits the vesicles‘ response to pathogenic bacteria while 
not responding to non-pathogenic bacteria by using encapsulating carboxyfluorescein 
within vesicles. Section 5.6 concludes the chapter and summarises the key findings.  
   
5.1  Formation and Purification of TCDA/phospholipid Vesicles  
5.1.1  Materials  
TCDA/phospholipid vesicle in this work is a hybrid which is composed of two types of 
lipids, cholesterol, and self-assembled diacetylene monomers. DMPC, DMPE, 
cholesterol have been described in section 4.1.1 and will not be discussed here. The 
main functions of TCDA are described as follows.  
 
5.1.1.1  TCDA  
10, 12-tricosadiynoic acid is a type of diacetylene monomers (figure 5.1A). It is 
composed of two different parts: a polar head group and a hydrophobic tail with 
diacetylene moiety. The TCDA is a self-assembly material when it is exposed to aqueous 
solution. The diacetylene will undergo 1,4-addition under UV irradiation(figure 5.1B) to 
form a cross-linked polymer. The detailed scheme of how they form polymerised 
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Figure 5.1: Chemical structure and polymerisation of 10, 12 - tricosadiynoic acid.  
A) Chemical structure of 10, 12-tricosadiynoic acid (TCDA, C23H38O2, mw: 346.55, mp: 56-60 
o
C); B) 
Organisation of the polymerised backbone from the diynoic acid monomers after UV irradiation.  
 
5.1.1.2  Structure and Phase Separation  
The vesicle system consists of a mixed assembly of membrane lipids and other 
membrane constituents such as cholesterol, combined with polymerised diacetylenic 
lipids which are called PDA. Lipid/TCDA mixed vesicles are generally prepared by 
mixing the lipids and diacetylene monomers in appropriate molar ratios.The resultant 
lipid/TCDA vesicles exhibit a blue colour after photo-polymerisation due to the 
conjugated backbone of the PDA polymer. The study of the colorimetric properties will 
be described in section 5.2. Furthermore, such vesicular aggregates have been shown to 
undergo distinct blue-red colorimetric changes owing to conformational transitions in 
the conjugated (ene-yne) polymer backbone, induced by external structural 
perturbations.
1
 It is shown that the lipids and PDA part are interspersed within the mixed 
assemblies and they are likely to form distinct domains
1 
(figure 5.2).Such organisation 
and association would assist the stability and sensitivity by adjusting the molar 
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concentrations of the TCDA part.   
 
 
Figure 5.2: Organisation of phospholipid/TCDA vesicles and their colorimetric sensing.  
Structural/colorimetric transformations of PDA (blue part) can be induced by external molecules (grey 
part) which interact with the lipid bilayer domains (black part).
 2  
 
5.1.1.3  Temperature Effect of TCDA on Mixed Vesicle System  
Temperature plays an important role in determining the stability and sensitivity of 
vesicle systems as described in section 4.1.1.4. The vesicle system becomes leaky if it is 
in its liquid crystalline phase; the system lacks sensitivity which makes it impossible to 
be lysed by virulent factors if it is all in the gel phase. In this work, various 
concentrations of TCDA from 5 mol% up to 60 mol% have been incorporated into the 
phospholipid part to find out the optimal system which can be sensitive to toxins as well 
as be stable enough for the long term. Most of the lipid mixtures would be in liquid 
crystalline phase with small amount of TCDA incorporation at room temperature. The 
concept is to produce a ‗hard‘ polymerised TCDA shell which contains patches of liquid 
crystalline phospholipid. Furthermore, the insertion of cholesterol further improves the 
stability of the lipid bilayer and provides both firmness and fluidity in lipid bilayers. 
Therefore, the TCDA/phospholipid vesicles are maintained in a sufficiently fluid phase 
by insertion of appropriate molar concentration of TCDA into the bilayer moiety. Such 
functionality is suitable to be used as drug carriers at 37 
o
C as all microbiological work 
was carried out at 37
o
C for optimal growth of bacteria. 
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5.1.2  Vesicle Formation and Polymerisability  
Lipid extrusion was used here for the synthesis of phospholipid/TCDA vesicles to obtain 
uniform size distributions and the detailed procedure has been presented in the 
experimental section. In the case of polydiacetylene vesicle formation, the lipids must 
hydrate and organise into the correct packing and orientation to undergo the 1,4-addition 
to form conjugated polymer. The resultant vesicle solution exhibits a colour transition 
from transparent to blue. Therefore, the polymerisation reaction itself and the optical 
detection of the blue colour provide indirect evidence of an ordered lipid assembly. 
Vesicle formation can be determined by scanning electron microscope which is shown in 
figure 5.3. The image shows vesicles with relatively uniform size distributions. Vesicles 
were extruded by using 100 nm of pore size. Vesicle used here was composed of 10 
mol% TCDA and the SEM study was conducted after 1 week of vesicle formation. 
Therefore, the diameter of resultant vesicles was around 150 nm due to the some degree 
of vesicle-vesicle fusion. This is because that vesicle growth could, in principle, occur 
by the incorporation of free amphiphilic molecules or micelles, or through 
vesicle-vesicle fusion.  
 
 
Figure 5.3: SEM image of phoshpolipid/TCDA vesicles composed of 10 mol% TCDA, 20 mol% 
cholesterol, 2 mol% DMPE and 68 mol% DMPC.  
The average partical size is approximately 150 nm.  
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5.1.3  Purification of Phospholipid/TCDA Vesicles  
TCDA/phospholipid vesicles were purified in the same manner using NAP-25 columns 
purchased from GE Healthcare. The detailed study of purification has been described in 
section 4.1.3.  
  
5.2  Study of Colorimetric Property of Polydiacetylene/Phospholipid 
Vesicles   
One of the most interesting aspects of polydiacetylene chemistry is the colour and 
chromism of the materials. This can be ascribed to many factors such as the original 
packing state of the monomers and the exposure of the polymeric moiety to 
environmental perturbations such as heat (thermochromism),
3-5
 mechanical stress 
(mechanochromism),
6-7




The colorimetric property of vesicles assembly constructed from phospholipid 
molecules and conjugated polydiacetylene was studied here. UV-Vis spectroscopy was 
applied to characterise their chromatic property and their contributions to the observed 
blue-to-red colour transitions.  
 
5.2.1  UV-Vis Spectra of Vesicles Depending upon the Molar Ratios of 
Lipid-PDA  
The mixed vesicle system shows color transition from colorless to blue after 
photo-polymerisation because of conjugation of TCDA. Figure 5.4 shows a photograph 
depicting the appearance and UV-Vis spectra of aqueous solutions of vesicles with 
different molar ratios of DMPC and TCDA at 640nm. The figure clearly shows that the 
intensity of the blue color and the corresponding absorbance spectrum are closely related 
to the DMPC-TCDA ratio within the vesicles. The visual image also shows that the 
extent of color changing strongly depends upon the ratios of the lipids-TCDA. Indeed, 
the formation of vesicles with relatively high mol% of DMPC yields completely 
colorless vesicles (figure5.4b10%). The dependence of colorimetric property of the 
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vesicles upon the DMPC-TCDA molar ratio indicates that the two components are 
interspersed and they do not form two separate vesicle phases in solution. It can be 
explained that the similar conjugation and blue appearance of the solutions would be 
observed if they form two distinct vesicle solutions. However, such result is not 
observed here. Furthermore, the optical detection of the blue colour for the diacetylene 
system can provide direct evidence of the polymerisation of diacetylenic lipids.  
 
 .          





















 10 mol % polydiacetylene
 20 mol % polydiacetylene
 40 mol % polydiacetylene
 50 mol % polydiacetylene








                       
                
                        
                                   
Figure 5.4: Colorimetric properties of phospholipid/TCDA vesicles after UV irradiation.  
(a) Visible absorption spectra of phospholipid/TCDA vesicle solution irradiated with UV light and plots of 
absorption at 640 nm; (b) Photograph depicting the appearance of vesicles with different mol % of 





5.2.2  Thermochromic Property of Phospholipid/PDA Vesicles   
This part of the study investigates the temperature effect upon the chromatic properties 
of the vesicles. The colour transition of the vesicles was monitored by visible absorption 
spectroscopy with peaks within the range of 620-640 nm (PDA blue phase) and 490-540 
nm (PDA red phase). The blue to red transition is associated with a conformational 
change of the polydiacetylene backbone from planar to nonplanar.
9 
It is proposed that 





Figure 5.5: The transition of backbone structures of polydiacetylene from planar to nonplanar 
 
Vesicles with 40 mol % TCDA were formed in this experiment which is due to the 
reason that low concentration of TCDA (10, 20, 30 mol% TCDA) would lead to 
undetectable colour change. To evaluate the colour changes, colorimetric response was 
defined as the relative change in ―percent blue‖ for the vesicle preparation. PB0, the 
initial percent blue, is defined as:  
 
PB0 = A blue/ (A blue + A red) x 100%                                    (5.1)                                                      
 
In this expression, A is the absorbance at the wavelength of either the blue or red form. 
The colorimetric response gives the percent conversion to the red form at a given 
temperature, which is defined as: 
 
CR = (PB0 – PBI )/PB0 x 100%                                      (5.2) 
                                              
The resulting plot was the extent of blue-red colour transition (CR %) of vesicle samples 




Figure 5.6 shows the dependence of colorimetric and dynamical properties of different 
compositions of vesicles upon temperature. The percentage of colorimetric transition 
(CR) was induced by temperature. Higher CR value indicates more colour transitions, 
for example, more reddish appearance of the solution was observed. The photograph 
insert above shows the colour change of vesicles (DMPC/DMPE/Cholesterol/TCDA) 
was induced by heating the solution from 20 
o
C to 40 
o
C. At various points in between, 
the vesicle solution takes on a purple to pink colour compared to the initial faint blue. 
The graph also shows that the lipid composition affects the thermal sensitivity of the 
vesicles. From the data, the DMPC/DMPE/TCDA assemblies undergo stronger blue-red 
transitions as compared with DMPC/DMPE/Cholesterol/TCDA vesicles. This is due to 
the fact that the presence of cholesterol increases rigidity of the colorimetric membrane 
bilayer. Therefore, it can reduce its temperature sensitivity. Again, incorporation of 
cholesterol into the lipid membrane is necessary because the chromatic property of the 
vesicles would interfere with fluorimetric response if a fluorescent dye encapsulated 
within vesicles and probably have a negative effect on the fluorimetric response of the 
vesicle system. Therefore, 20 mol% cholesterol was used here for stabilising vesicle 






           
Figure 5.6: Graph of colorimetric response (CR) calculated from the visible absorption spectra of 
DMPC/DMPE/ 40 mol % TCDA and DMPC/DMPE/Cholesterol/40 mol % TCDA as a function of the 
solution temperature.  
The insert photograph showing plastic tubes containing the vesicle solution 
(DMPC/DMPE/TCDA/Cholesterol) before heating, at room temperature (faint blue), at 30 
o
C (purple) and 
at 40 
o
 C (pink) 
 
5.2.3  Colorimetric Detection of Bacteria-Vesicle Interactions 
Several reports have demonstrated that lipid/PDA vesicles undergo colour transitions 
upon binding of bacteria or antimicrobial peptides.
1, 10
 This part of the study investigated 
the colorimetric transition of the vesicles with addition of bacteria and the differentiation 
of colour response between pathogenic bacteria and non-pathogenic bacteria. P. 
aeruginosa (PAO1) and S. aureus (MSSA 476) as the pathogenic model and E.coli 
(DH5α) as the non-toxic model were cultured with phospholipid/TCDA vesicles at 37 oC. 
It was speculated that the colour changes could yield distinct colours by binding 
different bacteria which would be an indication of differentiating pathogenic and 
non-pathogenic bacteria: the binding of P.aeruginosa PAO1 and S.aureus MSSA 476 
would undergo a stronger colour transition. Unfortunately, UV-visible spectra and the 
photographs insert (figure 5.7) show no distinct colour is observed, suggesting the 
colorimetric transition of such vesicle system is not affected by different types of 



















bacteria. The photographs show that the vesicles undergo stronger colour transition in 
comparison with the photograph in figure 5.6 at relatively similar condition (37 
o
C), 
which suggest the colorimetric transition is affected by more than one factor. The 
transition is mainly ascribed to the interaction between vesicles and compounds/agents 
(either toxic or non-toxic) produced by bacteria. Such a property is not appropriate to be 
used in the further experiments as it affects the fluorescence sensing system if any 
fluorescent dye is encapsulated in the vesicles. The optimal way to reduce such 
colorimetric response is to form vesicles with a small amount of TCDA as well as 
retaining sensitivity and stability which is quite controversial and complicated.  
         
Figure 5.7: UV-Vis absorption spectra showing colour transitions of vesicles (DMPC/DMPE/Cholesterol/ 
40 mol % TCDA) induced by three strains of bacteria.  
Photographs insert showing the appearance of colours before and after addition of bacteria; left: P. 
aeruginosa; middle: S. aureus (MSSA 476); right: E. coli (DH5α)  
 
5.3  Fluorescence Sensing System   
This part of the study explores the ideal fluorescence sensing system based on the use of 
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self-quenched 5(6)-carboxyfluorescein. Carboxyfluorescein offers advantages for its use 
as a probe because it is easy to use, non-toxic, and self-quenching dependent upon 
concentration. In addition carboxyfluorescein has been reported to leak out of the cell 
less than fluorescein.
11
 Such advantage may overcome the problem of a continuous 
background fluorescence production. The use of such a system is on the basis that 
carboxyfluorescein is self-quenched within the vesicle and prior to release; following 
release, and subsequent dilution in the wound environment, the dye ‗ switches on‘ , 
becoming fluorescent.     
 
5.3.1  Preparatory Work   
Figure 5.8 is the image of the vesicle system (with carboxyfluorescein encapsulated 
inside) in both pre lysis and post lysis forms. It shows that a system that releases a 
quenched probe which is activated by dilution in the external solution. Such a system 
aims to be influenced by biological aspects and analysed by its ability to react to a 
microbiological environment.  
 
 
                                              
                       
 
Figure 5.8:  Chemical structure of 5(6)-carboxyfluorescein and images of the system in its pre-lysis (on 
left of frame) and post lysis (on right of frame) forms by Triton.  
(a) The image is under ambient lighting; the colour change is obvious from orange to green after lysis by 
Triton; (b) The image was taken under a low power (8W) long wavelength UV lamp at 365 nm 
illumination; right side shows obvious fluorescent colour change after lysis by Triton and self-quenched 
fluorescence by dilution in the bulk solution.  
 




selectively sense pathogenic bacteria, while not responding to non-pathogenic bacteria. 
The next part of the study investigates the concentration effect of carboxyfluorescein 
and the influence of UV irradiation on photobleach of such systems. Actual assessment 
of such theoretical systems will be discussed in next sections. 5(6)-carboxyfluorescein is 
most commonly used for the fluorescence sensing detection in the thesis.  
5.3.2  Carboxyfluorescein Fluorescence – Concentration Analysis  
In order to find at which range of concentration, carboxyfluorescein begins to self 
quench, the study of various concentrations of carboxyfluorescein in HEPES buffer 
solution versus fluorescence intensity was analysed. Figure 5.9 shows the fluorescence 
intensity of 5(6)-carboxyfluorescein against varying concentrations. The graph indicates 
the concentration at which self quenching begins to occur. It suggests that 
carboxyfluorescein has dose response behaviour at low concentration (< 9Mm); the 
fluorescence intensity is dramatically decreased when the concentration is above 9 mM. 
It is suggested that in carboxyfluorescein solutions, the fluorescence lifetime decreased 
drastically as concentration changes over the narrow range 20-50mM which is due to the 
energy transfer to dimers.
11
 The quenched concentration of 50 mM is most commonly 
used in this work and as shown here up to a 10
5
 dilution will provide an increase in 
fluorescence.  
      

























Figure 5.9: Graph showing self-quenching behaviour depending upon varying concentrations. 
The concentration at which self-quenching occurs is when the concentration higher than 9 mM.  
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5.3.3  Calculation of Fluorescence Release from Vesicles After Total Lysis  
The change in concentration of fluorescent probe can be estimated when all the vesicles 
are ruptured. The most straightforward way to do this is to consider total internal volume 
of the vesicles which has been based upon a uniform size population of vesicle spheres 
with an outer diameter of 110 nm and an inner diameter 100 nm. Such a calculation has 
been detailed in section 2.5.2. Detailed calculation is shown as follows: 30 mol% 
TCDA/Phospholipids is used here as an example.   
 
The calculated value of internal volume of phospholipid/30 mol% TCDA vesicles is 132 
µL in total 5 mL. Given that the initial encapsulated concentration of carboxyfluorescein 
is 50 mM, it can be calculated that the final concentration of carboxyfluorescein is 
around 1.32 mM when it is released to bulk solution (5 mL). Such a value is almost 35 
times lower than initial concentration which yields a fluorescent colour change exposed 
to low power UV illumination. The calculation of internal volume of phospholipid/ 
polydiacetylene vesicles is described in section 2.5.2.  
 
5.3.4  Carboxyfluorescein Fluorescence – Photobleach Analysis by UV 
Irradiation 
Carboxyfluorescein used in this work was subject to a great deal of irradiation with UV 
light, for example in the use of hard UV irradiation for polymerisation of diacetylene 
monomers (TCDA) which have been incorporated into the lipid vesicles. This assay 
aimed to explore the detrimental influence of UV irradiation on carboxyfluorescein. To 
evaluate the detrimental affect of UV irradiation on the fluorophore, free 
carboxyfluorescein with both quenched and un-quenched concentrations was exposed to 
UV irradiation using Hamamatsu UV-Vis Fiber Source L10290 fibir optic with the 
irradiation time of 10 minutes. Table 5.1 shows the resulting fluorescence intensity 
before and after UV irradiation. The table shows that the UV irradiation has no effect on 
the fluorophore. It is estimated that irradiation may have greater effect on a quenched 
50mM sample than on unquenched 500 µM and 50 µM samples.     
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Table 5.1: Fluorescence intensity of three difference concentrations of 5(6)-carboxyfluorescein before and 




sample diluted to 




diluted to 50 µ M ) 
Normalised   
Response  
50 mM      17865   16932   0.9479 
500 µ M      215322   211544   0.9825 
50 µ M      247411   238713   0.9648 
 
5.4  Study of Vesicle Stability and Sensitivity  
This part of the study looked at producing relatively stable lipid vesicles which would 
survive attachment to fabric, part drying and re-hydration, but still respond to pathogenic 
bacteria by breaking apart and releasing their payload, a fluorescent dye 
(carboxyfluorescein). Both studies were based upon the use of self-quenched 
carboxyfluorescein encapsulated within vesicles. Two main toxins used in this work are 
described as follows.  
 
5.4.1 Alpha-Haemolysin (α-HL) and Phospholipase A2 (PLA 2 ) 
α-Haemolysin belongs to the family of pore-forming toxins. The proteins are secreated 
by human pathogen: S. aureus. The description of such toxin has been discussed in 
chapter 1.   
PLA2 can target various phospholipids and exert its function. The phospholipids include 





5.4.2  Stability Study  
The stability of the vesicles is a key concern in lipid-vesicle-based sensor systems, both 
within an aqueous environment and following drying and re-hydration. A number of 
vesicle stabilisation approaches have been reported in the literature, including the use of 
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sugars and photo-polymerisable lipids.
13
 This work was followed on from the work of 




Initial experiments studied the effect of the mol % of the photo-polymerisable fatty acid 
TCDA on the stability of vesicles following partial drying for 48h and re-hydration in 
appropriate buffer. (Figure 5.10) 
 
Figure 5.10: Graph showing study of vesicle stability  
changes in the initial fluorescence of vesicles (left bar or pair) and fluorescence increase following partial 
drying and rehydration in HEPES buffer (pH 7.4, carboxyfluorescein eluent buffer system) (right bar) as a 
function of TCDA mol% in vesicles.Error bars represent standard deviations based on three 
measurements. 
 
The dehydration-rehydration graph shows that incorporation of diacetylene part (TCDA) 
does stabilise lipid vesicles: higher concentration of TCDA incorporated into the lipid 
part, smaller increase in fluorescence on re-hydration. Total lysis of lipid vesicles (0 % 
TCDA) by Triton indicates the expected fluorescence if all vesicles are lysed. Loss of 
fluorescence is decreased by incorporation into more concentration of TCDA. This 




































































TCDA concentration ≥ 30 mol %.  
5.4.3  Sensitivity Study  
This part of the study explored vesicle sensitivity to lysing agents: detergents and toxins 
with varying concentrations of TCDA. Figure 5.11A is the plot of vesicle lysis by 
detergent: Triton X-100 versus time. There is a clear decrease in fluorescence with 
higher concentration of TCDA incorporation. It is therefore concluded that an 
over-abundance of TCDA in the membrane may lower the sensitivity of the vesicle to 
lytic agents. It is also likely that large amount of TCDA may alter the vesicle size and 
shape such that they cannot carry a sufficient fluorescent payload. At hour-15, 
fluorescence intensity was increased faster between 0 mol% TCDA and 30 mol% TCDA 
vesicles, compared to the range of 40 mol% - 100 mol% with gradual increase of 
fluorescence intensity and following a relative no release of fluorescence intensity after 
hour-16. This is possibly due to the relative rigid shell of vesicle in 40%, 50%, 60% and 
100% and therefore small/no release of fluorescent dye iduced by Triton. Figure 5.11B 
shows the sensitive response of vesicles by two types of lytic toxins and triton as a 
function of mol% TCDA. The plot indicates that as the TCDA concentration increases 
from 0 to 40%, the fluorescent increase upon lysis by Triton, haemolysin or PLA2 
decreases from a four-fold increase at 20% TCDA to a less than two-fold increase at 




           
                
Figure 5.11: Graphs of vesicle sensitivity to lytic agents.  
(A) the graph showing vesicle sensitivity to Triton as a function of TCDA mol%; (B) graph showing 
vesicle sensitivity to Triton, α-haemolysin and phospholipase A2 (PLA2) as a function of TCDA mol % , 
the 0 % TCDA gives the maximum fluorescence change possible for full lysis in absence of TCDA. For 
each system, the greater change in fluorescence on adding lytic toxin, the higher the sensitivity. Error bars 
in figure B represent standard deviations based on three mearsuements of each sample.   
 
5.4.4  Summary  
TCDA improves the stability of the vesicles, but negatively affects the sensitivity of 
























































































































figure 5.10, combined with figure 5.11, indicate that such vesicle system can relatively 
retain both stability and sensitivity between the ranges of 20 mol %-30mol % of TCDA. 
Therefore, such range of TCDA vesicle was chosen as an optimal system to be 
commonly used in the further study including construction of prototype which will be 
discussed in chapter 6.  
  
5.5  Pathogenicity Assay in Suspension   
The sensitivity of the vesicles to bacteria and their ability to discriminate between the 
non-pathogenic E. coli strain from the two pathogenic strains (P. aeruginosa PAO1 and 
S. aureus MSSA 476) was tested here. This part of work studied the fluorescence release 
from vesicles with varying mol% TCDA as bacteria grow and release toxins. All the 
experiments were performed on vesicles suspended in buffer/ bacterial growth medium. 
(TSB for S. aureus; LB for P. aeruginosa and E.coli)   
 
Figure 5.12 demonstrates that the vesicles only responded to the two pathogenic species 
of bacteria as they grow (S. aureus and P. aeruginosa), but not to the non-pathogenic 
E.coli. Although the graph for the E.coli (a) (b) shows a slight increase in fluorescence 
intensity in comparison with the control system (vesicles suspended in buffer). This is 
due to the passive leakage because only small amount of TCDA are incorporated within 
the phospholipid vesicles. Therefore, such a system would lack relative rigidity and 
renders the vesicle system leaky. Although graphs (c) and (d) demonstrate that vesicles 
still respond to pathogenic strains (S. aureus, P aeruginosa), there is a decrease in 
fluorescence intensity with more mol% TCDA incorporated within the lipid bilayer, 
suggesting vesicles are gradually losing their sensitivity to toxins produced by 
pathogenic strains with more TCDA incorporation. In addition, P. aeruginosa grown 
with 50 mol% TCDA/lipid vesicles in LB medium shows a 5-fold decrease in 
fluorescence in comparison with its growing with 30 mol % TCDA/lipid vesicles as 
shown in figure (a). Interestingly, it seems that S. aureus is either more virulent, or 
secretes more toxins during its exponential growth phase when grown in TSB medium. 
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The four graphs show that toxins produced by S.aureus can cause more release of 
fluorescence from vesicles compared to P.aeruginosa. 
  
The pathogenicity assay further proves that vesicles can still retain their stability and 
sensitivity when the TCDA concentration is in the range of 25% - 30%. However, there 
was still some degree of passive leakage of encapsulated contents from the vesicles, as 
presented in figure 5.10 (a), (b). Higher concentration of TCDA can significantly 
stabilise vesicles and showed no significant leakage of carboxyfluorescein from the 
vesicles, as shown in figure 5.10 (c) and (d). Overall, the TCDA concentration for 
optimum stability was chosen as 30% in this work; this provides stability without 
comprising flexibility. 
 
Figure 5.12: Time course of the kinetics of the interaction of bacteria with phospholipid/TCDA vesicles. 
Toxins secreted by P.aeruginosa PAO1 and S. aureus MSSA 476 (OD = 0.01) induces permeabilisation of 
different concentration of TCDA/PC vesicles at pH7.4 as revealed by the increase of fluorescence of 
5(6)-carboxyfluorescein when this is released into the external solution; E. coli (DH5a) as control did not 
permeabilise vesicles as they do not secrete any lysing toxins or enzyme. MSSA476 was cultured in TSB 
medium which seems to secrete more virulent toxins to cause leakage of membrane of vesicles. More 
concentrated TCDA is incorporated in the mixture, more cross linked vesicles and hence the more stable 
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the system. Error bars represent standard deviations based on three measurements of each sample.  
  
Figure 5.13 shows the similar results of fluorescence release from vesicles as bacteria 
grow and release toxins. The only difference between the two graphs is the medium for 
growing S. aureus; TSB medium was used as growing medium for S. aureus in (a), 
while LB medium was used in (b). In fact LB broth has been commonly used in all 
microbiologically related assays. Later, TSB was found to be an optimum culture 
medium for growing S. aureus as MSSA 476 is either more virulent, or secretes more 
toxins during its exponential growth phase in TSB medium than in LB medium. This is 
proved by the pathogenicity assay. Figure 5.13 (a) shows that S. aureus can secrete more 
virulent toxins and the graph shows more significant increase in fluorescence in 
comparison with (b). Therefore, TSB was chosen as the growth medium for S. aureus in 
this experiment.  
 
  
Figure 5.13: Similar graphs showing fluorescence release from vesicles (30 mol % TCDA/lipid vesicles) 
as bacteria grow in different media.  
S.aureus MSSA 476 grown in TSB medium and other two strains grown in LB medium; (b) three strains 
all grown in LB medium. The graph suggests S.aureus is either more toxic or secretes more virulent toxins 
when grown in TSB medium. Error bars represent standard deviations based on three measurements of 
each sample.   
 
5.6  Conclusion  
In this chapter, a new methodology of detecting the microbiological state of wound 
dressing in terms of fluorescent indication has been developed. And a new stabilised 
vesicle system has been developed by inserting diacetylene monomers within the 
phospholipid bilayer. Such nanocapsule systems obtain chromatic properties due to the 
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conjugated structure and can undergo colorimetric transition under external stress 
including interaction of bacteria and lipid bilayers, or temperature increase. It is known 
that more conjugated component will yield a stronger colorimetric transition. Such 
property may interfere with fluorescence measurement if carboxyfluorescein is 
encapsulated within vesicles. Further stability/sensitivity tests suggest that the optimal 
vesicle system is around 30 mol% TCDA. Such a range of vesicles would not yield 
strong colour after UV irradiation and thus would not affect the further test of 
fluorescence sensing measurement in suspension which can be seen in figure 5.12 and 
5.13. The pathogenicity assay further proves that such vesicle system can respond to 
pathogenic strains (P.aeruginosa PAO1 and S. aureus MSSA 476) and not respond to 
non-pathogenic strains (E.coli DH5 α). Both stability/sensitivity and pathogenicity tests 
demonstrate that a relatively stable vesicle system can be fabricated using an optimum 
concentration of TCDA as a stabiliser. The next chapter is to build up a simple prototype 
dressing to examine whether vesicle modified fabric would be sufficiently sensitive to 
pathogenic bacteria and to give a visual response under weak UV light, whilst not 
responding to non-pathogenic E. coli. In addition vesicles with 30 mol % TCDA are 
relatively more resistant to damage resulting from partial drying than in the absence of 
TCDA, but will not survive in a completely dry environment. Therefore the next part of 
study will also investigate to construct various prototypes to maintain vesicles stability 
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Chapter 6   Construction of a Prototype for Stabilising 
Vesicles and Assisting Wound Healing 
 
While the previous chapter was devoted to the development of a new nanocapsule 
system which can detect the presence of pathogenic bacteria by utilising the 
self-quenching of carboxyfluorescein, the present chapter describes the construction of a 
simple prototype to maintain the vesicle intact as well as maintain a moist environment 
in order to assist wound healing. In this chapter, various methods including 
plasma-polymerised maleic anhydride and photo-polymerisation of poly (acrylic acid) 
grafted onto non-woven polypropylene have been discussed for stabilising vesicles. 
Following measurements were carried out to examine whether vesicle-modified fabric 
would be sufficiently sensitive to pathogenic bacteria to give a visual response, while 
not responding to non-pathogenic E. coli. In section 6.4, a simple prototype was 
constructed by utilising a hydrogel in order to maintain vesicle stability and to maintain 
a moist environment for assisting wound healing. Stability tests of prototypes were then 
studied for further research.  
 
6.1  Construction of Wound Dressing  
The wound dressing is based on the principle of creating and maintaining a moist wound 
environment. Characteristics of an ideal dressing are described as follows: 
1
 
1) Capable of maintaining a moist environment at the wound site while removing 
excess exudate 
2) Non-toxic and non-allergenic 
3) Capable of protecting the wound from further trauma 
4) Can be removed without causing trauma to the wound 
5) Impermeable to bacteria 
6) Thermally insulating 
7) Allows gaseous exchange 
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8) Comfortable and pain relief 
9) Require only infrequent changes 
10) Cost effective    
  
Therefore, the construction of wound dressings should meet the standards of the above 
requirements. A bilaminar wound dressing is composed of an outer semi-permeable 
membrane and an inner three-dimensional matrix of a fabric or a sponge to constitute an 
ideal structure that promotes wound healing.
2 
The outer membrane normally controls 
release of moisture vapour, provides an effective barrier to water or wound exudate, and 
protects the wound surface from bacterial invasion; inner matrix encourages adherence 
by tissue growth into the matrix. This project aims to develop a biosynthetic wound 
dressing with a drug delivery capability as well as a visual response in the presence of 
pathogenic bacteria. This medicated wound dressing is composed of several sheets 
modified with non-woven polypropylene fabrics and vesicle (containing 
antimicrobials/fluorescent dyes) which are laminated with hydrogel layer by layer. This 
structure of the proposed inner membrane is shown in figure 6.1.  
     
 
 
Figure 6.1: Schematic representation of the hydrogel-vesicle modified fabric-hydrogel construction.  
 
Hydrogel layer (collagen or gelatine) 
Vesicle modified non-woven polypropylene 
(fluorescent dye encapsulated inside vesicles) 
Vesicle modified non-woven polypropylene 
(antimicrobial encapsulated inside vesicles) 
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6.2  Pulsed Plasma Deposited Maleic Anhydride Thin Films as 
Supports for Vesicles  
The attachment of giant unilamellar vesicles containing DMPE lipids, using plasma 
deposited maleic anhydride, has been discussed in chapter 4. This part of the work 
follows on the use of pulsed plasma deposited maleic anhydride on polypropylene fabric 
with retention of the anhydride group functionality. Following film deposition, the fabric 
was immersed in an aqueous suspension of the lipid vesicles allowing formation of 
amide linkages between the anhydride group and amine functionality on PE lipids. 
Vesicle mediated pp-MA fabrics could be considered as a middle layer of wound 
dressing.    
 
6.2.1  FT-IR for Surface Characterisation  
Figure 6.2 is the FT-IR graph showing vesicles has been successfully attached onto 
pp-MA polypropylene. Similar graph shows an expected anhydride group at 1780 cm 
-1 
on pp-MA polypropylene nonwoven. Following vesicles attachment, a strong and broad 
absorption at 1643 cm 
-1 
suggests an amide bond formation, which primarily results from 
ester C=O bond from phospholipids and TCDA and a fraction of the peak results from 





























Figure 6.2: FT-IR data showing vesicles attachment onto treated non-woven polypropylene.  
Black, standard polypropylene fabric; Red: non-woven polypropylene was modified with plasma 
polymerised maleic anhydride and shows anhydride group; Green: modified non-woven fabric was 





6.2.2  SEM for Analysis of Vesicle Modified Surface  
Scanning electron microscopy was used here to observe the surface morphologies of the 
vesicle modified non-woven polypropylene, which was deposited with a thin film of 
plasma polymerised maleic anhydride before vesicle attachment, as presented in figure 
6.3. The regions are labelled at the top right corner of each image. SEM image in figure 
6.3 A depicts a single fibre of polypropylene which was purchased from Boots, the 
chemist. Such non-woven polypropylene has been coated with unknown materials in 
order to improve its hydrophilicity before purchase. The surface of polypropylene was 
not further treated and was directly used in the experiment for plasma polymerisation. 
Figure 6.3 B represents appearance of the polypropylene deposited with a thin film of 
plasma polymerised maleic anhydride. The figure reveals that the cross-linked polymers 
are randomly coated on the surface and thus make the surface quite rough compared to 
non-treated polypropylene(A). Figure 6.3 C&D show the images of 
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The vesicle mediated surface was rinsed with an appropriate buffer and then was imaged 
under SEM for visualisation. The freshly prepared vesicles are shown in C and D with a 
size range of hundreds of nanometres. Most of vesicles have irregular shapes with round 
edges. The variability in vesicle shapes is possibly due to incorporation of diacetylene 
part into lipid moiety and membrane crystallisation of PDA part at room temperature. 
The figures reveal that vesicles only exist on the region where the pp-MA is deposited.    
            
    
 
Figure 6.3: SEM images, recorded with JEM-6480LV scanning electron microscope 
A) image of a single fibre of polypropylene; B) microscopic image of the surface of pp-MA treated 
non-woven polypropylene; C) surface of vesicles attached onto the pp-MA treated fabrics with 
magnification of 15,000; (D) surface of vesicles attached onto pp-MA treated fabrics with magnification 
of 7,000. vesicle composition: 48 mol % DMPC/2 mol% DMPE/20 % Cholesterol/ 30 mol% TCDA; 
plasma parameter: pulse 10/40ms, 30 min.  
    
Figure 6.4 further illustrates the overview of the images of vesicles attached to the 
non-woven polypropylene coated with plasma polymerised maleic anhydride. The fibres 
of polypropylene shown here are coated with pp-MA almost everywhere. Therefore, 
vesicles can be attached onto treated area almost everywhere, suggesting more payloads 










Figure 6.4: SEM images of vesicles on non-woven polypropylene deposited with plasma polymerised 
maleic anhydride, recorded with JEM-6480LV scanning electron microscope.  
Vesicle composition: 48 mol % DMPC/2 mol% DMPE/20 % Cholesterol/ 30 mol% TCDA; plasma 
parameter: pulse 10/40ms, 30 min.  
 
6.2.3  Attachment of Vesicles to Fabric and Stability /Response Testing  
Figure 5.10 and 5.11 show vesicle stability before/after part dry and sensitivity to lytic 
agents on pp-MA modified non-woven fabrics. The results of the figures prove that 
vesicles can obtain both relative stability and sensitivity by selecting appropriate molar 
concentration of TCDA. This negative correlation with respect to TCDA concentration 
can be visually observed on vesicles attached via pulse plasma deposited maleic 
anhydride thin films on non-woven polypropylene fabric (figure 6.5). Figure 6.5 shows a 
visual response that correlates with the measurements in figure 5.10 and figure 5.11 B : 
too low a TCDA concentration results in the vesicles not being stable to partial drying (0, 
5, 10%); too high a concentration of TCDA results in vesicles not being sensitive to lysis 
by Triton (50 and 60%). Therefore, the optimum TCDA concentration for stable and 




    
 
Figure 6.5: Polypropylene modified with vesicles containing initially self-quenched carboxyfluorescein 
(left-hand swatch) and switching on of fluorescence of dye following either vesicle destruction following 
part drying or direct lysis by Triton, as a function of mol % TCDA. plasma parameter: pulse 10/40ms, 30 
min.  
 
The parallel experiment (vesicle containing self-queched carboxyfluorescein in 
appropriate HEPES buffer) was carried out in a 96-well plate under a low power UV 
lamp. The visual colour of fluorescence in the plate is shown in figure 6.6. Each sample 
in triplicate further shows that a higher concentration of TCDA stabilises the vesicle 






Figure 6.6: Fluorescent images of vesicles in 96-well plate.  
Vesicles containing initially self-quenched carboxyfluorescein (Plate 1) in HEPES buffer solution and 
switching on of fluorescent dye following vesicle destruction by doing dehydration in class II flow hood 
for 24 hours and rehydration by appropriate HEPES buffer (Plate 2) and following lysis by Triton and 
phospholipase A2, as a function of mol% TCDA.  
 
The results shown in figure 6.5 and 6.6 demonstrate that a relatively stable vesicle 
system can be fabricated using an optimum concentration of TCDA as a stabiliser. This 
part of the study tested the response of the optimised (in terms of sensitivity and stability) 
vesicle system bound to pp-MA treated fabrics to strains of the test bacteria. Figure 6.7 
shows the image of optimised vesicles (30 mol% TCDA) attached onto pp-MA treated 
non-woven fabrics responding to three strains of bacteria. The vesicles did not respond 
to non-pathogenic bacteria E.coli and only responded to pathogenic strains: 
P.aeruginosa PAO1 and S.aureus MSSA 476 as expected. This experiment, using 
pulse-plasma-deposited maleic anhydride to bind the vesicles to the fabric, and to create 
a thin hydrogel film, gave a clear indication that a fabric could be produced that 

















       
 
Figure 6.7: A crude ‗proof of principle‘ prototype: response of modified fabric following overnight 
growth of bacteria on polypropylene fabric with 30 mol% TCDA vesicles.  
 
6.3  Graft Polymerisation of Poly(acrylic acid) onto Non-woven 
Polypropylene  
This part of study looked at using alternative for attaching vesicles via hydrogen bond. 
Such fabrics were kindly offered by Dr. Thet Naing Tun, Department of Chemistry, 
University of Bath, UK. Non-woven polypropylene was surface-modified by 
photo-induced graft polymerisation of poly (acrylic acid) or PAA by utilising 
benzophenone as a photo initiator to improve the hydrophilicity of the fabrics. Vesicles 
were then attached onto modified non-woven polypropylene via hydrogen bonding due 
to negatively charged carboxylic acid functional groups on grated surface in grafted 
chains. The advantages of photo-grafting of polymerisation are: 1) photochemically 
produced triplet states of carbonyl compounds can abstract hydrogen atoms from almost 
all polymers so that polymerisation can occur; 2) high density and localisation of 
reactive chains onto the surface; 3) low cost and simplicity.
3 
Surface characterisation and 
wettability of surface have been studied by Dr. Thet Naing Tun and will not be detailed 
here. The schematic diagram for the process of surface graft polymerisation of PAA onto 









 A-UV-pretreated non-woven 
polyrpopylene 
B – One droplet addition of BP 
solution  
C - BP solution removal and drying 
D-Loading of AA monomer solution  
E – Polymerisation by UV exposure 
F- Monomer solution removal yields 
PAA grafted surface in center area  




             
           
Figure 6.8: Schematic representation of UV-induced graft polymerisation of poly (acrylic acid) on 
non-woven polypropylene.  
(A) Process of UV induced chemical modification of non-woven polypropylene with acrylic acids as 
grafting agents. BP: benzophenone; (B) General scheme for the UV-induced modification of non-woven 
polypropylene.  
  
Vesicle treated fabrics were incubated with the three strains of bacteria to examine 
whether the modified non-woven polypropylene responded to pathogenic bacteria 
P.aeruginosa (PAO1) and S. aureus (MSSA 476) and caused switch on of fluorescence 
of encapsulated carboxyfluorescein. The visual response was photographed under low 
power of UV light, as presented in figure 6.9 (B). Control system (vesicle on modified 
BP 
Substrate 




surface) did not cause any fluorescence release overnight, indicating that vesicles were 
stable at least for 16 hours at 37 
o
C, which can be seen from control system. 
P.aeruginosa PAO1 and S.aureus MSSA 476 caused significant switch on of 
fluorescence overnight. It is apparent that P.aeruginosa PAO1 caused more dye leakage 
from vesicles in comparison with S.aureus MSSA 476 when these two strains are all 
grown in LB medium.The possible reason is because either more toxins or more virulent 
toxins were produced by P.aeruginosa PAO1. Furthermore, the rate of switch on of 
fluorescence in P.aeruginosa PAO1 was faster in comparison with S.aureus MSSA 476, 
which can be concluded from the image that more fluorescence was released after 4 h in 
P.aeruginosa PAO1 than in S.aureus MSSA 476. In addition differences in the mode of 
action of these two pathogenic strains resulted in the difference in diffusion of 
fluorescence. E.coli DH5α as control system showed almost no fluorescence release 
compared to the two strains of pathogenic bacteria.  
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Figure 6.9: Images of photo-grafting polymerisation of PAA on non-woven polypropylene in the central 
area with a diameter of 1 cm and fluorescence response induced by toxins secreted by pathogenic bacteria 
(PAO1 and MSSA 476) after 4h and overnight.  
A) freshly made photo-grafting polymerisation of PAA on non-woven polypropylene in central area 
( diameter: 1 cm); B) vesicles (30 mol % TCDA) attached onto the modified surface by hydrogen bond 
due to negatively charged carboxylic acid groups from grafted polymers and induced by toxins and 
following the switch on of fluorescence of carboxyfluorescein. The fabrics were incubated at 37 
o
C and 
were photographed under low power UV light after 4 h and 16h, respectively.   
 
Here the fluorescence response experiment only confirms the efficiency of such 
modified fabrics and thus such a system is considered as an alternative for further 
prototype construction. The photo-grafted polymerisation onto non-woven 
Control + E.coli DH5α + P. aeruginosa +S.aureus 
Control + E.coli DH5α + P. aeruginosa +S.aureus 





polypropylene as a simple prototype is currently being studied in the Jenkin‘s group, 
Department of Chemistry, University of Bath, UK.  
 
6.4  A Simple Prototype Construction  
The prototype constructed in this work was an initial trial to investigate its stability and 
efficiency of response to pathogenic bacteria which could be applied for further 
application of wound dressing.  Although the relatively stable and sensitive vesicle 
system has been proved to be efficient in responding to pathogenic bacteria in section 
6.2 and 6.3, the vesicles are not able to survive in 100% dry condition. Furthermore, a 
moist environment allows the optimum environment for healing based on the work of 
Winter (1962).
4
 Most wound dressings nowadays have been designed to allow ‗moist 
healing‘ to prevent dehydration and help protect and maintain temperature. Therefore, 
the most appropriate dressing designed in this work should maintain a moist 
environment at the wound surface without causing maceration of the surrounding skin as 
well as maintain vesicles intact and stable for long term use. The requirements of the 
prototype constructed in this work should be: 1) maintain the stability of vesicles; 2) 
stable at least for several days both at room temperature and 37 
o
C which is the optimum 
temperature for cellular activity and division; 3) promote wound healing. 
 
6.4.1  Gelatine as Supports for Stabilising Vesicles  
Gelatine is a mixture of peptides and proteins produced by partial hydrolysis of collagen. 
It is mainly used as a gelling agent in food, cosmetic manufacturing and 
pharmaceuticals.
5
 Gelatine is a hydrolysed form of collagen, therefore it can aid wound 
healing as well as improve vesicle stability by incorporating gelatine in the prototype. 





                            
 
Figure 6.10: Schematic of simple prototype in single vial of 96-well plate, phospholipid/PDA vesicles (30 
mol% TCDA) containing self-quenched carboxyfluorescein sandwiched between two hydrolysed gelatine 
sheets.  
 
Relatively stable phospholipids/PDA vesicles were sandwiched between two gelatine 
sheets in order to maintain their stability and a moist environment. The experiment was 
carried out in 96-well plate and was sealed with transparent adhesive tapes when not in 
use. The stability was tested in terms of fluorescence released from vesicles each day. 
The stability data are shown in figure 6.11. The result shows that vesicles remain intact 
and stable in gelatines for almost 1 month at room temperature. The fluorescence 
intensity was 5-fold increase by the lysis of Triton. The photographs insert shows a 
visual image of vesicles between in gelatine sheets. No additional fluorescence was 
observed until the system was lysed by Triton. All measurements were carried out at 
room temperatures. Parallel experiment was carried out at 37 
o
C in order to measure the 
stability of the prototype at higher temperature. Unfortunately, gelatine sheets were 
melted at 37
o
C thus they were not able to maintain vesicles intact and stable at 37 
o
 C. 































Figure 6.11: Graph showing stability test of phospholipids/PDA vesicles (30 mol% TCDA) in gelatine 
sheets for 25 days and significant fluorescence increase after lysis by Triton.  
Photographs inserted are the images taken under low power UV light at room temperature. Error bars 
represent standard deviations based on three measurements of each sample.  
 
6.4.2  Plasma Polymerised Maleic Anhydride Deposited onto Non-woven 
Polypropylene and Following Subsequent Grafting of Collagen onto 
Polymer Films  
6.4.2.1  Stability Study of Collagen Grafted pp-MA Non-woven 
Polypropylene  
This part of the study follows on the work of section 6.2 and investigated the stability of 
the prototype which is pp-MA modified surface coated with collagen solution. The 
pp-MA deposited non-woven polypropylene was dip coated in the collagen solution to 
improve the hydrophilicity of the whole surface and thus maintain vesicles intact and 
stable. Vesicles were sandwiched between two modified sheets, as presented in figure 


















































                 
 
Figure 6.12: Schematic diagram of prototype construction: pp-MA modified non-woven polypropylene 
was dip coated in collagen solution, with vesicles containing self-quenched carboxyfluorescein following 
attached onto collagen grafted pp-MA surface.  
The layout of such prototype was then placed in 96-well plate for stability test in terms of fluorescence 
release from vesicles.   
 
The graph for the stability test at room temperature is shown in figure 6.13. The 
prototype was very stable for 25 days until lysis by Triton and did not show any change      
in fluorescence intensity on the histogram in comparison with figure 6.11, indicating that 
collagen grafted pp-MA non-woven polypropylene could provide an optimal 
environment to maintain vesicles intact and stability for long term use, possibly resulting 
from the covalent binding between vesicles and pp-MA treated surface and following the 
immersion of collagen solution which enhances the surface hydrophilicity. The stability 
test was only tested for 25 days at room temperature, whereas the prototype is assumed 





































Figure 6.13: Graph showing stability test of phospholipids/PDA vesicles (30 mol% TCDA) sandwiched in 
collagen grafted pp-MA non-woven polypropylene for 25 days and significant fluorescence increase after 
lysis by Triton.  
Photographs insert are the images taken under low power UV light. The images depict no release of 
fluorescent dye until the lysis by Triton addition. All measurements were carried out at room temperature. 
Error bars represent standard deviations based on three measurements of each sample.  
 
A parallel experiment was carried out at 37 
o
C.  The result indicated that such a 
prototype was not as stable as it was at room temperature, which is shown in figure 6.14. 
The data show progressively smaller increase for the first two days. A significant 
increase in fluorescence occurred from day-3 which is almost 5 times higher than the 
fresh system. It is possible that such a system would not carry a sufficient fluorescent 
payload in the process of time. Therefore, such system can retain its functionality for 1 
or 2 days for responding to pathogenic bacteria otherwise it would interfere with 
fluorescence sensing result. It is probably because that water evaporated from the 
surface of the modified fabrics (water was primarily from the collagen solution) due to 
the continuous heat in the incubator, resulting in the total dry condition of the treated 

















































able to survive in total dry conditions. This will lead to vesicle rupture and leakage of 
the fluorescent dye. Photographs insert here are in agreement with the graph, although 



















                                              
Figure 6.14: Graph showing stability test of phospholipids/PDA vesicles (30mol% TCDA)    
sandwiched in collagen grafted pp-MA non-woven polypropylene at 37 
o
C and fluorescence increase after 
lysis by Triton.  
Photographs insert are the images taken under low power UV light. The images depict gradual increase in 
fluorescence in process of time. All measurements were carried out at 37 
o
C. Error bars represent standard 
deviations based on three measurements of each sample.  
 
6.4.2.2  Pathogenicity Assay on Collagen Grafted pp-MA Non-woven 
Polypropylene  
 
This part of the work investigated whether the simple prototype constructed here 
responds to pathogenic bacteria S.aureus (MSSA 476) and P.aeruginosa (PAO1), while 
not responding to non-pathogenic bacteria E.coli (DH5α). Given that the system is only 
stable for 1 or 2 days at 37 
o
C, such pathogenicity measurement is possible to be carried 
out in incubator at 37 
o
 C for 16 hours. The result shown in figure 6.15 indicates that 



































such a system effectively responds to pathogenic bacteria. It is illustrated that the 
vesicles can be coated on to a fabric and are sensitive to pathogenic bacteria when 
dispersed in broth, ‗switching on‘ as the bacteria grow, as shown in figure 6.15 B. 
 
       
 
Figure 6.15: Simple prototype dressings: fluorescence response of modified fabric following overnight 
growth of bacteria on polypropylene fabric with 30 mol % TCDA vesicles.  
 
6.5  Conclusion  
In this chapter, three methods to stabilise phospholipid/PDA vesicles have been 
described including fabrics modified with plasma polymerised maleic anhydride, 
photo-grafting of polymerisation and gelatin sheets. Vesicles are attached on these 












modified surfaces via covalent bond, hydrogen bond or electrostatic interaction. 
Furthermore, a prototype detection system for pathogenic bacteria on a simple model 
wound dressing is shown. The stability result of gelatin shows that gelatin is melted 
when temperature increases, indicating that it is not suitable in the use of wound 
dressings at relatively high temperature. Although the results of stability and 
pathogenicity indicate that pp-MA modified surface with grafted collagen so far has 
been considered as a good system for stabilising vesicles. However, such system is not 
as stable as expected for long term use at 37 
o
C. Various alternatives e.g. commercial 
and laboratory synthesised hydrogels which can replace such system for long term use 
especially at 37 
oC is currently being studied in Jenkins‘ group.  
 
Many factors have been recognised to reduce or delay wound healing including moist 
environment, pH changing on the surface of injured wound, temperature, and individual 
differences, etc. These factors should also be taken into account when constructing a 
prototype. More measurements are being studied in Jenkin‘s group such as the stability 
tests of prototypes in different pH and temperatures.  
 
It is confirmed that the designed simple prototype can selectively respond to pathogenic 
bacteria by releasing fluorescent dye from vesicles to the external environment which 
provides an indication for clinical monitoring whether the wound is infected by bacteria 
or not. The ultimate aim of this work is to attempt to engineer a ‗smart‘ wound dressing 
system that not only shows color change in the presence of pathogenic bacteria, without 
responding to commensal/harmless bacteria but also releases an encapsulated 
antimicrobial agent in the presence of pathogenic bacteria to inhibit/kill pathogenic 
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Chapter 7  Development of Antimicrobial Property for 
Phospholipid/PDA Vesicles  
 
Besides the property of colour response in the presence of pathogenic bacteria, 
construction of a ‗smart‘ wound dressing requires that such nanocapsule system also has 
ability of killing/inhibiting bacterial growth if the infection occurs. This part of study 
looked at three types of topical antimicrobials which were encapsulated in the vesicles to 
make vesicle antimicrobial. The antimicrobial performances of vesicles were detected 
both in suspension and on plasma polymerised maleic anhydride deposited non-woven 
polypropylene.  
 
The structure of this chapter is organised as follows: section 7.1 outlines a type of 
antimicrobial—silver nitrate encapsulated within vesicles. The antimicrobial efficacy of 
vesicles was evaluated both in suspension and on pp-MA modified non-woven 
polypropylene. The MIC50 of the pathogenic bacteria P. aeruginosa (PAO1) and S. 
aureus (MSSA 476) and non-pathogenic bacterial strain E. coli (DH5α) have been 
studied in this section in order to understand the susceptibility of the three strains to 
silver nitrate. Section 7.2 and 7.3 investigates antimicrobial efficacy containing 
gentamicin sulphate and chlorhexidine both in suspension and on pp-MA modified 
fabrics using JIS. The final part of this chapter concludes the chapter and summarises the 
key findings.  
 
7.1  Silver Nitrate 
Silver nitrate as the first antimicrobial was chosen to be used in this study. It has some 
issues with staining problems as stated in chapter 1. However, AgNO3 is still a potent 
topical antimicrobial with high efficiency on a relatively wide range of bacterial 
infection. By utilising vesicles, cytotoxicity issues would be minimised due to a far 
lower concentration of silver nitrate released from vesicles and only when necessary.  
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7.1.1  Determination of Bacterial Susceptibility (MIC50)  
The minimum inhibitory concentration to kill 50% of the bacterial population (MIC 50) 
of AgNO3 against the three bacterial strains, S. aureus (MSSA 46), P. aeruginosa 
(PAO1), and E. coli (DH5α) was determined. Initially, a range-finding test was 
performed to gauge a rough indication of sensitivity to AgNO3.  Table 7.1 shows the 
concentrations of AgNO3 and at which bacterial growth was inhibited.   
 
Table 7.1: Range finding test of AgNO3 against three strains of bacteria (where ‗+‘ is positive growth and 
‗-‘ indicated no growth) 
AgNO3 (mg mL 
-1
) E.coli DH5α P.aeruginosa (PAO1) S.aureus (MSSA 476) 
0.000001 + + + 
0.00001 + + + 
0.0001 + + + 
0.001 + + + 
0.01 - - + 
0.1 - - - 
1 - - - 
 
The results of the range finding test indicates at which range of concentration AgNO3 
started to inhibit growth of bacteria. Triplicates with a narrow range of concentrations 
were then performed once a good indication of range finding test has been confirmed. 
The experiments over a narrow range of concentrations of AgNO3 against three bacterial 
strains were further performed on a BMG Labtech fluorimeter in absorbance mode at 
600 nm. The concentrations of AgNO3 to inhibit the three strains of bacteria are shown 
as follows:   
-  E.coli DH5α  : 0.001-0.01mg/mL AgNO3 
-  P.aeruginosa PAO1 : 0.001-0.01mg/mL AgNO3 
-  S.aureus  MSSA 476 : 0.01-0.1 mg/mL AgNO3 
Based on the range of concentrations analysed above, final optical density for varying 
concentrations were measured after overnight and plotted against log([AgNO3]), as 
presented in figure 7.1. These graphs were used to determine the value of MIC50 for E. 
coli DH5α, P. aeruginosa PAO1 and S. aureus MSSA 476.  
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Figure 7.1: MIC50 of silver nitrate to the three strains of bacteria. The shapes of bacterial optical 
density-antimicrobials graphs give a clue that at which concentration of bacteria starts to respond to 
AgNO3 and at which concentration of bacteria would be completely inhibited by the antimicrobial. Error 
bars represent standard deviations based on three measurements of each sample.  
 
 
The minimum inhibitory concentrations of AgNO3 versus three strains of bacteria were 
tested in solution and are summarised in table 7.2.  
 
Table 7.2: Summary of MIC50 of AgNO3 versus three bacterial strains 












AgNO3       1.5 x 10
-3
       7.2 x 10
-4




From the table, it can be observed that S. aureus MSSA 476 showed the most sensitive 
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to AgNO3, indicating that more S. aureus MSSA 476 would be killed compared to P. 
aeruginosa PAO1 and E. coli DH5α using same concentration of AgNO3, whereas E. 
coli DH5α showed the lest susceptible to AgNO3. The result of AgNO3 was contrary to 
previous MIC50   data of both gentamicin sulfate and sodium azide. Figure 7.1 shows 
that P. aeruginosa PAO1 started to respond (declines in concentration) to AgNO3 at the 
concentration of 0.76 µg mL 
-1 
and was almost completely inhibited at concentration of 4 
µg mL 
-1
; S. aureus MSSA 476 started to respond to AgNO3 at the concentration of 
0.5µg mL 
-1 
and was completely inhibited at the concentration of 1 mg mL
-1
; E. coli 
DH5α became sensitive to AgNO3 at 1 mg mL
-1
 and need 5 mg mL
-1 
for complete 
inhibition. The MIC results provide the information for the minimum encapsulation 
concentration of antimicrobials to be encapsulated within vesicles for antimicrobial test.  
  
7.1.2  Minimum Encapsulation Concentration  
MIC provides information for the further studies of antimicrobial measurement of 
vesicles and the calculation of minimum concentration of AgNO3 should be 
encapsulated within the vesicles given that total volume of vesicles has been known. The 
minimum concentration of AgNO3 to be encapsulated within vesicles is calculated as 
follows:  




The highest concentration of AgNO3 to inhibit 50% of the three strains:  
2.6 x 10 
-3
 mg mL -1 
Therefore, the highest concentration of AgNO3 which can completely kill/inhibit the 
three strains:  
5.26 x 10 
-3
 mg mL -1  
The minimum concentration of AgNO3 to be encapsulated within vesicles:  
5.26 x 10 
-3
 / 2.64 x 10
-2
 = 0.199 mg mL -1 
Therefore, the calculated concentration of AgNO3 is 0.199 mg mL 
-1
. A preliminary 
concentration of 2 mg mL -1 AgNO3 was encapsulated within vesicles to ensure a high 
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encapsulated concentration thus can totally inhibit the two strains of pathogenic bacteria. 
Calculations were assumed 100% was encapsulated and all vesicles had a uniform size, 
which in reality may not be the case.  
 
Another issue that needs to be considered is that AgNO3 is photosensitive and the 
possibility of exposure cannot be eliminated although all precautions to keep samples 
away from light were taken. Exposure of AgNO3 solution to light could cause any 
AgNO3 to precipitate out. Therefore, a relatively low concentration of AgNO3 
encapsulated within vesicles indicates that AgNO3 would be more soluble in solution 
and less photosensitive.  
 
7.1.3  Antimicrobial Activity of Vesicles Containing AgNO3 in Suspension 
Measurements of vesicle (AgNO3 encapsulated inside) lysis and subsequent 
self-destruction by toxins secreted from pathogenic bacteria were based on assessing 
viable numbers of bacteria by using BMG Labtech fluorimeter in absorbance mode at 
600 nm. Vesicles with varying molar concentrations of TCDA (25%, 30%, 40%) were 
incubated overnight in the presence of P. aeruginosa PAO1, S. aureus MSSA 476, E. 
coli DH5α alongside negative and positive controls. Pure LB medium was used to 
determine contamination and pure bacterial solution was used to detect bacterial 
standard growth curve. Figure 7.2 shows the resulting bacterial growth in terms of 
colony forming units (CFU mL
-1
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Figure 7.2:  Time course of viable numbers of pathogenic and non-pathogenic bacteria incubated with 
phospholipid/PDA vesicles containing AgNO3.  
A: Three strains of bacteria incubated with 25mol%TCDA vesicles. Black squares show normal growth 
curve of three strains of bacteria. P. aeruginosa PAO1 and S. aureus MSSA 476 were completely 
inhibited/killed by AgNO3 released from vesicles. B: Three strains of bacteria incubated with 
30mol%TCDA vesicles. Black squares show normal growth curve of three strains of bacteria. P. 
aeruginosa PAO1 was completely killed/inhibited by AgNO3 released from vesicles; S. aureus MSSA 476 
was partially inhibited by AgNO3 and showed growth eventually after overnight; C: Three strains of 
bacteria incubated with 40mol%TCDA vesicles. Black squares show normal growth curve of three strains 
of bacteria. Both P. aeruginosa PAO1 and S. aureus MSSA 476 show a retard of growth overnight. The 
difference in rate of growth in P. aeruginosa PAO1 and S. aureus MSSA 476 suggests the difference of 
susceptibility to AgNO3 and the differences in the mode of action of these two bacterial strains. High error 
bars in graph c (P.aeruginosa with vesicles) was possibly due to the contamination of the bacteria. Error 
bars represent standard deviations based on three measurements per experiement.  
 
As can be seen from the figure, black curves are all standard growth curves of three 
strains of bacteria. Vesicle samples all showed a standard growth curve when incubated 
with E. coli DH5α, indicating that vesicles were not ruptured by E. coli DH5α as it does 
not secrete any toxic/lytic agents. In P. aeruginosa PAO1, inhibition of growth was 
observed compared to the standard growth curve (black), meaning that vesicles were 
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lysed by toxins produced by P. aeruginosa PAO1 and thus antimicrobials released from 
vesicles killed/inhibited P. aeruginosa PAO1. Interestingly, P. aeruginosa PAO1 was 
completely killed/inhibited by AgNO3 released from the vesicles in the beginning in 
25 %, 30% TCDA vesicles, whereas P. aeruginosa PAO1 was inhibited in the beginning 
and then started to grow from hour-9 in 40% TCDA vesicles, meaning that the 
concentration of AgNO3 released from vesicles was not sufficient to kill/inhibit P. 
aeruginosa PAO1 in 40% TCDA vesicles. This is due to the fact that the system is more 
stable with higher concentration of TCDA incorporated within lipid bilayer, making it 
difficult to be lysed by toxins/enzymes. Similarly, S. aureus MSSA also shows a large 
inhibition of growth compared to the standard growth curve (black). S. aureus MSSA 
shows a small growth after overnight in 30% TCDA vesicles compared to the complete 
inhibition/killing in P. aeruginosa PAO1, which negatively correlates the results of 
MIC50. This is possibly because P. aeruginosa PAO1 is either more virulent or secretes 
more toxins during its exponential growth phase than S. aureus MSSA 476. Therefore, 
more AgNO3 will be released from vesicles during lysis of vesicles by toxins/enzymes 
secreted by P.aeruginosa. In 40% TCDA vesicles, both P.aeruginosa PAO1 and S. 
aureus MSSA476 were inhibited in the beginning and started to grow. The rate at which 
S. aureus MSSA476 started to grow was faster than P. aeruginosa PAO1, which also 
negatively correlates with the result of MIC50. The results further confirm that TCDA 
does stabilise vesicles, making it difficult to be lysed by pathogenic bacteria with a 
higher concentration of TCDA.  
  
7.1.4  Antimicrobial Activity on Vesicle Modified Fabrics ---JIS  
Having successfully confirmed the antimicrobial property of vesicles (AgNO3 inside) in 
suspension, this part of the study investigated the antimicrobial performance of vesicles 
on pp-MA modified plasma non-woven polypropylene against the two pathogenic 
bacterial strains P.aeruginosa PAO1 and S. aureus MSSA 576 and a non-pathogenic 
control E. coli DH5α. A concentration of 2 mg mL-1 AgNO3 encapsulated within 30 
mol% TCDA vesicles was first used to ensure a high encapsulated concentration. Agar 
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plates containing physiological saline samples of each fabric were cultured in incubator 
overnight and then each separate colony should be counted. It is important to dilute each 
sample appropriately as highly concentrated sample can cause a large number of 
colonies to grow, resulting in difficulty in counting accurately and increasing the risk of 
colonies merging and no longer being isolated. The number of viable bacterial colonies 
is calculated in terms of colony forming unit.  
 
The antimicrobial performance of the AgNO3 containing vesicles attached to fabrics was 
tested using the JIS methodology which has been described in the experimental section. 
The results in figure 7.3 show that test samples had a significant reduction in the number 
of viable bacteria after 4 hours, as the two pathogenic strains were able to lyse vesicles 
by producing toxins, resulting in the release of antimicrobial AgNO3 to kill/inhibit 
bacteria. In E. coli DH5α, the test fabric samples show a similar number of viable cells 
compared to control fabric samples (with no vesicles). It is suggested that the growth of 
E. coli DH5α was not affected by AgNO3 vesicles on modified fabric. The results are 
positively correlated with the results performed in suspension and are in agreement with 
the proposed hypothesis: pathogenic bacteria lyse the vesicles and ensure their 






































Figure 7.3: JIS result of TCDA vesicle (containing AgNO3) bound to pp-MA nonwoven polypropylene 
against three strains of bacteria.  
Graphs show persistence and growth of two pathogenic bacteria: S. aureus MSSA 476 and P. aeruginosa 
PAO1 and one non-pathogenic strain E.coli DH5α on fabric modified with vesicles containing AgNO3 in 
comparison to non-modified, UV sterilised nonwoven PP (control), over a 4 h period. The pathogenic 
bacteria secrete membrane damaging toxins which lyse the vesicles, releasing AgNO3 at a concentration 








 of  
S. aureus MSSA 476 being measured after 4 h. Error bars represent standand deviations based on six 
measurements of each sample. 
 
7.2  Gentamicin Sulfate  
Gentamicin is a common aminoglycoside antimicrobial which inhibits bacterial protein 
synthesis. It is bactericidal instead of bacteriostatic. Gentamincin sulphate is a very 
expensive compound purchased from Sigma-Aldrich. It was used sparingly and in low 
concentrations due to toxicity and bacterial resistance issues.  
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7.2.1  Determination of Bacterial Susceptibility (MIC50)  
The range finding test and MIC50 results has been discussed in 4.3.3 and will not be 
detailed here. Table 7.3 lists the MIC 50 of the three strains of bacteria.  
 
Table 7.3: Summary of MIC50 of gentamicin sulphate versus three bacterial strains 












Gentamicin Sulfate      8.9 x 10
-4
       4.5 x 10
-3
     4.8 x 10
-4
 
7.2.2  Minimum Encapsulation Concentration 
The minimum encapsulation concentration is 0.034 mg mL-1 and a preliminary 
concentration of 5 mg mL-1 was encapsulated within vesicles to ensure a high 
encapsulation in order to completely inhibit the two strains of pathogenic bacteria. The 
details of calculation are referred to section 4.3.3.2.  




 gentamicin sulphate was encapsulated within vesicles.  
Antimicrobial performance of vesicles containing gentamicin sulphate in the presence of 
three strains of bacteria (E. coli DH5α as control, P. aeruginosa PAO1 and S. aureus 
MSSA 476 as pathogenic strains) was measured in BMG Labtech fluorimeter in 
absorbance mode at 600 nm. Pure broth was set up to detect contamination and pure 
bacterial solution to detect the standard growth curve. Figure 7.4 shows the result of 
bacteria incubated with vesicles with 25%, 30%, 40% TCDA (containing gentamicin 
sulphate ) overnight.  
 
The results show that E. coli DH5α had no effect on the lysis of vesicles and thus was 
not killed/inhibited by the antimicrobial released by vesicles. All vesicle samples 
showed a standard growth curve when incubated with E. coli DH5α. In P. aeruginosa 
PAO1 and S. aureus MSSA 476, the growth was completely inhibited by gentamicin 
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sulphate in 25%, 30%, 40% TCDA vesicles, indicating that gentamicin was released 
through the lysis of vesicles. In addition, the shape of inhibition curve in gentamincin 
sulphate was different from AgNO3, (AgNO3 showed a retard in growth with higher 
concentration of TCDA). This is probably because too high a concentration of 
gentamicin sulphate was encapsulated within the vesicles, resulting in complete 
killing/inhibition of bacteria even if small amount of the antimicrobial was released to 
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Figure 7.4:  Time course of viable numbers of pathogenic and non-pathogenic bacteria incubated with 
phospholipid/PDA vesicles containing gentamicin sulphate.  
A: Three strains of bacteria incubated with 25mol%TCDA vesicles. Black squares show normal growth 
curve of three strains of bacteria. P. aeruginosa PAO1 and S. aureus MSSA 476 were completely 
inhibited/killed by gentamicin sulphate released from vesicles. B: Three strains of bacteria incubated with 
30mol%TCDA vesicles. Black squares show normal growth curve of three strains of bacteria. P. 
aeruginosa PAO1 and S. aureus MSSA 476 were completely killed/inhibited by gentamicin sulphate 
released from vesicles; C: Three strains of bacteria incubated with 40mol%TCDA vesicles. Black squares 
show normal growth curve of three strains of bacteria. Both P. aeruginosa PAO1 and S. aureus MSSA 476 
were completely killed/inhibited by gentamicin sulphate after overnight. Error bars represent standard 
deviations based on three measurements of each sample.  
 
7.2.4  Antimicrobial Activity on Vesicle Modified Fabrics ---JIS  
JIS was used to detect the antimicrobial property of vesicle modified non-woven 
polypropylene. A primary gentamicin sulphate concentration of 5 mg mL -1 was 
encapsulated inside 25, 30, 40 mol% TCDA vesicles for detecting antimicrobial 
activities in suspension. The concentration of gentamicin sulphate was later reduced to a 
value of 1 mg mL 
-1 
closer to MIC for JIS test in order to give a significant bacterial 
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response that proves fabric with antimicrobial encapsulated vesicles is capable of 





















Figure 7.5: MIC results of TCDA vesicle (containing gentamicin sulphate) bound to pp-MA nonwoven 
polypropylene against three strains of bacteria.  
Graphs show persistence and growth of two pathogenic (S. aureus MSSA 476 and P. aeruginosa PAO1) 
and one non-pathogenic strain E. coli DH5α on fabric modified with vesicles containing gentamicin 
sulphate in comparison to non-modified, UV sterilised nonwoven PP (control), over a 4 h period. The 
pathogenic bacteria secrete membrane damaging toxins which lyse the vesicles, releasing gentamicin 




 of P. aeruginosa PAO1 
and 25 CFU mL
 -1
 of  S. aureus MSSA 476 being measured after 4 h. Standard deviations represents 
standard deviations based on six measurements for each experiment.  
  
Results in figure 7.5 show that the vesicle (30 mol% TCDA) modified nonwoven fabric 
inhibited the growth of both P. aeruginosa PAO1 and S. aureus MSSA 476, while the 
non-pathogenic E .coli DH5α (which did not secrete membrane damaging toxins) 
colonised the vesicle-modified fabric to almost the same extent as the non-modified 
control fabric.  Growth of P. aeruginosa PAO1 was highly prevented as toxins 
produced lysed vesicles on the fabric, releasing gentamicin sulphate. P. aeruginosa 



























































































PAO1 was almost clearly inhibited/killed by gentamicin sulphate, with 25 CFU mL
-1 
of 
P. aeruginosa PAO1 being measured after 4 hour. S. aureus MSSA 476 test fabric 
samples also shows a high inhibition in the number of live bacteria present compared to 
control fabric samples (no vesicles). Bacterial growth was prevented, however to not as 
great an extent as P. aeruginosa PAO1. Furthermore, it can be concluded that the rate at 
which P. aeruginosa PAO1 was inhibited was greater than S. aureus MSSA 476 at low 
concentration of gentamicin sulphate from MIC 50, indicating that the difference in rate 
appears to superficially correlate with the JIS results of the two bacteria. However, other 
factors should be also taken into consideration such as expression levels of virulence 
factors from the two bacterial species, which are not clearly known.  
 
Overall, vesicles encapsulated low concentration of gentamicin sulphate can retain good 
efficacy when bound to non-woven fabrics. However, antimicrobial tests with high 
concentration of gentamicin sulphate (15 mg mL -1) encapsulated vesicles have been also 
measured both in suspension and on modified fabrics. All three strains were killed by 
gentamicin sulphate released from the vesicles. This is due to the fact that high 
encapsulated concentration of gentamicin sulphate and passive leakage from vesicles all 
cause complete killing/inhibition of bacterial growth.  
7.3  Chlorhexidine  
Chlorhexidine was used as an antimicrobial to be encapsulated within vesicles because it 
has a broad spectrum of activity and has high efficacy in both gram-positive and 
gram-negative bacteria.  
 
7.3.1  Determination of Bacterial Susceptibility (MIC50) 
A range finding test was firstly carried out to determine between which concentrations 
of chlorhexidine three strains of bacterial growth was inhibited. Chlorhexidine had a 
very low aqueous solubility and thus higher concentrations were not analysed. Table 7.4 
shows the concentrations of chlorhexidine and between which concentrations bacterial 
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growth was inhibited.  
 
Table 7.4: Range finding results for chlorhexidine agains three strains of bacteria (where ‗+‘ is positive 
growth and ‗-‘ indicated no growth) 
[Chlorhexidine]mg mL -1 E.coli DH5α P.aeruginosa PAO1 S. aureus MSSA 476 
0 + + + 
0.00001 + + + 
0.0001 + + + 
0.001 - - - 
0.01 - - - 
 
The experiments of narrow range of concentrations of chlorhexidine against three 
bacterial strains were further performed on a BMG Labtech fluorimeter in absorbance 
mode at 600 nm. The concentrations of chlorhexidine to inhibit the three strains of 
bacteria are shown as follows:   
-  E. coli DH5α  : 0.0001-0.001 mg mL -1 chlorhexidine 
-  P. aeruginosa PAO1 : 0.0001-0.001 mg mL -1 chlorhexidine 
-  S .aureus  MSSA 476 : 0.0001-0.001 mg mL -1 chlorhexidine 
Based on the range of concentrations analysed above, optical density for varying 
concentrations were measured after overnight and plotted against log([chlorhexidine]), 
as presented in figure 7.6. The shapes of bacterial optical density-antimicrobials graphs 
give a clue that at which concentration of bacteria starts to respond to chlorhexidine and 

































Figure 7.6:MIC50 of chlorhexidine versus the three strains of bacteria. Error bars represent standard 
deviations based on three measurements of each experiment.  
 
The minimum inhibitory concentrations of chlorhexidine versus three bacterial strains 
were tested in solution and are summarised in table 7.5.  
 
Table 7.5: Lists of MIC50 of three strains of bacteria 












Chlorhexidine      2.5 x 10
-3
       4.83 x 10
-4




It can be observed from the table that S.aureus are the most sensitive to chlorhexidine, 
which means that more S.aureus would be killed compared to P.aeruginosa PAO1 and E. 
coli DH5α using the same concentration of chlorhexidine, while P.aeruginosa showed 
the lest susceptible to chlorhexidine. Figure 7.6 shows that P. aeruginosa PAO1 started 
to respond (declines in concentration) to chlorhexidine at the concentrations of 0.6 µg 
mL
-1 
and was almost completely inhibited at concentration of 5µg mL
-1
; S .aureus 
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MSSA 476 became sensitive to chlorhexidine at 0.25µg mL
-1 
and need 0.9 µg mL
-1 
for 
complete inhibition; E. coli DH5α started to respond to chlorhexidin at concentration of 
0.2 µg mL
-1 
and was completely inhibited at 1.12 µg mL
-1
.   
 
7.3.2  Minimum Encapsulation Concentration  
The minimum concentration of chlorhexidine to be encapsulated within vesicles is 
calculated as follows:  




The highest concentration of chlorhexidine to inhibit 50% of the three strains:  





Therefore, the highest concentration of chlorhexidine which can completely kill/inhibit 
the three strains:  





The minimum concentration of chlorhexidine to be encapsulated within vesicles:  
5x 10 
-3
 / 2.64 x 10
-2
 = 0.190 mg mL 
-1
  
Therefore, the calculated concentration of chlorhexidine is 0.190 mg mL
-1
. A 
preliminary concentration of 2 mg mL
-1
 chlorhexidine was initially encapsulated within 
vesicles to ensure a high encapsulated concentration. MIC50 calculations give a 
chlorhexidine concentration when all vesicles obey ideal mechanisms; all are 100 nm in 
diameter, all are spherical, all are unilamellar and all encapsulate the same concentration 
of chlorhexidine. However, it is difficult to determine the exact dimensions of vesicles 
and so that the exact encapsulated concentration may not be the same as calculated.  
 




 chlorhexidine was encapsulated within vesicles to ensure high encapsulation 
concentration. Initially, antimicrobial activity of 30 mol% TCDA vesicles containing 
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chlorhexidine in the presence of three strains of bacteria (E. coli DH5α, P. aeruginosa 
PAO1, S. aureus MSSA 476) was measured in BMG Labtech fluorimeter in absorbance 
mode at 600nm. As usual, pure broth and pure bacterial solution were set up to detect 
contamination and bacterial standard growth curve. Figure 7.7 shows the result of 
bacteria incubated with vesicles with 30% TCDA overnight. E. coli DH5α was used as 
control system to provide important information on whether the fundamental hypothesis 
is correct: pathogenic bacteria lyse the vesicles and ensure their self-destruction, while 
non-pathogenic bacteria are largely unaffected.  














 E.coli (DH5)+ 30 mol% TCDA vesicles 














 P.aeruginosa (PAO1) + 30 mol% TCDA vesicles 
 














 S. aureus (MSSA 476)
 S. aureus (MSSA 476 )+ 30 mol% TCDA vesicles 
 
Figure 7.7: Overnight growth of pathogenic and non-pathogenic bacteria incubated with 
phospholipid/PDA vesicles containing chlorhexidine.  
All three strains were all killed by chlohexidine released from the vesicles. Error bars represent standard 
deviations based on three measurements of each sample.  
 
In figure 7.7, pure bacterial solution all showes a standard growth curve. Bacterial 
suspensions should have shown no effect on E. coli DH5α and a significant reduction in 
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the number of viable bacteria both in P. aeruginosa PAO1 and S. aureus MSSA 476. 
However, a large inhibition of growth was observed in all 3 strains, indicating that there 
must be free antimicrobials in solution. Efforts such as double filtration using NAP-25 
columns and reducing encapsulation concentration of chlorhexidine (0.5 mg mL
-1
) were 
attempted to obtain pure vesicles with chlorhexidine encapsulated inside. Subsequent 
antibacterial measurements in suspension were carried out to detect the efficacy of 
vesicles. However, the results showed vesicles still inhibited/killed all three strains. This 
indicates that most chlorhexidine was not encapsulated within the vesicles. It is thought 
to be relevant to poor solubility of chlorhexidine in aqueous solution and possible 
interaction between chlorhexidine and lipid bilayer of vesicles which makes 
chlorhexidine difficult to be encapsulated within vesicles. The mechanism of such 
interaction is not known. Therefore, chlorhexidine is not appropriate to be used in the 
further investigation on modified fabrics.  
7.4  Conclusion  
 
This chapter demonstrates that a simple vesicle bound to pp-MA non-woven fabrics can 
be used for controlling bacterial growth and infection. Three types of topical 
antimicrobials were separately encapsulated within vesicles and antimicrobial efficacy 
was evaluated.  
 
Although TSB medium was later proved to be an optimal medium to grow S. aureus 
MSSA 476 as S. aureus MSSA 476 seems to produce more toxins in TSB medium. LB 
broth was used for growing three strains of bacteria in both MIC and antimicrobial 
assays in this work because TSB became available in the late period of this project and 
was only used for growing S. aureus MSSA 476 in section 5.5. It is possible that MIC 
result of S. aureus MSSA 476 grown in LB medium would be quite different from grown 
in TSB medium.  
 





Unfortunately, all three bacterial strains were all inhibited when incubated with vesicles 
containing chlorhexidine. The solution assay indicated that such antimicrobial was not 
suitable in the use of vesicle system and subsequent fabric test. Furthermore, 
chlorhexidine has poor aqueous solubility (0.08g/100 mL) which makes it a limited 
antimicrobial to be encapsulated within vesicles with relatively high concentration.  
 
Silver nitrate was used as an alternative to be encapsulated within vesicles and 
antimicrobial measurement in solution showed all good responses in all three bacterial 
strains. The following fabric test (JIS) also showed good response in all three strains. 
Silver nitrate was selected as a suitable candidate to be encapsulated inside vesicles. 
However, silver nitrate has some issues regarding its inherent photosensitivity and 
solubility in aqueous solution. The compound stains a black colour and precipitates 
easily when it is exposed to light. Furthermore, it is reported that the use of silver can 
cause inherent cytotoxicity. Solutions of >1 % AgNO3 are known to be cytotoxic which 
limits the development of more concentrated vesicles against bacteria. Therefore, low 
concentration of silver nitrate is suitable to be used for the antimicrobial development of 
vesicle system; while higher concentration of AgNO3 will not be recommended to be 
used in the development of antimicrobial system in the long run.  
 
Gentamicin sulphate, however, has good aqueous solubility compared to the other two 
compounds assessed and does not exist cytotoxicity issue. Antimicrobial measurements 
both in suspension and on fabrics showed all three strains had a good response to 
gentamicin sulphate released from vesicles. Gentamicin sulphate in addition has no 
cytotoxicity. Therefore, it can be used as an ideal compound to be encapsulated within 
vesicles for further use.  
 
The main difficulty for the three compounds used in the work was the purification when 
they are encapsulated within vesicles. All three compounds in aqueous solution are 
colourless, meaning that purification is not accurate. This could be resolved by using 
double filtration by NAP-25 columns and removal of first 1 mL of eluate to ensure more 
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pure vesicle solution. It could also be resolved with the encapsulation of both dye such 
as carboxyfluorescein and antimicrobial within vesicles. This would maintain their 































Chapter 8    Conclusions  
 
This thesis has investigated an initial ‗smart‘ wound dressing which releases 
antimicrobials and changes colour only in the presence of pathogenic bacteria. It has 
been shown that its contributions are of both theoretical and practical interest and serve 
as a good starting point for additional research. In this concluding chapter, all the key 
findings from different chapters are summarised and several future research directions 
are suggested.  
 
8.1  Summary of Results  
In chapter 4, preliminary work for designing a simple nanocapsule system for selectively 
recognising and killing/inhibiting pathogenic bacteria has been developed. The work has 
demonstrated that a simple vesicle system can be used for controlling bacterial growth 
and infection when antimicrobials are encapsulated within vesicles. Giant unilamellar 
vesicles with diameter of 1 μm were firstly applied to such system due to its high 
encapsulation volume and easy manipulation by using rotary evaporation methodology. 
Antimicrobials including sodium azide and gentamicin sulphate were encapsulated 
within GUVs to selectively inhibit/kill pathogenic bacteria. This is based on the concept 
that pathogenic bacteria can be used to be the agents of their own destruction by 
releasing toxins that rupture vesicles containing an antimicrobial agent. Antimicrobial 
measurements in suspension confirmed such a hypothesis: pathogenic bacteria can 
secrete membrane damaging toxins to lyse membranes of vesicles, while non-pathogenic 
bacteria do not secrete lytic toxins. Subsequent surface design was used in this work to 
attach GUVs via covalent bonding. Surface characterisation using FT-IR confirms that 
GUVs have been attached surface successfully. Subsequent JIS results prove that GUV 
bound pp-MA modified non-woven fabrics is capable of killing/inhibiting pathogenic 
bacteria. Such a system provides an idea to construct a wound dressing which can 
prevent bacterial infection as well as provide a simple colorimetric or fluorometric 
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response to give patients or clinicians early warning of wound infection. Later, a 
fluorescence response system has been developed and detailed in chapter 5 by utilising 
self-quenched carboxyfluorescein. The idea is based on the concept that at high 
concentration, carboxyfluorescein is non-fluorescent. Following breakdown of the lipid 
vesicle containers by bacterial toxins, the dye becomes diluted and ―switches on‖.  
 
However, there is some degree of passive leaching of encapsulated contents from the 
GUVs. This is apparent in antimicrobial detection using conventional agar plating. It is 
likely that some passive leakage of sodium azide limited the growth of E. coli DH5α to 
an extent. This leakage is most likely due to both tonic imbalance between the interior 
and exterior of vesicles and the thermal instability of the bilayer lipid vesicles. 
Furthermore, GUVs are not as stable as expected especially when it is exposed to 
partially dry conditions. Again, the physical properties of vesicles must be optimised to 
ensure stability over a long period of time. Hence, there was a motivation to introduce a 
novel vesicle system based on incorporation of diacetylene fatty acids as constituents in 
the lipid bilayer of a vesicle to yield robustness compared to phospholipid vesicles. The 
PAD/phospholipid vesicles can be irradiated with UV light and polymerised to form 
polymer cage. This rigid polymer part could provide the stability required to increase 
shelf life and thermal stability. Such polydiacetylene vesicle system fulfils both 
prerequisites and yields a satisfactory efficiency by varying the molar concentration of 
PDA part. TCDA as a diacetylene fatty acid was used to incorporate into lipid bilayer 
part. TCDA ensures a certain amount of stability; however the higher concentration of 
TCDA would enable the vesicle system less sensitive to external environment. Overall, 
the TCDA concentration for optimum stability was chosen as 30% which provides the 
relatively stability without compromising sensitivity to toxins produced by pathogenic 
bacteria.  
 
Chapter 5 also explores physical properties of PDA/phospholipids. Such a vesicle 
system will undergo a colour transition after UV irradiation and may interfere with the 
result of the colorimetric response if a fluorophore is encapsulated within vesicles. 
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Stability and sensitivity measurements of vesicles provide that the ideal system is 
between 20 mol% - 30 mol% TCDA vesicles. In this range, the polydiacetylene part 
would not exhibit an intense colour. Hence, such colour transition will not significantly 
affect the colorimetric response if a fluorescent dye is encapsulated within vesicles.  
 
Aside from exploration of optimal vesicle systems, bacterial detection with 
carboxyfluorescein shows very promising result in solution which provides proof of 
concept to fundamental theory here. Although the stability of phospholipid/PDA has 
been enhanced by incorporation of diacetylene fatty acids into the lipid bilayer, such a 
vesicle system still has leaching problems as can be seen from figure 5.11 with a 
relatively low concentration of TCDA and is not able to survive in completely dry 
conditions. Therefore, the attempts to immobilise the vesicles in hydrogels to maintain 
vesicles intact and stable as well as promote wound healing are detailed in chapter 7. 
Chapter 7 describes various methods used in this thesis to immobilise PDA/phospholipid 
vesicles. Pulse plasma deposited non-woven polypropylene with grafted collagen 
(gelatine) shows that such modified fabric can retain vesicles for at least one month at 
room temperature and maintain vesicles intact at 37 
o
C for 2 days. Subsequent bacterial 
test on the simple prototype suggests such system is capable of differentiating between 
pathogenic and non-pathogenic bacteria by releasing a fluorescent dye. The visual 
colour response can be observed under low power UV light. Other modified fabrics to 
stabilise vesicles and hydrogels to maintain the stability of vesicles are now being 
investigated in the group currently.  
 
Apart from a simple colorimetric or fluorimetric response built into the system, the aim 
of this work is to attempt to engineer a ‗smart‘ wound dressing system that only releases 
an encapsulated antimicrobial agent in the presence of pathogenic bacteria. The last 
chapter outlines three topical antimicrobials which can be encapsulated in the vesicles 
and subsequent antimicrobial measurements against three strains of bacteria were 
investigated. pp-MA treated non-woven polypropylene was chosen to attach vesicles and 
was used in the study of JIS. The antimicrobial measurements both in suspension and on 
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modified fabrics show silver nitrate and gentamicin sulphate had good performance on 
the antibacterial activity. Chlorhexidine would not be recommended in the use of the 
antimicrobial study due to its low solubility. Silver nitrate is not appropriate to be used 
with higher concentration as it also has low solubility in aqueous solution and will 
precipitate when exposed to light, without responding to harmless bacteria.  
 
Rotary evaporation was the main methodology used in the synthesis of GUVs due to its 
relatively easy manipulation. However, the sizes of GUVs are not regular enough to 
obtain an accurate internal volume. Extrusion method was then applied to the synthesis 
of phospholipid/PDA vesicles by using Liposofast vesicle extruder. It is likely to be a 
better method for production with large capacity ready for scale up. The polycarbonate 
filters are stacked to give a very thorough processing of the bulk solution compared to 
rotary evaporation and to give a uniform size.  
 
The purification of vesicles was used for all systems in both antimicrobials and 
fluorophore encapsulating vesicles. Empirically, it can be concluded that the purification 
of antimicrobials including sodium azide, gentamicin sulphate and silver nitrate was 
successful as they were able to selectively inhibit/kill the growth of pathogenic bacteria, 
while not responding to non-pathogenic bacteria. Double filtration is necessary for 
purifying vesicles with encapsulated antimicrobials to ensure pure vesicle solution. The 
fluorophore containing vesicles were proved to elute separately from the free 
fluorophore as shown in figure 4.5. NAP-25 columns are of larger volume than the 
NAP-10 columns and this allows better separation and resolution of the eluting times.  
Initial work of purification for GUVs relied on the use of NAP-10 columns as NAP-25 
columns did not become available until starting the work of phospholipid/PDA vesicles. 
NAP-25 sephadex columns are proved to be more efficient to purify the vesicles from 




8.2  Future Research Areas  
There are several areas of this thesis that can be expanded at a future stage and some of 
these are outlined below:  
8.2.1  Stability  
In the short term, the physical properties of vesicles must be optimised to ensure 
stability over a long period of time. However, the incorporation of diacetylene moiety 
into lipid bilayer improves the stability of vesicles and enables such vesicle system to 
survive under partially dry condition. However, there is still some degree of passive 
leakage of encapsulated contents from the vesicles, as presented in figure 5.10 (a), (b). 
This is because the major constituent for constructing vesicles is phospholipid, which 
inevitably has some degree of leakage. On the other hand, the difference in length of 
hydrocarbon chains between TCDA fatty acids and DMPC can lead to the disruption of 
packing density of lipid bilayers, resulting in leakage of vesicle system. TCDA has 17 
carbons after photopolymerisation, which is longer than alkyl groups in both DMPC and 
DMPE (14 carbons). The differentiation in the length of alkyl chains results in 
disrupting packing density of bilayer arrangement of PDA-phospholipid. This is shown 
in figure 8.1.  
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Figure 8.1: Bilayer arrangements before/after UV irradiation in phospholipid/TCDA vesicles.  
Graphs show different length of alkyl groups in TCDA and phospholipid resulting in disrupting packing 
density of bilayer and subsequent resulting in possible leakage and instability of vesicles. (A): chemical 
structure of phospholipid and TCDA and their differences in the length of hydrophobic chains before and 
after photo-polymerisation; (B): different length of alkyl chains results in disruption of packing density of 
bilayer arrangement  
 
Therefore, DMPC and DMPE replaced by other phospholipids with longer acyl chains 
are being studied in the group including DPPC (16:0) and DSPC (18:0). The current 
study of DPPC/DMPE/PDA suggests such system is quite stable if encapsulating 
carboxyfluorescein in solution for almost one month. Further study with pathogenic 
bacterial strains will be investigated. However, the closely packed bilayer between PDA 
and phospholipid would decrease the sensitivity and flexibility of the whole system as 
transition temperature would increase with longer alkyl chains of phospholipid. 
Cholesterol is also necessary to be used to insert the lipid bilayer to maintain the system 
both flexible and stable at room temperature. Hence, phospholipids including both PC 
and PE should be carefully selected to maintain vesicles both stability and sensitivity. 
Such study is also being investigated in the group.  
 
8.2.2  Encapsulating Agents  
Carboxyfluorescein is used as a main agent to be encapsulated within vesicles to give a 
fluorimetric colour response for early detection of pathogenic bacterial infection. It is 
known that carboxyfluorescein is pH dependent which means the carboxyfluorescein 




in this thesis related to carboxyfluorescein was carried out in neutral environment. 
However, in reality the pH environment of chronic wounds has been recorded within the 
range of 7.15-8.9. As the wound progresses towards healing, the pH moves to neutral 
and then becomes acidic. Again, carboxyfluorescein is reported to be leaky if 
encapsulated in the vesicles and hence not suitable to be used as encapsulating agents for 
drug delivery. Therefore, more stable fluorescent dyes both in acidic and alkaline 
environment should be investigated and encapsulated in the vesicles for the further 
research.  
 
Furthermore, more appropriate antimicrobials should be encapsulated and investigated 
in the same manner as sodium azide, gentamicin sulphate, AgNO3 and chlorhexidine. 





laboratory synthesised antimicrobials can be chosen to be encapsulated within vesicles. 
A combination of antimicrobials (e.g. gentamicin and vancomycin combinations) is 
another possibility to be encapsulated in the vesicles. Zinc compounds such as zinc 
oxide and zinc pyrithione, a new area of antimicrobial research, could also be applied to 
the vesicles encapsulation.
4,5
 Furthermore, organisms such as viruses and bacteriophages 
instead of antimicrobials are alternatives to be encapsulated in the vesicles which can 




8.2.3  Bacteria Related to Wound Infection 
Apart from S. aureus and P. aeruginosa, a large variety of organisms can be found in 
burn wound infections, such as Enterococci, Acinetobacter, Klebsiella and more virulent 
strains of E.coil, S. epidermidis and S. pyogenes are additional bacterial species 
commonly found in normal skin flora and are able to cause burn wound infection. 
Vesicle system should also be evaluated with a broader spectrum of bacterial strains and 
species. In addition, the rise of multi-drug resistant organism (MDROs) has resulted in 
inefficacy of used antimicrobials. The most commonly known MDRO is 
methicillin-resistant Staphylococcus aureus (MRSA), which is responsible for several 
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difficult-to-treat infections in humans. Therefore, vesicle system could be designed to 
deliver effective antimicrobials as well as reduce the rate of acquisition of bacterial 
resistance.  
 
8.2.4  Prototype Construction 
The ultimate of this project is to attempt to construct a ‗smart‘ wound dressing system 
which can only release an encapsulated antimicrobial agent in the presence of 
pathogenic bacteria, without responding to commensal/harmless bacteria. Additionally, a 
simple colorimetric or fluorometric response could also be built into the device to give 
patients or clinicians early warning of wound infection. This proposed wound dressing is 
shown in figure 8.3. Various prototypes such as modified fabrics/hydrogels for 
maintaining both moist environment and vesicle integrity are now being developed in 
























                      
223 
 









Figure 8.2: A proposed ‗smart‘ wound dressing.  
The graphs illustrate that it can respond to the presence of pathogenic bacteria: gives a 
fluorimetric/colorimetric response; releases an antimicrobial agent to inhibit/kill growth of pathogenic 
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Appendix A  Detailed Operations of Plasma 
Reactor 
 
 Reactor cleaned manually: the reactor chamber and both flanges (reactor 1) were 
washed using acetone, water and ethanol, allowed to dry 
 Reactor cleaned using oxygen plasma 
 Monomer loaded to Young‘s flask. Freeze thawed several times (3+) by cooling 
flask with liquid nitrogen followed by gentle heating 
 Substrate loaded to the main chamber at one end: Vacuum was removed, one 
electrode was detached using wing-nuts (reactor 1) or retaining strap (reactor 2), 
the substrate loaded, lines reattached and vacuum applied. System was allowed 
to reach base pressure (ca. 2 x 10
-2
 mbar) 
 Monomer chamber was opened to vacuum, pressure was allowed to stabilise 
 Monomer flow rate was measured by closing the vacuum tap for 30s, pressure 
readings were taken at start (Ps) and end (Pf ) of this time period     
 The RF generator was switched on, mode set to ‗CW‘, plasma ignited (RF on) 
and desired input power set.   
 Input impedance was manually matched using ‗Tune‘ and ‗Load‘ to minimise the 
reflected power. The reflected power was reduced to <0.5% of the input power at 
all times during deposition 
 Deposition pressure was recorded along with the input and reflected power 
 Deposition was stopped after desired time, then the monomer chamber was 
closed 
 The substrate was removed after allowing the reactor to cool, then generally used 
immediately for analysis or biological assay 
NB: The initial step of degassing or removal of impurities was applied only to 
non-melting monomers as those compounds which melt when heated or are liquid at 
room temperature instantly degas under vacuum. 
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